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ABSTRACT 
Porcine reproductive and respiratory syndrome (PRRS) is a swine disease causing severe 
economic losses in the pork industry worldwide. In the present study, the modulation of host cell 
responses by PRRS virus (PRRSV) has been investigated. Non-structural protein 11 (Nsp11) 
contains a nidovirus-specific domain designated as NendoU, and this domain is known to have a 
endoribonuclease activity. This RNase activity is important but not essential for viral replication 
in equine arteritis virus (EAV), suggesting that Nsp11 may target cellular RNAs and thus may 
function to counteract the host’s antiviral response. By luciferase reporter assays, PRRSV Nsp11 
was shown to have potent inhibition of IFN-β, IRF3, and NF-κB activities. The suppression was 
mediated by the reduced phosphorylation of IRF3 and IκB, which might be resulted from the 
degradation of IPS-1 mRNA. Further studies indicated that the IPS-1 mRNA degradation was 
associated with the NendoU activity of Nsp11. The Nsp11 mutants that lost the NendoU activity 
was unable to degrade IPS-1 mRNA and thus unable to suppress IFN production. To study 
whether NendoU domain was essential for PRRSV replication, eight NendoU mutant viruses 
were constructed. The NendoU knockout mutant viruses were unable to replicate, indicating that 
the PRRSV NendoU activity plays an essential role for viral replication and modulation of innate 
immunity during infection. To determine if the IFN suppression was independent function from 
the NendoU activity of Nsp11, Nsp11 genes were cloned and sequenced from 16 different North 
American PRRSV isolates. Eleven of 16 Nsp11 sequences showed nucleotide sequence changes 
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but the NendoU catalytic sites were conserved. Most of the Nsp11 proteins exhibited strong 
inhibition of type I IFN production, but 17401-Nsp11 showed weak suppression when compared 
to FL12-Nsp11 and other Nsp11s. To map the site(s) causing this difference, nine substitutions 
were constructed based on the sequence alignment, and alanine at position 160 (Ala160) in 
17401-Nsp11 was identified as the responsible site. This may function as an additional 
mechanism besides the NendoU activity to impede the type I IFN production. In addition to the 
modulation of host innate immune response, Nsp11 was also found to participate in other cellular 
progresses to facilitate the virus replication. Using the retrovirus gene transfer system, a cell line 
was established to stably express the Nsp11 protein and an RNA microarray was conducted in 
these cells. Based on the microarray data, five major cellular pathways were identified to be 
regulated by Nsp11; histone-related, cell cycle and DNA replication, mitogen activated protein 
kinase (MAPK) signaling, complement, and ubiquitin-proteasome pathways. Among them, the 
cell cycle pathway was further examined. The flow cytometry and BrdU staining of the 
Nsp11-expressing cells showed that Nsp11 protein delayed the cell cycle progression at the S 
phase during infection. Taken together, these studies provide further insights into the molecular 
basis of the manipulation of host cells processes by PRRSV Nsp11. 
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CHAPTER 1: LITERATURE REVIEW 
1. Introduction of porcine reproductive and respiratory syndrome virus 
Porcine reproductive and respiratory syndrome (PRRS) is an important disease of pigs 
causing severe economic losses to the swine industry worldwide. The disease was first observed 
in the USA in 1987 and then in Germany in 1990 (Wensvoort et al., 1992). The clinical signs 
include reproductive failures in sows including late-term abortions, increased number of 
stillborns and mummified fetuses, and respiratory problems in pigs of all ages. The etiology of 
PRRS was first determined in 1990 in the Netherlands and the causative agent was named 
Lelystad virus (LV) (Wensvoort et al., 1992). Shortly after, porcine reproductive and respiratory 
syndrome virus (PRRSV) VR2332 was isolated in the USA and shown to be the sole causative 
agent for PRRS (Collins et al., 1992; Wensvoort et al., 1992). Comparative genomic sequence 
analyses have revealed the genetic differences between the European isolate LV and the North 
American isolate VR2332 and thus PRRS viruses are grouped into two genotypes; European 
(Type I) and North American (Type II) types (Allende et al., 1999; Nelsen, Murtaugh, and 
Faaberg, 1999). A highly virulent PRRSV (H-PRRSV) emerged in China in 2006, and this is 
thought to be a mutant form of PRRSV belonging to the North American type. Clinical studies 
show that the affected animals develop high fever, depression, anorexia, dyspnoea, reddening of 
the skin, edema of the eyelids, mild diarrhea, shivering, lamping, and unusually high morbidity 
(50%-100%) and mortality (20%-100%) in pigs of all ages (Xiao et al., 2010). 
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1.1 Virus structure and genome 
1.1.1 Virion 
PRRSV belongs to the genus Arterivirus which is placed in the family Arteriviridae together 
with equine arteritis virus (EAV), lactate dehydrogenase-elevating virus of mice (LDV), and 
simian hemorrhagic fever virus (SHFV). The Arteriviridae family comprises the order 
Nidovirales along with the Coronaviridae and Roniviridae families (Conzelmann et al., 1993; 
Gorbalenya et al., 2006; Meulenberg et al., 1993; Snijder, 1998). PRRSV virions are spherical 
particles with icosahedral core surrounded by an outer envelope (Benfield et al., 1992; Dea et al., 
1995; Dokland, 2010). The core contains the 15 kb genome packaged in a capsid consisting of a 
highly basic 15 kDa nucleocapsid (N) protein. In the envelope, there are 6 structural proteins 
consisting of non-glycosylated membrane (M) protein, glycosylated membrane proteins GP2, 
GP3, GP4, GP5, and small membrane (E) protein. While GP5 and M proteins are the most 
abundant membrane proteins and form heterodimers, GP2, GP3, GP4 and E proteins account for 
small amounts and form a covalently linked heteromultimeric complex which is required to 
render particles infectious (Fig. 1.1).  
1.1.2 Genome organization 
The PRRSV genome is a single-strand positive-sense RNA of 15 Kb in size and contains 10 
ORFs: ORF1a, ORF1b, ORF2a, ORF2b, ORF3 through ORF7, plus newly described ORF5a 
(Firth et al., 2011; Johnson et al., 2011). ORF1a and ORF1b code for two large polyproteins, 
PP1a and PP1ab, with expression of the latter by ribosomal frameshifting (den Boon et al., 1991; 
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Wootton et al., 2000). PP1a and PP1ab are proteolytically processed into 14 nonstructural 
proteins (Nsp’s) by the papain-like cysteine protease (PCP) in Nsp1, poliovirus 3C-like cysteine 
protease (CP) in Nsp2, and serine protease (SP) activities in Nsp4. Nsp3 through Nsp12 are 
cleaved by the SP activity, while PCP generates Nsp1α and Nsp1ß and CP generates Nsp2 (Fang 
and Snijder, 2010). ORF2a, ORF2b, ORF3 through ORF7, and ORF5a code for seven structural 
proteins: GP2, E, GP3, GP4, GP5, M, N proteins, and the newly identified ORF5a protein (Dea 
et al., 2000a; Firth et al., 2011; Johnson et al., 2011; Meulenberg et al., 1995a) (Fig. 1.2). These 
genes are expressed from 3’ co-terminal nested set of 7 sg mRNAs. These sg mRNAs contain a 
leader sequence which is derived from the 5’ end of the viral genome. Following the leader 
sequence, transcription-regulating sequence (TRSs) are found at 6 different locations within the 
genomic RNA molecule.  
1.2 Viral proteins 
1.2.1 Structural proteins 
1.2.1.1 The major proteins 
GP5 is a 25 kDa protein encoded by ORF5. GP5 includes an N-terminal signal peptide of 30 
amino acid (aa) residues which is assumed to be cleaved after translation, and the ectodomain of 
35 aa residues, an internal hydrophobic tranmembrane (TM) region which is predicted to span 
the membrane three times, and a hydrophilic endodomain composed of 70 aa (Dea et al., 2000b; 
Meulenberg, 2000; Meulenberg et al., 1995a). The GP5 protein is considered as the most variable 
protein in PRRSV (Mardassi et al., 1995; Meng et al., 1995), and this variation of GP5 is likely 
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responsible for the lack of immunological cross-protection between viruses. 
The M protein is a non-glycosylated membrane protein encoded by ORF6. It is an 18 to 19 
kDa type III integral membrane protein. The M protein lacks a potential N-terminal signal 
sequence but has an N-terminal ectodomain and a C-terminal endodomain (de Vries et al., 1992; 
Faaberg et al., 1995; Meulenberg et al., 1995b). The M protein is the most highly conserved 
structural protein of PRRSV (Mardassi et al., 1995; Meulenberg et al., 1993). GP5 and M 
proteins are the major components of PRRSV and comprise at least half of the viral proteins. 
They form disulfide-linked heterodimers, which is essential for virus infectivity (Dea et al., 
2000a; Mardassi et al., 1996; Meulenberg et al., 1995b). 
The N protein is consisted of 123-128 aa and interacts with the viral RNA to form the viral 
nucleocapsid. The N protein is the most abundant and immunogenic viral protein in 
virus-infected cells (Dea et al., 2000a), but anti-N antibodies are non-neutralizing and 
non-protective (Murtaugh et al., 2002). The N protein is divided into the N-terminal 
RNA-binding domain and the C-terminal dimerization domain. The N-terminal domain contains 
a hydrophobic sequence predicted to form a α-helix and a large number of positive charges 
consistent with the role in RNA binding (Wootton and Yoo, 2003; Yoo et al., 2003). The 
C-terminal half of the protein comprises a well-ordered “capsid-forming” domain that forms 
dimers in solution. The crystal structural of this domain showed a dimer comprised of a four 
standard antiparallel β-sheet floor that is capped and flanked by α-helix (Perera et al., 2001). 
Furthermore, N is serine-phosphorylated in both N- and C- terminal domains (Wootton et al., 
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2002). N is targeted to the nucleolus by nuclear and nucleolar localization signal sequences (NLS 
and NoLS), despite the entire replication cycle of the virus occurs in the cytoplasm (Yoo et al., 
2003). Its specific localization and interaction with cellular proteins suggest that N protein may 
play a role in the modulation of host cell functions. 
1.2.1.2 The minor proteins 
The GP2 glycoprotein has 256 a.a. residues and contains a predicted N-terminal signal 
sequence followed by a 168-aa ectodomain, a single TM helix, and a 20-aa endodomain (Wissink 
et al., 2004). The E protein is expressed from ORF2b which is fully embedded within ORF2a 
encoding GP2 (Snijder et al., 1999; Wu et al., 2001). The E protein is a non-glycosylated 
envelope protein of 70-73-aa (Wu et al., 2001; Wu et al., 2005). E consists of a single predicted 
TM helix and is thought to form an oligomeric ion channel required for uncoating of the virus 
(Lee and Yoo, 2006). Therefore, this protein is most likely involved in the viral fusion and 
internalization process.  
GP3 is the 254-aa protein and the most heavily glycosylated envelop protein of PRRSV 
containing 6 predicted glycosylation sites in the ectodomain. GP3 is predicted to have two TM 
domains and the first TM is thought to function as a signal peptide (Gonin et al., 1998; Wieringa 
et al., 2002). Although some of the GP3 proteins are secreted into the cell culture medium during 
infection (Gonin et al., 1998; Wieringa et al., 2002), immune-EM demonstrated that GP3 is 
exposed in the viral surface as a membrane component (de Lima et al., 2009).  
The GP4 protein ranges from 178 (type 2) to 183 (type 1) a.a. in size. GP4 contains a 
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predicted signal peptide at the N-terminus and a hydrophobic sequence at the C-terminus, which 
resembles a class I type integral membrane protein, but it lacks a hydrophilic cytoplasmic tail 
downstream of the C-terminal hydrophobic transmembrane region (Wieringa et al., 2002). 
Structurally, it has been shown to be a glycosylphosphatidylinositol (GPI)-anchored protein, 
suggesting that it may be associated with lipid rafts for viral entry or function for cellular signal 
transduction (Du et al., 2012; Varma and Mayor, 1998). 
The ORF5a protein is a newly identified structural protein and is likely expressed from the 
same subgenomic (sg) mRNA for GP5 via leaky scanning translation (Firth et al., 2011). ORF5a 
encode 51 aa in sg mRNA5 with its initiator AUG 10 bases upstream of the consensus ORF5 
AUG. The ORF5a protein is predicted to be a type I membrane protein with a highly conserved 
basic RQ-rich motif near the C-terminus and two adjacent cysteine residues at the interior edge 
of the TM domain, which may allow for disulfide linkages to form to assist oligomerization with 
other ORF5a protein (Johnson et al., 2011). In PRRSV infected pigs, anti-ORF5a antibodies are 
detected 4 weeks after infection (Johnson et al., 2011). In addition, inactivation of EAV ORF5a 
dramatically affects the virus production and the complementary study using EAV ORF5a 
knockout defective virus shows a partial recovery of the mutant virus (Firth et al., 2011).  
GP2, GP3, and GP4 form a heterotrimer that may facilitate the virus entry (Mardassi et al., 
1996; Wissink et al., 2005). The E protein is also part of this complex, and the lack of any of 
these four proteins leads to the failure to incorporate the other three proteins (Wissink et al., 
2005).  
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1.2.2 Non-structural proteins (Fig. 1.3) 
Nsp1 is the 382 a.a. protein and is the first viral protein synthesized during virus replication. 
Nsp1 is auto-cleaved into two subunits, Nsp1α and Nsp1β (den Boon et al., 1995; Snijder, 1998). 
Each of Nsp1α and Nsp1β contains a papain-like cysteine protease (PCP) domain designated 
PCPα and PCPβ, respectively. Nsp1α cleaves itself out at the position 180 and exists as a dimer. 
Two zinc finger motifs are found in Nsp1α. The mutagenesis studies indicate that the first zinc 
finger motif (ZF1) formed by 4 cysteines residues is more important for both mRNA 
transcription (Kroese et al., 2008; Tijms et al., 2001). The active sites of PCPα are comprised of 
Cys76 and His146 and are stabilized by a zinc ion (Sun et al., 2010a). The C-terminal extension 
of Nsp1α was bound to the active site of the protease after releasing from Nsp1β and thus 
self-inhibites the PCPα activity (den Boon et al., 1995; Ziebuhr et al., 2000). Nsp1β contains the 
N-terminal nuclease domain. The nuclease activity functions on ssRNA and dsRNA, and the 
PCPβ is composed of Cys90 and His159, which cleaves itself from Nsp2. As with Nsp1α, Nsp1β 
also forms a dimer via interaction between the nuclease domain (Xue et al., 2010). 
   Nsp2 is a large membrane protein of 1168 to 1196 a.a. in size (Fang et al., 2004; Nelsen et al., 
1999). It is the most variable Nsp with only 32% sequence identity among isolates (Allende et al., 
1999; Fang et al., 2004). Highly virulent PRRSV emerged in China has 30 aa deletions in Nsp2 
region. Nsp2 contains a papain-like protease domain (CP) near its N-terminus, followed by a 
hypervariable region that is rich in prolines, a hydrophobic region containing four TM helices, 
and a conserved C-terminal domain. Residues Cys55, Asp89, and His124 form the active site of 
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CP which is responsible to cleave Nsp2 from Nsp3 (Han et al., 2009). The PRRSV CP domain is 
also identified as a member of the ovarian tumor domain (OTU) family of deubiquitinating 
enzymes (Frias-Staheli et al., 2007). Nsp2 also appears to be involved in the formation of a 
replication complex in specialized cellular structures known as double-layered membrane 
vesicles (DMVs). DMVs are observed in EAV infected cells, which is expected to be true for 
PRRSV replication (Pedersen et al., 1999; Snijder et al., 2001).  
PRRSV Nsp11 is a cleavage product of PP1a/b, which is a large multidomain replicase 
polyprotein translated directly from the viral genome. Nsp11 is composed of 223 amino acids 
and contains a highly conserved NendoU domain unique for the order Nidovirales. The NendoU 
domain resides in the C-terminal region of Nsp11 and spans for 78 amino acids (Gorbalenya et 
al., 2006; Ivanov et al., 2004). The NendoU domain shows a distant relationship with the 
XendoU family, an endoribonuclease derived from Xenopus laevis (Laneve et al., 2003). It has 
the activity for uridylate-specific cleavage of RNA and is divided into two sub-domains. 
Subdomain A contains nuclease catalytic sites while subdomain B is important to maintain the 
overall protein structure. In Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the 
NendoU activity is mapped to nsp15 (Bhardwaj, Guarino, and Kao, 2004; Gorbalenya et al., 
2006; Xu et al., 2006). The crystallographic study shows that nsp15 forms a hexamer to reach the 
optimal activity (Joseph et al., 2007). For EAV, Nsp11 is the endoribonuclease and this activity is 
important for virus replication (Nedialkova et al., 2009). Although replacements of any of the 
active site residues of EAV NendoU were not lethal, they yielded severely crippled mutant 
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viruses exhibiting a moderate but specific defect in sg mRNA synthesis and a dramatic reduction 
of infectious progeny titers by up to 5 logs. 
Studies using XendoU and coronavirus NendoU have shown that two His residues and a Lys 
residue at amino acid positions 6345, 6360, and 6401, respectively of the PP1a/b in human 
coronavirus form a catalytic center (Gioia et al., 2005; Ivanov et al., 2004). In the case for the 
NendoU activity of EAV-Nsp11, a double mutation of two His residues at 2963 and 2978 and a 
single substitution at 3007 reduced the cleavage of RNA to undetectable levels. In addition, two 
Asp residues at 3014 and 3038 in subdomain B of EAV NendoU were shown to be critical for 
viral RNA synthesis (Posthuma et al., 2006). Both Asp mutations rendered the protein insoluble 
(Nedialkova et al., 2009), which was confirmed for NendoU of SARS-CoV (Joseph et al., 2007; 
Nedialkova et al., 2009). The two Asp residues form part of an extensive hydrogen bond network 
in close proximity to the active site and thus replacing those residues may have an indirect effect 
on the activity of the protein by disturbing its secondary structure (Fig. 1.3C). 
Since many viruses develop a variety of mechanisms involving RNA cleavages to evade 
from the host innate immune system, such as influenza virus and bovine viral diarrhea virus 
(Magkouras et al., 2008; Min and Krug, 2006), Nsp11 may also play a role in modulation of host 
immune response as a viral RNase. 
Nsp3 has four predicted TM helices, which also appear to play a role in the formation of 
replicase complex and in anchoring other Nsps in replication complex membranes (Han et al., 
2009; Posthuma et al., 2008). Nsp4 is the main viral protease and cleaves most of the Nsp’s. The 
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protease domain of Nsp4 has a canonical chymotrypsin-like fold consisting of two six-stranded 
antiparallel β-barrel domains in the crystal structure. And this fold is referred to as a 3C-like 
protease (3CLP) (Allaire et al., 1994; Choi et al., 1991). The active sites of PRRSV Nsp4 are 
formed by residues Ser118, His39 and Asp6 (Snijder et al., 1996). The remaining cleavage 
products of PP1a, Nsp5 through Nsp8, are not well studied and have unknown functions. Nsp9 
through Nsp11 are the most conserved proteins in nidoviruses (Gorbalenya et al., 2006). Nsp9 is 
the viral RNA-dependent RNA polymerase (van Dinten et al., 1996), and Nsp10 is a helicase that 
contains a zinc finger motif. The zinc-binding domain is critical for the helicase activity of 
Nsp10 (Bautista et al., 2002; Seybert et al., 2000). Thus Nsp9 and Nsp10 form the core viral 
enzymes responsible for the viral replication and sg mRNA synthesis. 
Some of the PRRSV proteins are shown to have multiple functions. Besides their major 
functions in virus life cycle, these proteins also play important roles in manipulating host 
immune system (Fang and Snijder, 2010; Yoo et al., 2010) and other cellular processes, including 
interferons (IFNs), apoptosis and cell cycle. 
1.3 Replication cycle (Fig. 1.5) 
1.3.1 Virus entry 
The first step in PRRSV infection of macrophages appears to be a low affinity attachment of 
the virus to heparin sulfate via the M-GP5 complex (Delputte, Costers, and Nauwynck, 2005; 
Delputte et al., 2002). This step is not absolutely required for infection, but may concentrate the 
virus on the cell surface for subsequent binding to a higher affinity receptor. The internalization 
 11  
of virus and the initiation of productive infection require a high affinity binding of the 
macrophage-specific sialic acid-binding protein (lectin) sialoadhesin (Delputte, Costers, and 
Nauwynck, 2005). This interaction is mediated via sialic acid present on GP5 (Delputte and 
Nauwynck, 2004) which binds to the N-terminal immunoglobin domain on sialoadhesin (Sn) 
(Delputte et al., 2007). However, MARC-145 cells do not seem to have Sn, and therefore, other 
cellular factors are presumably used. Recent studies have shown that the scavenger receptor 
CD163 is the viral receptor for PRRSV (Calvert et al., 2007). Expression of this protein in a 
number of cell types makes the cells susceptible to PRRSV infection (Delrue et al., 2010; Welch 
and Calvert, 2010). The full susceptibility seems to require both sialoadhesin and CD163 (Van 
Gorp et al., 2008).  
1.3.2 Translation, genome replication and sg mRNA transcription 
After the viral nucleocapsid and genomic RNA released into the cytoplasm, the 
positive-sense genomic RNA serves as mRNA to express two large 5’ proximal replicase ORFs, 
generating PP1a and PP1ab. ORF1b is located in the -1 reading frame relative to ORF1a and 
does not contain a start codon and thus PP1ab is synthesized by the -1 ribosomal frame-shifting 
mechanism (den Boon et al., 1991). Two typical signals are required in the ORF1a/1b overlap 
region for the frameshifting process; the “slippery’ sequence and a downstream RNA 
pseudo-knot structure. The replicase polyproteins are then proteolytically processed by four 
ORF1a encoded viral proteinases to yield 14 Nsps (Snijder, 1998). These Nsps are mostly 
associated with intracellular membranes mainly in the ER, and form DMVs. The replicase 
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subunits are targeted to DMVs and associated to form a replicase complex which directs RNA 
synthesis. 
Upon formation of the replication complex on DMVs, new genomic and subgenomic RNAs 
(sg RNAs) are synthesized. Structurally, all of the sgRNAs share the 5’- and 3’-coterminal 
sequences with the genome, but the sequences that follow the leader sequences at their 5’ ends 
are different. Specifically, all sgRNAs consist of a leader RNA derived from their 5’ end of the 
genome and a body sequence derived from various downstream sequences. Since the translation 
of eukaryotic mRNA takes place at the first initiation codon from the 5’ end of an ORF, only the 
5’ most ORFs are translated. Therefore, the sg mRNAs are structurally polycistronic but 
functionally monocistronic with the exception of sg mRNA2 and sg mRNA5 which are 
bicistronic (Mounir et al., 1995; Wu et al., 2001) (Fig. 1.4). 
There are two models to address the mechanism of transcription of PRRSV: the 
leader-primed transcription model and the discontinuous transcription model. The former model 
proposes that the incoming positive-strand genomic RNA is first replicated into genomic-length 
negative-strand RNA. The leader RNA is transcribed from the 3’ end of the negative-strand RNA 
and released from the template. The leader RNA subsequently associates with the template RNA 
at a short and conserved TRS element which proceeds every transcription unit in the genome. 
TRS is also present at the 3’ end of the leader sequence and primes sg mRNA synthesis in the 
minus-strand template RNA (Pasternak et al., 2006). In the latter model, TRSs on the genomic 
RNA serve as a termination or pausing signal for negative-strand synthesis such that the nascent 
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sg negative-strand RNA jumps to the 5’ leader sequence of the genomic RNA to continue RNA 
synthesis. As a result, the nascent negative-strand sg RNA contains an anti-leader sequence at its 
3’ end and a poly(U) sequence at its 5’ end. These various lengths of negative-strand RNAs thus 
serve as a template for uninterrupted transcription to synthesize sg mRNAs (Sawicki and 
Sawicki, 1995; Sawicki et al., 2007). 
1.3.3 Viral assembly and release 
In the cytoplasm, the newly synthesized viral genomic RNAs are encapsidated by the N 
protein in DMVs. The preformed nucleocapsids (N protein associated with RNA genome) are 
then budding into lumen of ER and/or Golgi apparatus to associate with membrane-embedded 
proteins to acquire the viral envelope. Several structural proteins undergo Golgi specific 
maturations (Mardassi et al., 1996; Meulenberg et al., 1995b) and the viral particles are believed 
to be transported through the Golgi apparatus and finally release from the cells via exocytosis or 
cell lysis (Pol et al., 1997). 
2. Cellular responses to PRRSV infection 
During infection, the virus replicates in the cytoplasm where numerous host signaling 
pathways and complicate interactions between virus and host cells occur during replication cycle 
from entry to exit. One of the most important such interactions is the modulation of host cell 
environment to help the virus can replicate successfully. The fact that viruses utilize the host 
components to satisfy their needs is of great significance, since they can become major 
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pathogenic factors (Zhong et al., 2012). Studies on the infection of PRRSV have shown various 
modifications of host innate immunity, stress responses, cell cycle, autophagy, and apoptosis 
(Cavanagh, 2007; Cottam et al., 2011; de Haan and Reggiori, 2008; Miller and Fox, 2004). Some 
of these modifications are discussed below. 
2.1. Cellular innate immune responses to viruses 
IFNs are multifunctional cytokines that play important roles for antiviral defense and shaping 
adaptive immunity. IFNs are classified into type I, type II, and type III. Type I IFNs are the main 
cytokines for innate immunity against viral infections and include various subtypes depending on 
the animal species. Type I IFNs in humans consists of 13 subtypes for IFN-α and a single 
subtype for IFN-ß, -ω, -κ, and –ε (Randall and Goodbourn, 2008). Limitin/IFN-like 1 is an 
additional type I IFN-like cytokine recently identified in mice that also binds the type I IFN 
receptor (Decker et al., 2005). Similar to humans, IFN-α in swine is encoded by as many as 17 
functional genes. The IFN-δ-like molecule is found only in pigs and cattle and designated SPI 
IFN (Sang et al., 2010; Takaoka and Yanai, 2006). IFN-γ is the sole representative of type II IFN. 
While type I IFNs are produced in most cell types in response to different viruses, type II IFN is 
produced by limited types of cells including natural killer (NK) cells, activated T lymphocytes, 
macrophages, and neurons. Type III IFNs have recently been described to contain 3 subtypes of 
IFN-λ1, IFN-λ2, and IFN-λ3, but their role in antiviral defense remains to be established 
(Randall and Goodbourn, 2008). Since type I IFNs are the most notable cytokines in the fight 
against viral infection at an early stage, a focus will be given to discuss how they are produced in 
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virus-infected cells and act on neighbor cells to prevent the spread of virus (Fig. 1.6). 
2.1.1. Toll-like receptor (TLR) signaling 
Toll-like receptors (TLRs) are a family of proteins recognizing different pathogen-associated 
molecule patterns (PAMPs). The key signaling domain unique to the TLR system is the 
toll/interleukin (IL)-1 receptor (TIR) domain located in the cytosolic face of each TLR and also 
in the adapters (O'Neill et al., 2003). Once engaged to TLRs, PAMPs recruit different kinases 
through different adaptors by the TIR domain and thus trigger different signaling pathways, 
leading to the expression of specific genes that are involved in the removal of invading viruses. 
Ten TLRs have so far been identified for humans and 11 TLRs for mice (Zhang et al., 2007). Of 
these, TLRs 3, 7, 8, and 9 contribute the most to the control of virus infection (Baccala et al., 
2007). TLR3 is mostly expressed in the intracellular endosomes (Matsumoto et al., 2003), which 
mediates the response to both poly(I:C) and dsRNA (Kariko et al., 2004; Okahira et al., 2005). 
TLR7/8 recognize dsRNA as short as 19-21 bps in size and are constitutively expressed at high 
levels in specific peripheral blood mononuclear cells (PBMCs). TLR9 senses unmethylated CpG 
DNA in pDCs (Vollmer et al., 2004). TLR7/8/9 are all anchored on the endosomal membranes 
(Baccala et al., 2007). Their pathways activate IRF7 through MyD88 and account for production 
of IFN-α in pDCs, which plays a crucial role during virus infection. The TLR3 activates IRF3 
and NF-κB through TRIF, which serves as an additional scenario to induce IFN-ß gene 
expression to fight against RNA viruses, including PRRSV. 
2.1.2. Cytoplasmic receptors and their signaling  
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2.1.2.1 RIG-I/MDA5 Pathway  
Retinoic acid inducible gene I (RIG-I) is an intracellular receptor for viral dsRNA. It contains 
a C-terminal DExD/H box-RNA helicase domain and two N-terminal caspase recruitment 
domains (CARDs) through which RIG-I induces type I IFN. Only RNA molecules that can be 
efficiently recognized and unwound by the helicase domain of RIG-I have the potential to induce 
type I IFN through CARD. Therefore, the helicase domain of RIG-I acts as a switch to control 
whether CARD is revealed and available for activation of downstream processes (Gantier and 
Williams, 2007). Once the CARD domain of RIG-I is uncovered by conformational changes 
under stimulation, another CARD-containing protein IFN-ß promoter stimulator-1 (IPS-1) is 
recruited as an adaptor through CARD-CARD interaction. The CARD-CARD interaction 
between RIG-I and IPS-1 is essential for dsRNA-induced activation of NF-κB, IRF3, and IRF7 
(Bowie and Unterholzner, 2008). For IRFs activation, IPS-1 transduces signals through TRAF3, 
a signaling factor involved in the TLR-activation pathway, which in the case of the RIG-I-IRF 
pathway associates with NEMO and TANK to facilitate the recruitment of TBK1 and IKKε to 
form the IPS-1-TRAF complex. This complex leads to TBK1/IKKε activation, which then 
phosphorylates IRF3 and IRF7. Phosphorylated IRF3 and IRF7 form homo- or hetero-dimer and 
are transported to the nucleus. For NF-κB activation, IPS-1 interacts with TRAF2, TRAF6, and 
RIP1, which is similar to TLR3-activated NF-κB activation (Edwards et al., 2007). Once in the 
nucleus, the active form of IRF3 or IRF7, NF-κB, AP-1, together with other co-transcription 
factors, such as CREB-binding protein (CBP) form an IFN enhanceosome to produce IFN-ß and 
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IFN-α (Honda et al., 2006). 
RIG-I and MDA5 are cytoplasmic receptors to recognize RNA. They are structurally similar, 
but functionally different. Studies show that MDA5 is essential for the recognition of 
picornaviruses and poly (I:C) (Gitlin et al., 2006; Kato et al., 2006). RIG-I is required for the 
recognition of many negative-strand RNA viruses including Sendai virus and influenza A virus, 
and poly (I:C) is often used to stimulate the RIG-I/MDA5 pathway (Kato et al., 2006). Compared 
to MDA5, RIG-I senses RNA transcribed in vitro by polymerases. Actually, both single- and 
double-strand RNA with a triphosphate moiety at the 5’ end can activate type I IFN production 
via RIG-I (Hornung et al., 2006; Pichlmair et al., 2006). This leads to a crucial question ‘How 
the host or such cytoplasmic receptors distinguish viral RNAs from self-RNAs’. The answer is 
not hard but complicated. Cellular RNAs like ribosomal RNA (rRNA) and transfer RNA (tRNA) 
possess a 5’ monophosphate instead of 5’ triphosphate and thus would not be detected by RIG-I. 
For messenger RNA (mRNA) and small nuclear RNAs (snRNAs) however, the 5’ end is 
modified with a methyl-guanosine cap which protects RNAs from degradation. In addition, 
cellular RNAs are often post-transcriptionally modified by pseudouridine, 2-thiouridine, or 
2’-O-methylation, and these modifications suppress the immune-stimulatory activity of RNA 
even if the RNA contains a 5’ triphosphate (Hornung et al., 2006; Unterholzner and Bowie, 
2008). Last but not least, cellular RNA generally does not exist as “naked” molecules in a 
cellular environment but rather forms complexes with a multitude of RNA-binding proteins. 
Thus, it is conceivable that protein components of the complexes may also play a role in marking 
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certain RNA species as ‘self’ (Unterholzner and Bowie, 2008). 
2.1.2.2 IPS-1 Signaling  
IPS-1 has been proven to play an essential role in the antiviral signaling pathway. 
Over-expression of IPS-1 leads to activation of both IRF3 and NF-κB and thus type I IFN 
production. Besides the N-terminal CARD domain, IPS-1 also contains a proline (PRO) region 
and a C-terminal hydrophobic transmembrane (TM) region that anchors to the mitochondrial 
outer membrane (Seth et al., 2006; Seth et al., 2005). Mutational analysis shows that the CARD 
and TM domains are both essential for IPS-1 to retain its function. The mislocalization of IPS-1 
greatly impairs the ability to induce IFNs (Seth et al., 2006), suggesting the involvement of 
mitochondria in innate immunity. IPS-1 is also able to interact with Fas-associated death domain 
(FADD) or to directly bind to the C-terminal region of IKKα and IKKβ kinases to activate 
NF-κB. Both FADD and mitochondria have the ability to induce the apoptosis pathway through 
recruiting apoptotic factors and releasing pro-apoptotic proteins, respectively. This hints that 
apoptosis may be one of the innate immune responses and IPS-1 may act as a bridge between 
apoptosis and type I IFN response. 
2.1.3. IFN signaling pathways 
After the first wave of IFN-ß production, the response enters into the second stage, where 
hundreds of genes are upregulated and the resulting proteins are involved in a variety of 
functions. These genes are referred to as IFN-stimulated genes (ISGs), and the pathway that 
transduces the IFN signal for expression of ISGs is the JAK-STAT pathway. 
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The JAK-STAT signaling pathway is initiated when IFN-α and IFN-ß bind to their receptors 
on the cell surface. The receptor binding activates Janus kinase (JAK) and Tyk2 to phosphorylate 
the signal transducers and activators of transcription 1 (STAT1) and STAT2. Phosphorylated 
STAT1 and STAT2 form heterodimers which associates with IRF9 to form the 
interferon-stimulated gene factor 3 (ISGF3) complex. The ISGF3 complex is imported into the 
nucleus and binds to IFN stimulated response element (ISRE) to induce ISGs resulting in the 
establishment of an antiviral state. Once the ISGF3 complex translocates to the nucleus, both 
phosphorylated STAT1 and STAT2 undergo dephosphorylation and are redistributed back to the 
cytoplasm (Schindler and Darnell, 1995). 
The JAK-STAT pathway is regulated by feedback inhibitors of three STAT negative regulators. 
The suppressor of cytokine signaling (SOCS) family suppresses the phosphorylation of STATs 
by inhibiting the association of JAK with the IFN receptors (Krebs and Hilton, 2001). The 
protein inhibitor of activated STATs (PIAS) family consists of PIAS1, PIAS3, and PIASy. PIAS1 
and PIAS3 compete against STAT1 and STAT3 for ISRE within the promoter region, respectively, 
and thus suppress the expression of ISGs (Shuai and Liu, 2005). PIASy can recruit other factors 
to repress the transcription activities of STAT1. In addition to the negative regulation of STATs, 
PIAS is also identified as a SUMO E3 ligase. SUMO is a small ubiquitin-like modifier and many 
proteins are post-translationally modified by SUMO, which is a process known as sumoylation. 
Sumoylation occurs similarly to ubiquitinylation in such a way that a SUMO molecule is 
conjugated to its target protein through specific sequence recognition by E3 ligase (Wilkinson 
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and Henley, 2010). Sumoylation plays roles in diverse biological processes including regulation 
of gene transcription, chromatin structure, protein localization and functions. SUMO E3 ligase is 
required for ubiquitinylation of certain proteins and mediates degradation. 
More than 300 ISGs have been identified so far but a relatively few of these ISGs have been 
implicated in instigating the antiviral state including catalysis of cytoskeletal remodeling for 
apoptosis, regulation of post-transcriptional events, and post-translational modifications. Many 
other ISGs function as pattern-recognition receptors (PRRs) to sense viral molecules or encode 
transcription factors that participate in the amplification loop increasing IFN production and 
preventing dissemination of virus (Sadler and Williams, 2008). ISG15, GTPase, myxovirus 
resistance A (MxA), ribonuclease L (RNaseL), and protein kinase K (PKR) are some of the 
well-known ISGs. 
2.2. Modulations of innate immune responses by PRRSV 
Recent studies have described cytokine responses during PRRSV infection. In 
PRRSV-infected pigs, TNF-α is down-regulated while IL-10 production is up-regulated. Pigs do 
not show typical innate immune responses including type I IFN response, although PRRSV is 
highly susceptible to IFN-α/β and its growth is inhibited. PRRSV-infected pigs display low levels 
of IFN-α despite the abundant presence of viral RNA in infected cells. IFN-α is not detectable in 
the lungs of virus-infected pigs where PRRSV actively replicates (Albina et al., 1998; Van Reeth 
et al., 1999). The suppression of IFN production is also evident in virus-infected MARC-145 and 
PAM (porcine alveolar macrophage) cells (Albina et al., 1998; Buddaert, Van Reeth, and 
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Pensaert, 1998; Miller et al., 2004), suggesting that PRRSV suppresses IFN production. Such 
inhibition by PRRSV is RIG-I mediated (Luo et al., 2008). In pigs infected with the newly 
emerged highly pathogenic PRRSV (HP-PRRSV), the virus replicates rapidly and readily 
persists. RNA microarray analysis of HP-PRRSV-infected cells shows that production of swine 
type I IFNs are suppressed, suggesting that the host innate immune response is blocked (Xiao et 
al., 2010). The European genotype of PRRSV has also been examined by microarray analysis for 
its ability to modulate global gene expression (Ait-Ali et al., 2011).A repression of IFN-α 
transcription and a delay of IFN-ß transcript accumulation in infected-microphages was shown. 
Here, we discuss below the manipulation of IFN signaling pathways by PRRSV during infection 
(Fig. 1.7). 
2.2.1. TLRs and the PRRSV 
Porcine TLR3 and TLR7 seem to be important for PRRSV (Sang et al., 2008a; Sang et al., 
2008b). Differential expressions of TLRs have been studied for PAMs and porcine bone marrow 
hematopoietic cell-derived immature dendritic cells (imDCs) in response to poly (I:C) and 
PRRSV (Chaung et al., 2010). PRRSV down-regulates TLR3, TLR7, and TLR8 expression 
levels at 6 h post-infection (p.i.) in imDCs, which return to basal levels by 24 h p.i.. TLR7 
expression decreased continuously through 24 h of infection. In other study, the TLR3 activation 
caused increased antiviral response to PRRSV and decreased viral replication (Sang et al., 
2008a). TIR-domain truncated TLR3 was found to increase the PRRSV infection in MARC-145 
cells, while wild-type TLR3 inhibited PRRSV replication. Another study (Miller, Lager, and 
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Kehrli, 2009) using poly (I:C) as a TLR3-specific agonist and LPS as a TLR4-specific agonist 
showed that PRRSV infection increased IFN-α expression at 16 h p.i. in PAMs, and this was an 8 
h delay compared to poly(I:C) stimulation alone. No significant increase of IFN-α was observed 
upon infection. When PRRSV-infected cells are stimulated by poly (I:C) or LPS, TLR4 was not 
influenced but TLR3 was significantly reduced, and the TLR3 down-regulation facilitated virus 
replication. Thus, TLR3 seems to play an important role in establishing effective innate 
immunity to PRRSV. 
2.2.2. PRRSV targeting IFN enhanceosome through IRF-mediated RIG-I/MDA5 pathways 
During PRRSV infection, IFN-α, IFN-ß, ATF-2, and IRF3 (but not NF-κB and JUN), were 
significantly reduced (Miller et al., 2004), and this virus-mediated inhibition was proved to be 
via the RIG-I signaling pathway (Luo et al., 2008). Nsp1 contains the strongest potential to 
inhibit the IFN-ß promoter activity, and Nsp1ß have the ability to inhibit IRF3-mediated type I 
IFN production. The phosphorylation and nuclear translocation of IRF3 are inhibited by Nsp1ß. 
The mechanism for Nsp1-mediated IFN inhibition is partly due to the degradation of CREB 
(cyclic AMP responsive element-binding)-binding protein (CBP) in the nucleus (Kim et al., 
2010), which disrupts the formation of enhanceosome crucial for IFN gene expression. The CBP 
degradation is proteasome–dependent but independent from the PCP activity of Nsp1.  
Nsp2 also down-regulates type I IFN induction. Nsp2 is a membrane-anchored protein that 
contains a CP activity and a deconjugation activity associated with ovarian tumor (OTU) 
domain-containing protease activity. While the deconjugation activity is suggested to function in 
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ISGs and NF-κB signaling, the CP activity inhibits IRF3 phosphorylation and nuclear 
translocation (Li et al., 2010). The mechanism for the CP mediated-IRF3 deactivation is 
unknown. 
2.2.3. Modulation of NF-κB signaling by PRRSV 
Viruses may activate or inhibit the NF-κB signaling for their own benefits. The NF-κB 
signaling pathway may function as a protective response of the host to a virus, and thus, many 
viruses have evolved to block NF-κB activation to evade host innate immunity. In this scenario, 
NF-κB signaling is inhibited by PRRSV which suppresses a type I IFN response. However, a study 
shows that NF-κB may be up-regulated by PRRSV at 36-48 h post-infection (p.i.). (Lee and 
Kleiboeker, 2005). The NF-κB activation during this time of infection was dose-dependent and 
virus replication-dependent since UV-inactivated PRRSV did not up-regulate the response. In 
porcine pDCs, PRRSV promotes NF-κB phosphorylation when stimulated with transmissible 
gastroenteritis virus (TGEV) (Calzada-Nova et al., 2011). The data show that PRRSV actually 
activates the NF-κB pathway in MARC-145 cells and PAMs at a late stage of infection. Activation 
of the NF-κB pathway by viruses may optimize viral replication and control of host cell 
proliferations and apoptosis. However, blocking NF-κB activation by over-expressing the 
dominant negative form of IκBα did not alter viral replication (Lee and Kleiboeker, 2005; Luo et 
al., 2008), suggesting that the activation of NF-κB by PRRSV may be involved in other cellular 
progresses such as apoptosis or modulation of cytokines. 
The PRRSV N protein appears to stimulate NF-κB activation and the activation is 
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dose-dependent. The region at amino acid positions 30-73 of N is responsible for NF-κB 
activation (Luo et al., 2011), and within this region, both the nuclear localization signal (NLS) 
and nucleolar localization signal (NoLS) are located. Thus, it is plausible that NF-κB activation 
may be linked to the N protein nuclear localization. The region is also important for 
homo-dimerization of N, which is embedded in the NF-κB activation domain. This implies that 
N-N homo-dimerization may be associated with the NF-κB activation. 
Some PRRSV proteins are also reported to down-regulate NF-κB, including Nsp1α and Nsp2. 
In the presence of Nsp1α, the phosphorylation of IκBα was inhibited, leading to the block of 
NF-κB nuclear translocation upon stimulation with tumor necrosis factor α (TNFα) (Song et al., 
2010). PRRSV Nsp1α contains two zinc finger motifs; one motif (ZF1) of C8-C10-C25-H28 and 
another motif (ZF2) of C70-C76-H146-M180. A deletion mutant of Nsp1α lacking the 
C-terminal 14 amino acids, in which the second zinc finger motif is lost, shows no inhibition of 
IFN induction. This finding raises a possibility that zinc finger motifs of Nsp1α may take a part 
in the suppression of NF-κB or other type I IFN pathways. Although it is unclear whether the 
CBP degradation by Nsp1 is mediated by Nsp1α or Nsp1β, it is possible that the cytosolic form 
of Nsp1 blocks the NF-κB activation and the nuclear form of Nsp1 degrades CBP possibly 
through the zinc finger domain. The OTU domain of Nsp2 is able to deconjugate the ubiquitin or 
ISG15 from substrates (Frias-Staheli et al., 2007). Since ubiquitinylation is involved in the RIG-I 
and TLRs signaling such as the recruitment of adaptor proteins and degradation of IκBα, Nsp2 
likely inhibits the type I IFN production via its OTU domain. Indeed, Nsp2 has been shown to be 
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able to down-regulate the NF-κB activity although its mechanism is unknown (Li et al., 2010). 
Sun et al. (2010a) have reported that Nsp2 may interfere with polyubiquitinylation of 
phosphorylated IκB, resulting in the failure of IκB degradation. Further studies suggest that 
NF-κB may be down-regulated by Nsp’s at the early stage of virus infection. 
2.2.4. Inhibition of JAK-STAT signaling and ISG expressions by PRRSV 
PRRSV suppresses the type I IFN signaling not only during the production of IFNs but also 
after IFN secretion. In IFN-α-induced MARC-145 cells, the JAK-STAT pathway is suppressed at 
24 h post-infection when using ISG15 and ISG56 mRNAs as indicators. The ISGF3 nuclear 
translocation is blocked by PRRSV (Patel et al., 2010). In TGEV-stimulated pDCs, the nuclear 
translocation of STAT1 is inhibited by PRRSV (Calzada-Nova et al., 2011), and Nsp1ß is the 
viral protein responsible for this inhibition. Nsp1ß, not Nsp1α, inhibits phosphorylation of 
STAT1 and nuclear translocation of ISGF3 (Chen et al., 2010; Patel et al., 2010). In our 
laboratory by yeast-two-hybrid assays, Nsp1α has been found to interact with PIAS1 
(unpublished data). PIAS functions as a negative regulator for STAT1 and also as the SUMO E3 
ligase. The interaction of Nsp1α with PIAS1 may lead to the Nsp1α sumoylation and facilitate 
the Nsp1α transport into the nucleus. Besides, degradation of CBP by Nsp1 may also require the 
E3 ligase activity of PIAS. Nsp1 may bring CBP to PIAS1 and then CBP is sumoylated by 
PIAS1, which facilitates the ubiquitinylation of CBP for degradation. 
Less is known about the effects of PRRSV infection on ISGs. In MARC-145 cells, 
anti-PRRSV activity of type I IFNs is highly correlated with the MxA promoter activity and less 
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correlated with IRF3 and IRF7 induction (Sang et al., 2010). This suggests that MxA would be a 
better biomarker to monitor the IFN induction during PRRSV infection than other ISGs. ISG15 
is an ubiquitin-like molecule and can be reversibly conjugated to proteins to mediate important 
innate antiviral responses. The OTU domain in Nsp2 of PRRSV contains a deubiquinylation 
activity. Nsp2 can decrease ubiquitinylation and ISGylation in 293T cells, indirectly indicating 
that Nsp2 may help the virus evade the innate immune response by deconjugation (Frias-Staheli 
et al., 2007). Typically, PKR is found in the both cytoplasmic and perinuclear regions in cell, but 
its distribution is altered by increased signals in the perinuclear region and within the nucleoli of 
PRRSV-infected cells. This localization pattern of PKR is similar to that of PRRSV N protein but 
N and PKR are not co-localized in the nucleoli (Rowland et al., 2001).  
2.3. Other cellular responses during PRRSV infection 
2.3.1 Apoptosis and PRRSV 
The autocrine and paracrine actions of type I IFNs and other cytokines encompass the 
comprehensive host immune response to defend against viral infection. This is accompanied by a 
reciprocal activation of programmed cell death in virus-infected cells and the reduction of viral 
load in the host. Virus-induced apoptosis and type I IFN production occur via common pathways.  
Certain viruses have evolved strategies to both counteract and induce apoptosis in order to 
maximize the production of virus progeny and promote its spread to neighboring cells. The 
unique SARS-CoV encoded protein, 7a, was discovered to have caspase-dependent, 
pro-apoptotic functions (Tan et al., 2004), while TGEV accessory gene 7 contained negative 
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modulation of apoptotic pathways (Cruz et al., 2011).  
Apoptotic cells are observed in PRRSV-infected tissues of pigs (Suarez et al., 1996), while in 
other studies, apoptotic cells are not PRRSV-infected (Sirinarumitr et al., 1998; Sur, Doster, and 
Osorio, 1998). GP5 has reported to relate to PRRSV-induced apoptosis. Expression of GP5 
induces apoptosis, and specific apoptotic enzyme such as caspase-3 is activated (Gagnon et al., 
2003), which is inhibited by Bcl-2 protein. Further studies reported that the first N-terminal 119 
aa of GP5 is shown to be the inducing region for apoptosis (Fernandez et al., 2002). However, 
the stable expression of GP5 in HeLa cells did not induce apoptosis (Lee et al., 2004) and some 
researchers also found some cells without GP5 expression undergo apoptosis. Based on these 
observations, some researchers propose that ‘bystander’ cells undergo apoptosis during PRRSV 
infection. Microarray data support the minimal increases of pro-apoptotic gene transcripts in 
PRRSV-infected cells compared to uninfected cells (Miller and Fox, 2004). PRRSV-infected 
cells tend to undergo necrosis rather than apoptosis. Therefore, it is possible that PRRSV may 
actively interfere with the induction of apoptosis, which may be partially due to its ability to 
inhibit type I IFN production especially at the early stage of viral infection. 
2.3.2 Modulation of cell cycle by viruses  
Viruses may also exploit the host cell cycle to benefit their own replication. The traditional 
subdivisions of cell cycle are G1 (gap1), S (synthesis), G2 (gap2), and M (mitosis). DNA 
replication occurs in the S phase and the S phase is preceded by G1 during which the cell is 
preparing for mitosis and is followed by G2 during which the cell prepares for mitosis. Therefore, 
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the DNA content of the cell at G1, S, and G2 are 2N, 4N, and 4N, respectively. Cells in G1 can 
enter a resting state called G0 during which cells are not active and do not cycle (Norbury and 
Nurse, 1992). Key regulatory proteins include the cyclin-dependent kinase (CDK) which 
complexes with the cyclin proteins and is activated at specific points of cell cycle. They can 
regulate the progression of the cells together with other proteins including p53, p21, p19, p16, 
and cell division cycle 25 (cdc25). Once CDK is activated, target proteins become 
phosphorylated. During early G1, pRb becomes phosphorylated and this leads to the release of 
the transcription factors E2F-1 and DP-1, which positively regulate the transcription of genes 
required for S phase progression. The CDK activity can be counteracted by CDK inhibitor (CKI) 
and the intracellular localization of those regulatory proteins also distributes to a correct cell 
cycle progression (Vermeulen et al., 2003). The inactivation of CDK can also be reversed by 
dual-specific phosphatase of the cdc25 family (Pines, 1999) and cdc25 proteins are, in turn, 
inactivated by checkpoint 1/checkpoint 2-mediated phosphorylation. 
Cell cycle regulation typically involves the machinery critical to the surveillance and 
correction of DNA damage and thus prevents abnormal cell division. Many pathogens including 
viruses have been reported to modulate the cell cycle by various strategies. The modulation of 
cell cycle is more common in DNA viruses and retroviruses whose replications occur in the cell 
nucleus. For DNA viruses, normal growth of host cell is destroyed and thus the viruses can 
replicate more efficiently. Kaposi’s sarcoma-associated herpesvirus (KSHV) encodes vcyclin 
protein, which can interact with CDKs and activates these kinases constitutively. This 
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unregulated kinase activity results in the independence of the cell cycle on growth signaling and 
the loss of normal check points, allowing the cells from quiescence and re-enter cell cycle 
(Direkze and Laman, 2004). For retroviruses, human immunodeficiency virus (HIV) has been a 
good model to study cell cycle interruption. Viral protein R (Vpr) of HIV has been indicated to 
cause G2 arrest of host cells by affecting several cell-cycle regulatory proteins, including p53, 
p21, and pRb. The Vpr-induced G2 arrest allows the optimal viral replication (Amini et al., 
2004).  
For other RNA viruses including PRRSV whose replication of which occurs entirely in the 
cytoplasm, the interference with cell cycle has also been reported. For these viruses, different 
phases of the cell cycle are usually prolonged to provide more time or sufficient cellular 
machineries for virus replication. Avian infectious bronchitis coronavirus (IBV) infection results 
in the host cells arresting at the both S and G2/M phase by regulating the expression of multiple 
cell cycle regulatory genes such as corresponding CDK complexes (Dove et al., 2006) and G1 
phase regulatory cyclin D1 and D2 (Xu et al., 2011). The IBV N protein appears to target CDK2, 
cyclin A and D1 for proteasome-mediated degradation and causes the accumulation of 
hypophosphorylation of pRb (Harrison et al., 2007; Li et al., 2007; Zhong et al., 2012). Similar 
to N of IBV, the N protein of PRRSV has also been suggested to regulate the cell cycle 
progression by modulating the ribosomal RNA synthesis in the nucleolus (Yoo et al., 2003). As 
mentioned before, the PRRSV N is an RNA-binding protein which contains the nuclear 
localization signal (NLS) and thus locates in the nucleus and nucleolus. N interacts and colocalizes 
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with the nucleolar protein fibrillarin. Through the yeast-2 hybrid screening, the inhibitor of MyoD 
family ‘a’ (I-mfa) domain-containing protein was identified to interact with the PRRSV N protein 
(Song et al., 2009). Since the I-mfa domain-containing protein interacts with cyclin T1 (Young et 
al., 2003), which is known to participate in the control of cell cycle, this interaction suggests the 
participation of N in the regulation of cell cycle (Yoo et al., 2010). 
3. Host responses to PRRSV infection  
3.1. PRRSV persistence 
Two types of PRRSV infection have been described, an acute infection with viremia that lasts 
for 3 to 4 weeks and a persistent infection that pigs develop prolonged viremia and a low level of 
virus replication in lymphoid organs (Lamontagne et al., 2003). The virus does not enter a latent 
stage and are eventually cleared from the body in most cases. The persistence in postnatally 
infected pigs has been reported for up to 150 days, while congenitally infected pigs may contain 
the virus for up to 210 days (Cho and Dee, 2006). PRRSV is thought to persist through a 
smoldering type of infection in which the virus continuously replicates at a low level. During 
persistence, viremia is absent and virus replication is restricted primarily to lymphoid tissue or 
other immune-privileged sites such as tonsils and lymph nodes (Beyer et al., 2000; Rowland et 
al., 2003) but absent from active replication sites such as lung tissues and alveolar macrophages 
(AMs) (Benfield D.A., 1998). Persistence of PRRSV is also common in the semen of infected 
boars (Christopher-Hennings et al., 1995; Swenson et al., 1994). During persistence, viral genes 
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for glycoproteins and M protein undergo some mutation while the gene for N protein remains 
relatively stable. From field studies, pigs persistently infected with PRRSV may continue to shed 
viruses, become reinfected, and may suffer as repeat episode of the disease. More importantly, 
the virus shedding from persistently infected pigs is one vital source for transmission and is one 
of the main factors to control PRRSV infection in the field (Rossow, 1998). PRRSV particles are 
assembled within the cell by budding of nucleocapsids into the lumen of ER and/or Golgi 
compartments and thus viral proteins are retained in and accumulated at the budding site. As a 
result, viral proteins are not incorporated into the plasma membrane of the cell and thus infected 
cells are not recognized by PRRSV-specific antibodies and become resistant to antibody- or 
complement-mediated cell lysis (Costers et al., 2006; Kimman et al., 2009). The suppression of 
host immunity and the antibody-mediated enhancements may also contribute to the PRRSV 
persistence.  
3.2. Host immunity to PRRSV 
3.2.1 Innate immunity  
Immunity to viruses begins with the innate antiviral response in the cytoplasm of infected 
macrophages. PRRSV infection, however, does not seem to elicit the type I IFN responses in 
AMs in vitro or in vivo as observed by numerous studies (Albina et al., 1998; Buddaert et al., 
1998; Van Reeth et al., 1999). At the transcriptional level, IFN-α mRNA was not expressed by 
PRRSV infected cells and this suppression was dependent on active infection by PRRSV (Albina 
et al., 1998). The down-regulation of type I IFN production would facilitate PRRSV replication. 
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Studies have been conducted and several viral proteins have been identified to be responsible for 
type I IFN suppression. In addition to type I IFNs, inflammatory cytokine expression is also 
important during the initial response to a variety of viral respiratory infection (van Reeth and 
Nauwynck, 2000). However, PRRSV infection does not seem to induce any significant cytokine 
expression (Thanawongnuwech et al., 2001; Van Reeth et al., 1999).  
Another innate immune response to counteract viral infection is immediate innate cellular 
response including the activation of natural killer (NK) cells. NK cells are potently activated and 
stimulated by type I IFN. The activated NK cells result in the production of immunoregulatory 
cytokines and the cytotoxicity to virus-infected cells (Biron et al., 1999; Tay et al., 1998). The 
major cytokines produced by activated NK cells are IFNγ and TNF and the NK cell population 
increased 5 to 7 days in the lung after PRRSV infection (Samsom et al., 2000).  
3.2.2 Humoral immunity 
The humoral immune responses to PRRSV in pigs are characterized by early production of 
non-neutralizing antibodies followed by the delayed appearance of neutralizing antibodies. In 
PRRSV-infected pigs, anti-PRRSV IgM antibodies appear in serum by 5-7 days p.i. and  
decline rapidly to the undetectable level (Joo et al., 1997; Loemba et al., 1996; Park et al., 1995; 
Yoon et al., 1995). Anti-PRRSV IgG antibodies are first detected 7-9 days p.i. with the peak at 
2-4 weeks (Labarque et al., 2000; Loemba et al., 1996; Yoon et al., 1995), remain constant, and 
then decline to low levels by 300 days (Nelson et al., 1994; Nielsen and Botner, 1997). 
Anti-PRRSV IgA can be detected in serum at 14 days p.i., peak at 25 days, and remain detectable 
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until 35 days (Labarque et al., 2000). The early antibodies are mainly directly to the N and M 
proteins but are non-neutralizing (Loemba et al., 1996; Plagemann, 2006). The neutralizing 
antibodies (NA) begin to appear at about 7-10 days p.i. and remain low titers, which are between 
2 and 12 (Labarque et al., 2000; Loemba et al., 1996). GP5 induces NA, and GP3 and GP4 
proteins may also partially contribute to NA induction (Cancel-Tirado et al., 2004; Meulenberg et 
al., 1997; Ostrowski et al., 2002; Weiland et al., 1999; Wissink et al., 2003). However, viremia 
may still occur even in the presence of NA (Christianson et al., 1992; Dee et al., 1998; Rossow et 
al., 1994). A low titer of neutralizing antibodies may increase the association of viral particles 
with permissive macrophages through binding of virus-antibody complexes to the Fc receptor, 
and thus facilitate virus infection. This phenomenon is known as antibody-dependent 
enhancement (ADE) (Christianson et al., 1993; Yoon et al., 1996; Yoon et al., 1997), which may 
be a factors to cause PRRSV persistence. One reason why PRRSV infection exhibits the delayed 
and low neutralizing antibody production may be the presence of a nearby immunodominant 
decoy epitope, which may induce a robust, early, and non-protective immune responses 
(Ostrowski et al., 2002). An alternative explanation may be a glycan-shielding phenomenon. The 
glycosylation of GP5 at certain residues diminishes the immunogenicity of the nearby 
neutralizing epitope and thus help the virus evade from the neutralizing antibody (Jiang et al., 
2007b). Together, these findings support the suggestion that PRRSV has evolved to evade 
immune responses such that a little NAs are produced and NAs in the serum do not react with 
virions due to the shielding of NA epitopes.    
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3.2.3 Cellular immunity 
PRRSV-specific T cell response first appears in peripheral blood at approximately 4 weeks 
after infection (Bautista and Molitor, 1997), which is mainly characterized by IFN-γ and IL-2 
production. IFN-γ mRNA is detected in the lymph nodes, lungs, and peripheral blood 
mononuclear cells of infected-pigs (Lopez Fuertes et al., 1999; Rowland et al., 2001). This 
response blocks PRRSV replication in cells by inhibiting of viral RNA synthesis via 
dsRNA-inducible protein kinase (Rowland et al., 2001). However, numbers of PRRSV specific 
IFN-γ-producing T cells are low, causing the relatively low IFN-γ response (Banyer et al., 2000; 
Diaz et al., 2005). IL-12 and IFN-α are involved in the differentiation of naïve T cells into 
antigen-specific IFN-γ secreting cells (Banyer et al., 2000; Cousens et al., 1999; Kadowaki et al., 
2000; Tough et al., 1999) and the levels of IL-10 seem to inversely correlated with IFN-γ 
response. During PRRSV infection, neither IL-12 nor IFN-α is stimulated significantly and IL-10 
level is found to be raised, resulting in deceleration of the development of PRRSV-specific IFN-γ 
response. Activated T cells appear to be directed against all the structural proteins (Bautista et al., 
1999; Jiang et al., 2007a; Jiang et al., 2007b; Lopez Fuertes et al., 1999), but their protective role 
is unknown.  
3.2.4 PRRSV immunosuppression and secondary infection 
PRRSV is often associated with other pathogens. This leads to an assumption that PRRSV 
may cause host immunosuppression to result in secondary diseases including postweaning 
multisystemetic wasting syndrome, arthritis, eye infections, and various other infections 
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(Buddaert et al., 1998; Chang et al., 2005; Cooper et al., 1995; Diaz et al., 2005). Since AMs 
comprise the first line of innate immune defense in the lungs and also are the primary target cells 
for PRRSV, suppression of macrophage functions by PRRSV infection would increase the host’s 
susceptibility to secondary infection. Although some researchers have suggested that PRRSV 
may not be immunosuppressive (Drew, 2000; Molitor et al., 1997), further studies on PRRSV 
immunity show that the IFN-α response to PRRSV is significantly weak, and the weak innate 
immune response is consistent with a delayed and minimal stimulation of antigen-specific 
humoral and cell-mediated immunity during PRRSV infection in pigs.  
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HYPOTHESIS AND OBJECTIVES OF THE THESIS 
Although PRRSV has been documented to down-regulate IFN production, genes responsible 
for IFN regulation and the mechanism of down-regulation are largely unknown. For severe acute 
respiratory syndrome coronavirus (SARS-CoV), at least 4 viral proteins have been reported to 
inhibit type I IFN pathways (Kopecky-Bromberg et al., 2007). For PRRSV, as illustrated above, 
Nsp1, Nsp2, Nsp4, and Nsp11 have been suggested to have potential for down-regulation of IFN.  
Among Nsp’s, Nsp11 has been of my interest as the potential protein regulating the type I 
IFN responses. Viral proteins containing an RNase activity have been shown to block type I IFN 
induction by inhibiting steps of the production pathways including the cleavage of extracellular 
or intracellular viral RNAs and degradation of cellular transcription factors (Li et al., 2006; 
Magkcuras et al., 2008; Weber et al., 2004). PRRSV Nsp11 contains an endoribonuclease 
activity for uridylate-specific cleavage of RNA in its NendoU domain (Nedialkova et al., 2009). 
Therefore, it is hypothesized that PRRSV Nsp11 may possess the inhibitory function for type I 
IFN production. Based on this hypothesis, we have developed three specific aims that form the 
chapters of my thesis. 
Objective 1: The inhibitory function of PRRSV Nsp11 for type I IFN production pathways was 
examined. The effects on both IRF3-mediated and NF-κB-mediated pathways by Nsp11 were 
investigated. NendoU mutant genes were constructed and examined for the suppressive ability of 
type I IFN. NendoU mutant viruses were generated using infectious clone to examine their 
viability and infectivity. 
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Objective 2: An attenuated virus containing weak IFN suppressive ability may be a possible 
vaccine candidate to control PRRSV. Therefore, we wanted to look for a natural Nsp11 mutant 
containing weak or no IFN inhibitory function. With this purpose, 16 PRRSV field isolates and 
their Nsp11 genes were examined for the IFN suppressive ability, and based on the results 
possible candidates were picked and aligned with the control Nsp11 sequence FL12-Nsp11. 
Possible mutations were constructed to research on the additional active site(s) within Nsp11 
responsible for type I IFN suppression. 
Objective 3: In order to understand other effects in virus-infected cells by Nsp11, the cellular 
transcription responses in the presence of Nsp11 were monitored and investigated. For this 
purpose, MARC-145 expressing Nsp11 stable cell line (MARC-Nsp11) were established using 
retrovirus transfer system and RNA microarray of cellular global genes transcription were 
conducted using this cell line. Based on the results of the RNA microarray, the cell cycle 
pathway was further studied.  
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CHAPTER 2: NON-STRUCTURAL PROTEIN 11 OF PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS AS AN INTERFERON ANTAGONIST AND THE 
ROLE OF NENDOU FOR INTERFERON PROMOTER STIMULATOR-1 
DEGRADATION AND VIRUS REPLICATION 
Abstracts 
Type I interferons (IFN-α/β) play a key role in antiviral defense, and porcine reproductive and 
respiratory syndrome virus (PRRSV) has been shown to down-regulate the IFN response in both 
virus-infected cells and pigs. We show in the present study that non-structural protein (Nsp) 11 of 
PRRSV contained a strong suppressive activity for IFN-β production. As a cytosolic protein, 
Nsp11 suppressed both IRF3 and NF-κB activities in the cytoplasm when stimulated with a 
dsRNA analogue and TNF-α, respectively. Nsp11 inhibited the phosphorylation of IRF3 and IκB, 
and as a consequence, their nuclear translocations were blocked, leading to the inhibition of IFN 
production. This inhibition was RIG-I dependent, and the mRNA of IPS-1 which is the common 
stimulator for both IRF3 and NF-κB was found to be degraded in both Nsp11 gene-transfected 
cells and PRRSV-infected cells. Since Nsp11 is a nidovirus-specific endoribonuclease (NendoU), 
the structure function relationship was examined using a series of Nsp11 mutants for their 
abilities for IFN down-regulation, including 3 substitutions at catalytic sites in NendoU domain, 
2 substitutions that impaired the protein structure, and 2 serine substitutions that retained the 
fully functional NendoU activity. The mutants that impaired the NendoU activity lost the IFN 
inhibitory activity and the degradation of IPS-1 mRNA was inhibited. When the mutations were 
introduced into infectious cDNA clones, all except the serine mutants appeared to be 
replication-defective and no progeny was produced. The NendoU catalytic mutant viruses 
expressed the N and Nsp2/3 proteins but their infectivity diminished after 2 passages. Taken 
together, our data show that Nsp11 functions as an IFN antagonist and the Nsp11 NendoU 
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activity is associated with IPS-1 mRNA degradation and PRRSV replication. 
Introduction 
Type I interferons (IFN-α/β) play a key role for antiviral defense in a host (Haller and 
Weber, 2007; Randall and Goodbourn, 2008; Sammuel, 2001). For their production, viral RNAs 
are first detected by specific receptors including toll-like receptor 3 (TLR-3), retinoic 
acid-inducible gene I (RIG-I), or melanoma differentiation-associated gene 5 (MDA5). 
Activation of these receptors will recruit IFN-β promoter stimulator 1 (IPS-1) and induce 
TANK-binding protein-1/I-κB kinase ε (TBK-1/IKKε) and TGFβ-activated kinase-1 (TAK-1) as 
downstream kinases, resulting in the phosphorylation of interferon regulatory factor 3 (IRF3) and 
subunits of the nuclear factor (NF)-κB (Bowie and Unterholzner, 2008; De Clercq, 2006a; Sadler 
and Williams, 2008). Nuclear-localized IRF3, NF-κB, and activating transcription factor-2 
(ATF-2)/c-Jun (activating protein-1) then form a transcriptionally competent enhanceosome 
along with cAMP response element-binding (CREB)-binding protein (CBP) and other 
transcription factors, leading to the production of type I IFNs (Panne, Maniatis, and Harrison, 
2007). 
Porcine reproductive and respiratory syndrome (PRRS) is a swine disease emerged in the 
late 1980s in the US and Germany independently and almost simultaneously (Benfield et al., 
1992; Keffaber, 1989). PRRS has since quickly spread globally and become one of the most 
economically important diseases to the pork industry worldwide. The causative agent is PRRS 
virus (PRRSV) which belongs to the family Arteriviridae that forms the order Nidovirales along 
with two other virus families, Coronaviridae and Roniviridae. The viral genome is a 
single-strandes positive-sense RNA containing 10 open reading frames (ORFs): ORF1a, ORF1b, 
ORF2a, ORF2b, ORF3 though ORF7, plus the newly identified ORF5a (Firth et al., 2011; 
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Johnson et al., 2011).  
PRRSV infection may cause the suppression of IFN production in the lungs of pigs where 
PRRSV actively replicates by infecting alveolar macrophages (Buddaert, Van Reeth, and 
Pensaert, 1998; van Aken et al., 2006). Numerous mechanisms have been reported for viruses to 
escape from host innate immune response. Since dsRNA plays a central role in IFN induction, 
viral proteins containing RNA-binding capability have been shown to block IFN production and 
action. The E3L protein of poxviruses is able to inhibit activation of IRF3, NF-κB, and AP-1 by 
sequestering its viral dsRNA (Xiang et al., 2002) and the NS1 protein of influenza virus blocks 
the RNaseL pathways (Min and Krug, 2006). Viral proteins containing an RNase activity have 
also been shown to block the type I IFN induction. The Erns protein of bovine viral diarrhea virus 
(BVDV) is an exoribonuclease, targeting extracellular RNAs which trigger IFN secretion 
(Magkouras et al., 2008). As with those viruses, PRRSV may have developed a similar 
RNA-involved mechanism to suppress IFN production. PRRSV non-structural 11 (Nsp11) is a 
cleavage product of the PP1ab polyprotein. PP1ab is a large multi-domain-containing replicase 
protein translated directly from the viral genome. Nsp11 is a 223 amino acids protein containing 
a highly conserved NendoU domain unique for viruses in the order Nidovirales. The NendoU 
domain resides in the C-terminal region of Nsp11 (Gorbalenya et al., 2006; Ivanov et al., 2004) 
and shows a distant relationship with the XendoU family, an endoribonuclease derived from 
Xenopus laevis (Laneve et al., 2003). NendoU has the activity for uridylate-preference cleavage 
of RNA and is consisted of two subdomains. Subdomain A contains the nuclease activity while 
subdomain B may be important for the overall protein structure. In severe acute respiratory 
syndrome coronavirus (SARS-CoV), the NendoU activity is mapped to Nsp15 (Bhardwaj, 
Guarino, and Kao, 2004; Gorbalenya et al., 2006; Ivanov et al., 2004; Ricagno et al., 2006; 
 41  
Snijder et al., 2003; Xu et al., 2006), and the crystallography shows that Nsp15 forms a hexamer 
to achieve the optimal activity (Joseph et al., 2007). For equine arteritis virus (EAV) in the family 
Arteriviridae, Nsp11 is the endoribonuclease and this activity has been shown to be essential for 
virus replication (Posthuma et al., 2006). Here we show that PRRSV Nsp11 contained the ability 
for IFN-β suppression in cells. The suppressive activity was mediated by the reduced 
phosphorylation of IRF3 and IκB, which was resulted from the degradation of IPS-1 mRNA. The 
Nsp11 mutants that lost the NendoU activity was unable to degrade IPS-1 mRNA and thus 
unable to suppress IFN production. The NendoU knockout mutant viruses were also unable to 
replicate. Our data show that the PRRSV NendoU activity plays an essential role for viral 
replication and modulation of innate immunity during infection. 
Materials and Methods 
Cells and viruses: MARC-145 (a subline of MA104 Africa green monkey kidney cells;(Kim et 
al., 1993) and HeLa (NIH AIDS Research Reference Reagent Program, Germantown, MD) cells 
were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Mediatech Inc, Manassas, 
VA) containing a 10% heat-inactivated fetal bovine serum (FBS; Hyclone, Logan, UT) in a 
humidified incubator with 5% CO2 at 37°C. Baby hamster kidney (BHK-21) cells were 
maintained in modified Eagle’s medium (MEM; Mediatech Inc, Manassas, VA) supplemented 
with a 10% heat-inactive FBS. PRRSV strain FL12 was generated from its infectious clone 
pFL12 (Truong et al., 2004) and propagated in MARC-145 cells. Recombinant vesicular 
stomatitis virus expressing green fluorescent protein (VSV-GFP) was kindly provided by Adolph 
Garcia-Sastre (Mt. Sinai School of Medicine, New York, NY). VSV-GFP was propagated in 
BHK-21 cells and titrated in MARC-145 cells using the standard plaque assay. Equine arteritis 
virus (EAV) strain Bucyrus was amplified and titrated in MARC-145 cells. 
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DNA cloning: The PRRSV Nsp11 coding sequence was amplified by PCR from pFL12 (Truong 
et al., 2004) using primers listed in Table 2.1. The PCR fragment was cloned into the 
pCMV-Tag1 mammalian expression vector (Strategene, La Jolla, CA) using BamHI and XhoI. 
The Nsp11 gene fused with the N-terminal Flag tag was digested using BamHI and XhoI and 
ligated into the pXJ41 mammalian expression vector (Xiao et al., 1991), which was designated 
as pXJ41-Flag-Nsp11. All Nsp11 NendoU mutant plasmids were generated using 
site-mutagenesis as described below using pXJ41-Flag-Nsp11 as the backbone plasmid. The 
luciferase reporter plasmids pIRF3-luc and pIFN-β-luc were provided by Stephen Ludwig 
(Institute of Molecular Medicine, Heinrich-Heine-Universitat, Germany). The pIRF3-luc plasmid 
contains the luciferase gene in front of four copies of positive regulatory domain I/III (PRD I/III) 
of the IFN-β promoter. The pIFN-β-luc plasmid contains the luciferase reporter gene placed 
under the IFN-β promoter. pPRDII-luc contains two copies of the NF-κB binding region (PRD II) 
of the IFN-β promoter in front of the luciferase gene and was provided by Stanley Perlman 
(University of Iowa, Iowa city,  IA; (Zhou and Perlman, 2007). For pTATA-luc, the luciferase 
gene was placed downstream of the TATA-box promoter and was used as a basal level control. 
pRL-TK (Promega, Madison, WI) contains the Renilla luciferase gene under control of the 
herpes simplex virus thymidine kinase promoter and was used as an internal control to normalize 
transfection efficiencies. The pcDNA3-RIG-I and pcDNA3-IPS-1 plasmids were obtained from 
Joanna Shisler (University of Illinois at Urbana-Champaign, Urbana, IL). The pcDNA3-RIG-I 
plasmid contains the functionally activated caspase activation and recruit domain (CARD) and 
thus is constitutively active. 
Antibodies and chemicals: Polyinosinic:polycytidylic (poly[I:C]), anti-Flag MAbM2, 
anti-IPS-1 polyclonal Ab (PAb), anti-phospho-IκB monoclonal Ab (MAb), and anti-IκB 
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monoclonal Ab (MAb) were purchased from Sigma (St. Louis, MO). Anti-β-actin MAb, 
anti-IRF3 PAb, anti-human heat shock protein 90 (HSP90) MAb, and anti-human 
poly-[ADP-ribose] polymerase (PARP) PAb were purchase from Santa Cruz Biotechnologies Inc. 
(Santa Cruz, CA). PAbs for phosphor-IRF3 (Ser396) and TNFα were purchased from cell 
signaling (Danvers, MA). The peroxidase-conjugated goat anti-mouse IgG and fluorescein 
(FITC)-conjugated goat anti-mouse IgG were purchased from Jackson Immuno Research (West 
Grove, PA). The goat anti-rabbit antibody conjugated with Texas-red and the goat anti-mouse 
antibody conjugated with Alexa-green were purchased from Invitrogen (Carlsbad, CA).  
The PRRSV Nsp11-specific rabbit antiserum was generated as follow. Since PRRSV 
wild-type Nsp11 was toxic to E. coli (Nedialkova et al., 2009), one of its NendoU mutants, 
K3779A, was subcloned into the pET-28a(+) expression vector containing a His tag at the 
C-terminus, and this plasmid was transformed into E. coli BL21 (primers were listed in Table 3). 
Nsp11 produced in E. coli was purified and concentrated to 1 mg/ml using the HisTrap column 
according to the manufacturer’s instruction (GE Healthcare Life Sciences, Piscataway, NJ). A 
total 2 mg of protein was injected to a rabbit 5 times at 2-week intervals, and blood was collected 
periodically to examine the production of Nsp11-specific antibodies by immunoblot and 
immunofluorescence. Anti-Nsp11 antiserum was generated at the Immunological Research 
Center (University of Illinois, Urbana, IL).  
Dual luciferase assay: Luciferase reporter activities were determined in HeLa or MARC-145 
cells upon poly(I:C) stimulation. Cells were seeded in 12-well plates and in each well, 0.05 µg of 
pRL-TK, 0.5 µg of pIFN-β-luc, pIRF3-luc, pPRDII-luc, or pTATA-luc, and 0.5 µg of 
pXJ41-Flag-Nsp11 or its NendoU mutants were co-transfected using Lipofectamine 2000 
according to the manufacturer’s instruction (Invitrogen). At 24 h post-transfection, 0.5 µg of 
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poly(I:C) was transfected into cells for 16 h. Cells were lysed using the Passive lysis buffer 
(Promega) and supernatants were measured for luciferase activities using the Dual Luciferase 
Reporter assay system (Promega) and the luminometer (Wallac 1420 VICTOR, Perkin Elmer, 
Waltham, MA). For RIG-I and IPS-1 stimulation, 0.5 µg of pcDNA3-RIG-I or pcDNA-IPS-1 
was co-transfected with the pIFN-β-luc reporter. At 48 h post-transfection, cells were lysed and 
measured for luciferase activities, which was then normalized using Renilla luciferase according 
to the manufacture’s instruction (Promega). 
VSV-GFP bioassay: The VSV-based IFN bioassay is described elsewhere (Kim et al., 2010). 
Culture supernatants from HeLa cells were made for two-fold serial dilutions. MARC-145 cells 
grown in 96-well plates were incubated with each dilution of supernatants for 24 h and infected 
with VSV-GFP at a multiplicity of infection (MOI) of 0.1. GFP expression was visualized by 
fluorescent microscopy at 16 h post-infection. The amounts of IFN in the culture supernatants 
were inversely correlated with the numbers of green foci and were presented as the inhibitory 
ability for VSV-GFP replication. 
Immunofluorescence assay (IFA): HeLa cells were grown on coverslips for 16 h. Cells were 
then transfected with 2 μg of pXJ41-Flag-Nsp11 or pXJ41 for 24 h. For IRF3 nuclear 
translocation, cells were transfected with 1 μg of poly(I:C) for 6 h. For p65 nuclear translocation, 
cells were incubated with 20 ng/ml of TNF-α for 1 h at 24 h post-transfection. Cells were fixed 
with 4% paraformaldehyde in PBS at room temperature (R/T) for 15 min, followed by 
permeabilization for 10 min using 0.1% Triton X-100 in PBS at R/T. After washing 3 times with 
PBS, cells were incubated with anti-Flag MAb (1:600) together with anti-IRF3 PAb (1:200) or 
anti-p65 PAb (1:100) for 1 h at R/T. Following 3 washes again with PBS, cells were incubated 
with goat anti-rabbit antibody conjugated with Texas-red (1:500) or goat anti-mouse antibody 
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conjugated with Alexa-green (1:800) for 1 h. The nuclei were stained with 4, 
6-diamidino-2-phenylindole (DAPI; Molecular Probes Inc., Eugene, OR). For co-staining of 
Nsp2/3 and N proteins, PRRSV-infected MARC-145 cells were stained with rabbit 
Nsp2/3-specific PAb (1:2000; obtained from Eric Snijder, Leiden University Medical Center, 
Leiden, Netherlands) and SDOW17 MAb (1:200). For co-staining of IPS-1 and Nsp11 proteins 
in virus-infected MARC-145 cells, rabbit serum specific for PRRSV Nsp11 (1:400) and mouse 
IPS-1 specific PAb (1:200) were used. After staining, coverslips were mounted on microscope 
slides in the mounting buffer (60% glycerol and 0.1% sodium azide in PBS) and visualized by 
fluorescence microscopy (Laborlux 12, Leitz). 
Western blot: Cells were lysed in the RIPA buffer (50 mM Tris/HCl [pH 8], 150 mM NaCl, 1% 
NP-40, 1% SDS, 0.5% sodium deoxycholate) containing 1 mM phenylmethanesulphonyl 
fluoride (PMSF). Insoluble materials were removed by centrifugation at 4°C for 10 min at 
12,000 rpm in a microcentrifuge, and the lysates were resolved by 10% SDS-PAGE, followed by 
a transfer to Immobilon-P (Millipore). After blocking with 5% skim milk powder dissolved in 
TBS-T (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% Tween 20) for 1 h at R/T, membranes 
were incubated with a primary antibody in TBS-T containing 5% skim milk or 5% BSA at 4°C 
overnight. After 5 washes with TBS-T, membranes were incubated with a horseradish 
peroxidase-conjugated secondary antibody for 1 h at R/T and washed 5 times, followed by 
visualization using the ECL detection system (Thermo, Minneapolis, MN). 
Cell fractionation: HeLa cells were grown in 6-well plates to 80% confluency and transfected 
with 2 µg of pXJ41-Flag-Nsp11 each well for 24 h. Cells were stimulated by transfection with 1 
µg of poly(I:C) per well for 6 h and fractionated using the nuclear/cytosol fractionation kit 
(BioVision Technologies, Exton, PA) according to the manufacturer’s instructions with slight 
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modifications. Briefly, cells were collected in 800 µl PBS per well and centrifuged at 600 rpm 
for 10 min in a clinical centrifuge. Cell pellets were resuspended in CEB (cytosolic extraction 
buffer)-A and incubated for 10 min on ice prior to addition of CEB-B. The lysates were 
centrifuged at 4°C for 5 min at 12,000 rpm in a microcentrifuge and the supernatants were kept 
as a cytoplasmic fraction. The nuclear pellet was resuspended in NEB (nuclear extraction buffer) 
and vortexed for 30 s. This step was repeated 5 times. The nuclear pellet was centrifuged at 4°C 
for 10 min with 12,000 rpm and the supernatants were kept as a nuclear fraction. The 
cytoplasmic and nuclear fractions were resolved by 10% SDS-PAGE followed by immunoblot. 
Quantitative PCR: Real-time PCR was performed using ABI Sequence Detector System (ABI 
Prism 7000 and software; Applied Biosystems) in a final volume of 25 μl containing 2.5 μl of 
cDNA from RT reactions, primer mix (2.5 pM each of sense and antisense primers), 12.5 μl of 
SYBR Green PCR Master Mix (Applied Biosystems), and water. The oligonucleotide primers 
were designed using Vector NTI (Invitrogen) or obtained from literatures (Table 2.1). The 
reaction was amplified for 40 cycles of two steps, each cycle comprised of heating to 95°C and 
60°C. The final mRNA levels of genes were normalized using GAPDH.  
Cytotoxicity determination: MARC-145 cells were transfected with pXJ41, pXJ41-Flag-Nsp11, 
or individual mutants of Nsp11 NendoU, and at 24 h post-transfection, cell culture supernatants 
were collected. Cell monolayers were washed once with PBS, and the PBS was combined with 
the corresponding culture supernatants. Cells in monolayers were either trypsinized and collected 
to combine with the corresponding supernatants, or lysed with Trizol for total RNA extraction. 
To determine the number of dead cells for each sample, cells were spun down and resuspended in 
200 μl of PBS. Twenty μl was taken and stained with 20 μl of 0.4% trypan blue (Hyclone), 
followed by counting both dead and live cells using a hemocytometer. Both weakly stained cells 
 47  
and dark blue staining were considered as dead cells, and the cell cytotoxicity was calculated as 
follow: (total # of dead cells)/(total # of cells). The total cellular RNA was determined using the 
NanoDrop 1000 spectrophotometer (Thermo Scientific). 
Site-directed mutagenesis and construction of mutant viruses: Nsp11 NendoU mutations 
were introduced into the pFL12 infectious clone by PCR-based site-directed mutagenesis as 
described elsewhere (Lee et al., 2006). Briefly, PCR was performed using 5 μl of 10x buffer (500 
mM KCl, 100 mM Tris-HCl, pH 9.0, 1% Triton-X, 2 mM Mg2+), 200 ng of pFL12, 125 ng of 
each forward and reverse primer, 1 unit of Pfu, and 25 mM of each dNTP in a 50 μl reaction. The 
amplification was carried out under the following conditions: 95°C for 2 min followed by 18 
cycles of 95°C for 1 min, 58°C for 50 s and 68°C for 22 min, ending with 68°C for 7 min. PCR 
products were digested with 1 unit of Dpn I for 1 h and were transformed into XL Golden E. coli 
(QuikChange II XL Site-Directed Mutagenesis kit, Stratagene, La Jolla, CA). Desired nucleotide 
changes and respective primers were listed in Table 2.1. An out-of-frame Nsp11 defective mutant 
was made by inserting an additional ‘C’ immediately upstream of the first nucleotide of the 
H3735 codon. NendoU mutant plasmids were named as position of the mutation and NendoU 
mutant viruses were named as FL12-Nsp11-(position of the mutation). 
RNA transfection and generation of mutant PRRSV: The full-length infectious clone pFL12 
and its mutant derivatives were linearized with Acl I and used as a template for in vitro 
transcription of capped RNA using the mMESSAGE mMACHINE Ultra T7 kit (Invitrogen) 
according to the manufacture’s instruction. RNAs were precipitated with LiCl and pellets were 
resuspended in 20 μl RNase-free water. Transfection was performed in MARC-145 cells using 
the Amaxa Nucleofector device (Lonza, Walkersville, MD). Approximately 2×107cells were 
trypsinized, washed with PBS, and resuspended in the Nucleofector solution T. For one 
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transfection, approximately 2×106 cells in 0.1 ml were used. For each transfection, 7 µg of 
transcript was added to cell suspension and electroporated using the Amaxa program K-29. Cells 
were diluted in 10 ml of DMEM and seeded in 6-well plates. Supernatants were collected at 16, 
24, 48, and 72 h post-transfection (p.t.) and progeny viruses were recovered and designated as 
‘passage 1’ (P1). P1 viruses was transferred to fresh MARC-145 cells and incubated for 6 days, 
followed by collection of supernatants and designed as ‘passage 2’ (P2). Cytopathic effect (CPE) 
was monitored daily. IFA and RT-PCR were performed at 16 h p.t. and 6 days post-infection. P1 
and P2 supernatants were titrated by endpoint dilution assays, and progeny virus titers were 
expressed as tissue culture infective dose 50 (TCID50). 
Determination of intracellular viral RNA: Intracellular viral RNA was determined by RT-PCR 
from total cellular RNA extracted using Trizol (Invitrogen). The reverse primer Nsp11-R 
(genomic nt positions 11593-11611; 5’-TTCAAGTTGAAAATAGGC-3’) or ORF7-R (genomic 
nt positions 15197-15219; 5’- TGATGCGTCGGCAAACTAAACTC-3’) was used for RT, 
followed by PCR using the forward primer Nsp11-F (genomic nt positions 10943-10962; 
5’-GGGTCGAGCTCCCCGCTCCC-3’) or 5-UTR-F (genomic nt positions 1-26; 
5’-ATGACGTATAGGTGTTGGCTCTATGC-3’). The primer pairs produced either a 669 bp 
fragment from the genomic RNA or a 520 bp fragment from sub-genomic (sg) mRNA7. The 
β-actin transcript was amplified using actin-F (5’- GCGCGGCTACAGCTTCACCAC-3’) and 
actin-R (5’- GGGCGCCAGGGCAGTAATCTC-3’) to generate a 382 bp fragment. 
Results 
Suppression of IFN-β production by Nsp11: Many viruses express viral proteins that degrade 
cellular proteins or bind to RNA to avoid IFN induction and RNA-dependent antiviral effector 
functions (Jacobs, Langland, and Brandt, 1998; Langland et al., 2006; Magkouras et al., 2008; 
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Weber and Haller, 2007). PRRSV Nsp11 contains a motif for endoribonuclease activity referred 
as the NendoU domain. The NendoU knock-out mutants of EAV remained to be able to 
synthesize both genomic and sub-genomic viral RNA, although reduced, suggesting that Nsp11 
may also target cellular RNAs in addition to viral RNA synthesis. Thus, we hypothesized that 
Nsp11 might carry an ability to inhibit type I IFN production by targeting some cellular 
components involved in the IFN production pathway. This hypothesis was supported by previous 
suggestions (Beura et al., 2010; Shi et al., 2011). To confirm this premise, cells were transfected 
with pXJ41-Flag-Nsp11 and stimulated with poly(I:C) followed by IFN reporter assays. While 
cells transfected with the empty vector pXJ41 showed a high induction of IFN, 
Nsp11-transfected cells exhibited a strong suppression of IFN response (Fig. 2.1A). As the 
amount of pXJ41-Flag-Nsp11 was increased, the suppression also increased, indicating that the 
Nsp11-mediated IFN suppression was dose-dependent. To confirm the IFN suppression by 
Nsp11, a VSV-GFP bioassay was conducted (Solorzano et al., 2005) (Fig. 2.1B). Due to the high 
sensitivity of VSV to IFNs in the VSV bioassay, VSV-GFP would grow normally and express 
GFP when a little or no IFN was present in the supernatant whereas VSV replication would be 
inhibited and thus less or no GFP would be expressed when IFN was produced in cells and 
secreted into the culture supernatant. When cells were stimulated for IFN production, VSV-GFP 
did not grow up to the dilution of 1:64 of the supernatant. In cell expressing Nsp11 however, 
VSV-GFP replication was inhibited up to the dilution of 1:16 even without stimulation (Fig. 2.1B, 
bottom panels). The 4-folds reduction of VSV replication in the bioassay confirms the 
suppressive ability of PRRSV Nsp11 for IFN production. 
Construction of Nsp11 NendoU mutants: Studies for XendoU and coronavirus NendoU have 
shown that two His residues at positions 6345 and 6360 (H6345 and H6360), and a Lys residue 
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at 6401 (K6401) of SARS-CoV PP1ab form the catalytic center of the endoribonuclease activity 
of nsp15 (Gioia et al., 2005; Ivanov et al., 2004). In the case of the NendoU activity of EAV 
Nsp11, a double mutation of H2963A and H2978A or a single mutation of H3007A reduced the 
cleavage of RNA to undetectable levels (Posthuma et al., 2006). In addition, D3014 and D3038 
in subdomain B were shown to be critical for both genomic and subgenomic viral RNA synthesis 
(Posthuma et al., 2006) and the Asp mutations rendered the mutant proteins insoluble 
(Nedialkova et al., 2009). These findings were confirmed with the nsp15 protein of SARS-CoV 
(Joseph et al., 2007; Nedialkova et al., 2009). The two Asp residues take part of an extensive 
hydrogen bond network in close proximity to the active site and thus replacing those residues 
may have indirect effects on the Nsp11 activity by disturbing its secondary structure. Thus, to 
study the relationship between the NendoU function and the IFN suppression of PRRSV, 7 
Nsp11 mutants were constructed of which Ala mutations were introduced to the NendoU domain 
of PRRSV Nsp11 (Fig. 2.2A). According to the study of XendoU and the sequence alignments 
among EAV and PRRSV Nsp11 (Laneve et al., 2003; Nedialkova et al., 2009), H3735, H3750, 
and K3779 in subdomain A of PRRSV Nsp11 are thought to be the NendoU catalytic sites, and 
thus H3735A, H3750A, and K3779A mutations were made. D3786 and D3810 in subdomain B 
were thought to impair the secondary structure of PRRSV Nsp11, and thus D3786A and D3810A 
mutations were made. The residues S2982 and S3030 did not affect any functional changes of 
the NendoU activity in EAV (Posthuma et al., 2006), and thus the equivalent mutations of 
S3754A and S3802A were made for PRRSV Nsp11. 
The Nsp11 mutants were then individually examined for their ability for IFN suppression 
by co-transfecting with pIFN-β-luc. While both S3754A and S3802A retained their suppressive 
activities for IFN production by 4 fold as with Nsp11-WT at 16 h post-stimulation, H3735A, 
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H3750A, K3779A, D3786A, and D3810A lost their suppressive activities (Fig. 2.2B). In 
VSV-GFP bioassay, S3754A and S3802A exhibited a 4 fold reduction compared to that of control 
(Fig. 2C), while H3750A and D3810A caused a 2 fold reduction. The remaining mutants did not 
cause a reduction of IFN secretion in the supernatants (Fig. 2.2C). The bioassay data confirms 
the reporter assays and demonstrates that the NendoU activity of Nsp11 was closely associated 
with the suppressive activity for type I IFNs. 
Suppression of IRF3 and NF-κB activation by Nsp11: IFN production is tightly regulated by 
IRF3/7, NF-κB, and AP-1 transcription factors, and among these, IRFs and NF-κB are major 
factors. Thus to determine if the role of these factors were affected by Nsp11, we examined IRF3 
and NF-κB promoter activities using pIRF3-luc and pPRDII-luc. When cells were stimulated 
with poly(I:C), Nsp11-WT, S3754A, and S3802A exhibited a strong suppression of luciferase 
activities, while H3735A and H3750A showed a relatively low suppression (Fig. 2.3A, 2.3B). 
K3779A, D3786A, and D3810A in particular did not result in any significant suppression. These 
results show that Nsp11-WT inhibited the activation of both IRF3 and NF-κB, and since previous 
studies using EAV Nsp11 showed that the NendoU mutation affected the nuclease activity of 
Nsp11, PRRSV Nsp11 NendoU activity is suggested to likely associate with the IRF3- and 
NF-κB-mediated IFN suppression.  
Cytotoxicity of Nsp11: The nsp11 protein of EAV has been shown to be toxic in both 
prokaryotic and mammalian cells (Nedialkova et al., 2009) and thus it is possible that the IFN 
suppression by Nsp11 observed in the luciferase assays may be due to the cell cytotoxicity. To 
exclude this possibility, the viability and the amounts of total cellular RNA were determined in 
cells expressing Nsp11-WT and its mutant proteins (Table 2.2). The amounts of total cellular 
RNA for individual mutants were similar from each other, indicating that the number of cells was 
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comparable for each mutant. In MARC-145 cells expressing Nsp11-WT, the cell viability was 
slightly lower than in control, indicating the toxicity of Nsp11 to a certain extent. However, the 
cells expressing individual mutants showed similar or higher cytotoxicity compared to those of 
Nsp11-WT expressing cells. For D3810A in particular, the cytotoxicity was 13.4, which was 
significantly higher than those of other mutants and the D3810A mutant was the one that lost the 
IFN suppressive activity in the luciferase assays (Fig. 2.2B, 2.2C, 2.3A, 2.3B), indicating that the 
IFN suppression by Nsp11 was not due to the cell cytotoxicity.  
Inhibition of phosphorylation and nuclear translocation of IRF3 by Nsp11: In the resting 
state, IRF3 remains in the cytoplasm as an inactive form, and by stimulation, is phosphorylated 
and translocated to the nucleus. Nuclear localized IRF3 then binds to CBP/p300 and is stabilized 
at the PRD-III/I regions of the IFN-β promoter along with AP-1 binding at PRD-IV and NF-κB 
binding at PRD-II. Thus to examine the basis of Nsp11-mediated IFN suppression, the nuclear 
localization of IRF3 was first examined in the presence of Nsp11 by immunofluorescence and 
cell fractionation. While IRF3 remained in the cytoplasm in unstimulated cells (Fig. 2.4A, top 
panel), the poly(I:C) stimulation caused most IRF3 localized to the nucleus as anticipated (Fig. 
2.4A, second panel). In the presence of Nsp11, IRF3 was distributed in the both nucleus and 
cytoplasm (Fig. 2.4A, bottom panel, white arrows), and in cells where Nsp11 was absent, IRF3 
remained in the nucleus after stimulation (Fig. 2.4A, bottom panel, yellow arrows). The cell 
fractionation study showed similar results to those of immunofluorescence, as the stimulation 
caused the nuclear translocation of IRF3 (Fig. 2.4B, top panel, lanes 1, 2), and in the presence of 
Nsp11, the IRF3 nuclear translocation was reduced (Fig. 2.4B, top panel, lane 3). Poly 
ADP-ribose polymerase (PARP) and heat shock protein 90 (Hsp90) as the nuclear and 
cytoplasmic markers, respectively, were localized in the corresponding compartments indicating 
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the minimal contamination in the cell fractionation. These results show that Nsp11 inhibited the 
IRF3 nuclear translocation. To understand the basis of this observation, the IRF3 
phosphorylation was examined. While the poly(I:C) stimulation triggered the IRF3 
phosphorylation (Fig. 2.4C, top panel, lane 2), its phosphorylation was significantly reduced in 
the presence of Nsp11 (Fig. 2.4C. top panel, lane 4) whereas the total amount of IRF3 remained 
unchanged (Fig. 2.4C, second panel, lanes 1, 2, 3). In contrast, the IRF3 phosphorylation 
remained normally in K3779A-expressing cells (Fig. 2.4C, top panel, lane 6), indicating that the 
NendoU catalytic mutant Nsp11 was able to phosphorylate and translocate IRF3 normally to the 
nucleus. 
Inhibition of NF-κB nuclear translocation and IκB phosphorylation by Nsp11: For 
activation of NF-κB, IκB needs to be phosphorylated and degraded via ubiquitination, which 
leads to the release of p65 and its translocation to the nucleus. Since the NF-κB reporter activity 
was suppressed by Nsp11 (Fig. 2.3B), the nuclear localization of p65 was first examined in cells 
expressing Nsp11. While p65 remained in the cytoplasm in unstimulated cells, the poly(I:C) 
stimulation triggered p65 to localize in the nucleus (Fig. 2.5A, second panel). In 
Nsp11-expressing cells however, p65 did not accumulate in the nucleus even after stimulation 
(Fig. 2.5A, bottom panel, white arrows), whereas the nuclear staining of p65 was evident when 
Nsp11 was absent (Fig. 2.5A, bottom panel, yellow arrow). Since the p65 nuclear translocation 
was inhibited by Nsp11, IκB phosphorylation was next examined in the presence or absence of 
Nsp11. Cells were transfected with pXJ41-Flag-Nsp11 and stimulated with TNF-α for indicated 
times. Cell lysates were prepared and subjected to Western blot using phospho-IκBα MAb. When 
stimulated with TNF-α, the phosphorylated IκBα was readily detectable within 5 min (Fig. 2.5B, 
top panel, lane 2) and degraded shortly after. By 20 min stimulation, the phosphorylated IκBα 
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was virtually undetectable due to rapid degradation. In cells expressing Nsp11, phosphorylated 
IκB was much less than that in the absence of Nsp11, especially at 5 min of TNF-α stimulation 
(Fig. 2.5B, top panel, lane 6). These results indicate that the IκB phosphorylation was inhibited 
by Nsp11. The phosphorylation and degradation of IκB were also examined using the K3779A 
catalytic mutant and IκBα MAb. When stimulated with TNF-α, IκB was rapidly reduced by 10 
min (Fig. 2.5C, top panel, lane 3, lower band) and the reduction was likely due to its 
phosphorylation (stars, Fig. 2.5C, top panel, lane 2, upper band). In the presence of Nsp11-WT, 
however, a less amount of phosphorylated IκB was identified (Fig. 2.5C, top panel, lane 6, upper 
band), whereas the total amount of IκB increased (Fig. 2.5C, lane 7, lower band, cross). This was 
consistent with the data obtained using phospho-IκB MAb. In K3779A-expressing cells however, 
phosphorylated IκB was normally identified after TNF-α stimulation (Fig. 2.5C, top panel, lane 
10, upper band, star) and a lesser amount of IκB was observed at 10 min (Fig. 2.5C, top panel, 
lane 11, lower band, cross), indicating that unlike Nsp11-WT, the catalytic mutant K3779A did 
not prevent the IκB phosphorylation. 
IFN suppression by activated RIG-I and IPS-1 in the presence of Nsp11: Sensors for viral 
RNA for IFN induction include TLR3, TLR7, and RIG-I/MDA5. RIG-I and MDA5 belong to the 
DEx(D/H) box RNA helicases family and function as a dsRNA sensor in the cytoplasm while 
TLR3 and TLR7 are extracellular receptor for dsRNA. Since IFN production was induced using 
poly(I:C) in the current study, an intracellular sensor would play a role and thus Nsp11 might 
have an effect on the RIG-I/MDA5 signaling pathways. Because the nuclear translocation of 
IRF3 and NF-κB was blocked by Nsp11 (Fig. 2.4; Fig. 2.5) which is a cytoplasmic protein, the 
blocking process may occur in the cytoplasm. We took an advantage of expressing IPS-1 and the 
N-terminal CARD domain of RIG-I which constitutively activates the RIG-I signaling as a 
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stimulator. When cells were co-transfected with pXJ41 or K3779A, pcDNA3-RIG-I induced the 
reporter activity strongly. When Nsp11-WT was expressed however, the induction decreased 
significantly and the decrease was dose-dependent (Fig. 2.6A). Similarly, in cells co-expressing 
IPS-1 and pXJ41 or K3779A, the luciferase activity was stimulated by up to 80 fold (Fig. 2.6B), 
but was significantly suppressed when co-expressed with pXJ41-Flag-Nsp11. The suppression 
by Nsp11 was dose-dependent. The reporter activities remained to a basal level in cells 
co-transfected with pTATA-luc and Nsp11-WT, along with each of the four inducers (Fig. 2.6C), 
indicating that the stimulation by poly(I:C), RIG-I, IPS-1, and IRF3 were all specific for the IFN 
promoter. Since Nsp11 suppressed the IFN-β production by both poly(I:C) and RIG-I stimulation, 
the Nsp11-mediated IFN suppression likely occurs  downstream of RIG-I.  
Degradation of IPS-1 mRNA by Nsp11: IPS-1 is a mitochondrial membrane-anchored protein 
which associates with RIG-I by the CARD domain and TBK-1 and TAK-1 through different 
adaptors. TBK-1 and TAK-1 phosphorylate IRF3 and downstream IKKα/β and activate IRF3 and 
NF-κB, respectively. Since the Nsp11-mediated IFN suppression was inducible by both activated 
RIG-I and IPS-1 (Fig. 2.6), Nsp11 was hypothesized to modify the IPS-1 function. We therefore 
first examined if IPS-1 would normally be expressed in the presence of Nsp11. MARC-145 cells 
were co-transfected with pcDNA3-IPS-1 and pXJ41-Flag-Nsp11, and total cellular RNA was 
extracted for RT-PCR for IPS-1 mRNA. Intriguingly, in cells co-expressing IPS-1 and Nsp11, 
IPS-1 mRNA was reduced significantly compared to that in cells absent of Nsp11 (Fig. 2.7A, 
lanes 3, 5). In cells expressing Nsp11 only, endogenous IPS-1 mRNA was almost undetectable 
(Fig. 2.7A, lanes 4), suggesting an IPS-1 mRNA degradation by Nsp11. To confirm this 
observation, quantitative RT-PCR was conducted. GAPDH mRNA was used as an internal 
control since it was not obviously changed in both Nsp11-expressing and non-expressing cells 
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(Fig. 2.7A, bottom panel) as determined by RT-PCR and quantitative (q)-RT-PCR (Fig. 2.7B, Ct 
numbers at the bottom of the bar chart). For endogenous IPS-1 mRNA however, the amount was 
reduced by almost 5 fold when Nsp11 was present, compared to that in cells in which Nsp11 was 
absent. In pcDNA3-IPS-1 transfected cells, the amount of IPS-1 mRNA reduced by more than 
half in the presence of Nsp11 compared to that of cells absent of Nsp11 (Fig. 2.7B). 
Since IPS-1 mRNA was found to be degraded by Nsp11, Western blot was conducted to 
examine the presence of IPS-1 protein. Since ectopically expressing IPS-1 was Flag-tagged, 
anti-Flag MAb would detect only exogenous IPS-1, while anti-IPS-1 polyclonal Ab would detect 
both exogenous and endogenous IPS-1 in cells. IPS-1 was identified as a 62 kDa protein (Fig. 
2.7C, top, lane 1), and in the presence of Nsp11-WT (Fig. 2.7C, top, lanes 2), it was not detected 
by anti-Flag MAb. For NendoU mutants, S3754A and S3802A which retained the NendoU 
activity showed the IPS-1 degradation as with Nsp11-WT (Fig. 2.7C, top, lane 5, 8), whereas all 
other mutants were unable to reduce the IPS-1 protein (Fig. 2.7C, top, lanes 3, 4, 6, 7, 9). In cells 
expressing Nsp11-WT, S3754A, or S3802A, IPS-1 was barely detectable only after 
over-exposure by anti-IPS-1 polyclonal Ab (Fig. 2.7C, middle, lanes 2, 5, 8,), and they were still 
much less compared to those of other mutants. This indicates that the IPS-1 expression was 
inhibited by Nsp11-WT, S3754A, and S3802A, but was not inhibited by other mutants that lost 
their NendoU activity. Taken together, our data show that Nsp11 was responsible for IPS-1 
mRNA degradation, and the NendoU activity of Nsp11 was most likely the cause of degradation 
to result in the blocking of IPS-1 translation. 
The IPS-1 mRNA degradation was confirmed in PRRSV-infected cells. MARC-145 cells 
were infected with PRRSV, EAV, or VSV at an MOI of 5, 5, and 0.1, respectively, and IPS-1 
mRNA was determined by q-RT-PCR. GAPDH was used as internal control since the cycle 
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numbers (Ct) of GAPDH did not vary from mock-infection and relative virus infection (ΔCt<1; 
Fig. 2.8A, bottom). In PRRSV-infected cells, the amount of IPS-1 mRNA decreased by 3 days 
post-infection compared to that of mock-infected cells (Fig. 2.8A, middle bar chart). It is 
noteworthy that IPS-1 mRNA did not change during the first 2 days of PRRSV infection (Fig. 
2.8A, middle chart), and it is likely due to the fact that PRRSV infection is generally slow and 
incomplete by this time even at infection of a high MOI. A decrease of IPS-1 mRNA was also 
observed in EAV-infected cells, and the decrease was evident by 16 h post-infection. This was 
probably because the EAV infection is generally faster than the PRRSV infection (Fig. 2.8A, 
right chart). The amount of IPS-1 mRNA increased slightly in VSV-infected cells, showing that 
the cells responded to virus infection as anticipated (Fig. 2.8A, left chart). 
RT-PCR indicates that the amounts of GAPDH mRNA were relatively consistent in 
mock-infected and virus-infected cells, but IPS-1 mRNA were less in virus-infected cells, which 
was evident at 3 days post-infection for PRRSV and 16 h post- infection in the case of EAV (Fig. 
2.8B). The consistent results were obtained from Western blot (Fig. 2.8C). For PRRSV infection, 
endogenous IPS-1 was readily detectable by anti-IPS-1 polyclonal Ab in mock-infected cells, but 
at 3 days post-infection, IPS-1 decreased compared to that of mock-infected cells (Fig. 2.8C, top 
panel, lanes 5, 6). The amount of IPS-1 was not reduced in VSV-infected cells (Fig. 2.8C, top 
panel, lanes 1, 2), but reduction was also observed for EAV at 16 h post-infection (Fig. 2.8C, top 
panel, lanes 9, 10). These results indicate that IPS-1 decreased in PRRSV-infected cells, and the 
reduction of IPS-1 was most likely due to the degradation of IPS-1 mRNA by Nsp11. 
The IPS-1 degradation by PRRSV Nsp11 was also examined by IFA during early in 
infection (Fig. 2.8D). MARC-145 cells were infected by PRRSV at an MOI of 5 and examined at 
24 h post-infection. Nsp11 was found to localize around the perinuclear region (Fig. 2.8D, white 
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arrow, second panel from top, lane 1), where IPS-1 was also localized (Fig. 2.8D, top panel, lane 
2). IPS-1 in virus-infected cells was found to decrease (yellow arrows) compared to that in 
uninfected cell (white arrow, Fig. 2.8D, second panel from top, lane 2). It is noteworthy that 
Nsp11 in gene-transfected MARC-145 cells was distributed throughout the cell which differed 
from that of virus-infected cells (Fig. 2.8D, second panel from bottom, lane 1). Regardless of its 
cellular distributions, IPS-1 was reduced in both gene-transfected cells and PRRSV-infected cells 
(white and yellow arrows, Fig. 2.8D second panel from bottom). By contrast, the K3779A 
NendoU mutant did not change the abundance of IPS-1 in K37739A-expressing cells and the 
intensity of IPS-1 staining remained similar to that in untransfected cells (white and yellow arrow, 
Fig. 2.8D, bottom panel, lane 1 and 2). 
Specificity of IPS-1 degradation: Since IPS-1 mRNA was degraded by Nsp11, it was of interest 
to determine whether the degradation was IPS-1 specific. To examine this, mRNAs for IPS-1, 
RIG-I, p65, and IRF3 were individually determined by q-RT-PCR in Nsp11-expressing cells, 
since they are 4 main components in the IRF3-mediated and NF-κB-mediated IFN-ß production 
pathways. Interestingly, q-RT-PCR showed that RIG-I mRNA was also reduced by more than 10 
fold as with IPS-1 mRNA, whereas p65 mRNA and IRF3 mRNA remained relatively unchanged 
(Fig. 2.9). These results suggest that IPS-1 mRNA may not be the only cellular substrate for 
Nsp11, and the Nsp11 function may be less specific. Yet in Nsp11-expressing cells, not all 
species of mRNAs were degraded, and thus it is possible that the folding of mRNAs and/or other 
cellular factors may participate. 
NendoU mutant viruses and their phenotypes: To examine the relationship between the 
NendoU activity and the virus viability, PRRSV mutants were generated. For these mutants, the 
same site mutations as the Nsp11 gene mutations were introduced to infectious cDNA clones as 
 59  
illustrated in Fig. 2.2. An additional mutant was made by inserting a ‘C’ before the first 
nucleotide of the H3735 codon to create an out-of-frame mutation. MARC-145 cells were 
transfected with the full-length genomic RNA transcribed from individual mutant genomic 
clones, and IFA was conducted at indicated times post-transfection (Fig. 2.10). The PRRSV 
Nsp2/3 and N proteins were not detectable for two Asp mutants FL12-Nsp11-D3786A and 
FL12-Nsp11-D3810A even after 72 h post-transfection (p.t.). FL12-Nsp11-H3735A, 
FL12-Nsp11-H3750A, and FL12-Nsp11-K3779A showed a significantly reduced signal for N 
protein compared to wild-type PRRSV at 16 h p.t., but the Nsp2/3 expression was evident (Fig. 
2.10). The numbers of Nsp2/3 positive cells increased by approximately 10% for 
FL12-Nsp11-H3735A, FL12-Nsp11-H3750A, and FL12-Nsp11-K3779A at 24 h p.t. compared to 
those at 16 h p.t. FL12-Nsp11-S3802A and FL12-Nsp11-S3754A expressed both Nsp2/3 and N 
proteins at comparable levels to those of wild-type PRRSV.  
To confirm the IFA results, viral RNA was examined at 16 h p.t. in mutant genomic RNA 
transfected cells. The replication of viral genome was determined for minus-strand RNA using 
Nsp11 gene-specific primers for a 669 bp fragment, and the sub-genomic (sg) mRNA for ORF7 
was determined using a forward primer representing the 5’-UTR and a reverse primer 
representing ORF7 for a 520 bp fragment (Fig. 2.11A). FL12-Nsp11-S3802A produced both 
genome RNA and sgmRNA7 as with FL12-Nsp11-WT (Fig. 2.11B). FL12-Nsp11-D3786A and 
FL12-Nsp11-D3810A however did not produce the genomic RNA and sgmRNA7. 
FL12-Nsp11-H3735A, FL12-Nsp11-H3750A, FL12-Nsp11-S3754A, and FL12-Nsp11-K3779A 
showed similar levels of genomic RNA. FL12-Nsp11-H3735A, FL12-Nsp11-H3750A, and 
FL12-Nsp11-K3779A produced much less sgmRNA7 compared to that of FL12-Nsp11-S3754A 
(Fig. 2.11B). To determine the production of progeny viruses from the mutant genomic clones, 
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the supernatants from transfected cells were transferred to fresh MARC-145 cells and their 
infectivity was monitored over time. FL12-Nsp11-WT, FL12-Nsp11-S3754A, and 
FL12-Nsp11-S3802A exhibited extensive CPEs by 6 days post-infection, and the titers of these 
viruses were determined to be 5.6x102, 5.6x10, and 3.2x102 TCID50/ml, respectively (Table 2.3). 
For FL12-Nsp11-D3786A, FL12-Nsp11-D3810A, FL12-Nsp11-H3735A, FL12-Nsp11-H3750A, 
and FL12-Nsp11-K3779A, no CPE was observed even at 6 days post-infection. The N protein 
staining at 6 days post-infection showed a specific signal for FL12-Nsp11-WT, 
FL12-Nsp11-S3754A, and FL12-Nsp11-S3802A, but no staining was observed for 
FL12-Nsp11-H3735A, FL12-Nsp11-H3750A, FL12-Nsp11-K3779A, pFL12-Nsp11-D3786A, 
and FL12-Nsp11-D3810A. RT-PCR of the supernatants from cells infected with ‘passage 1’ virus 
also confirmed the absence of genomic RNA and sgmRNA7 for these mutant clones, and they 
were the mutants containing the impaired NendoU activity: FL12-Nsp11-H3735A, 
FL12-Nsp11-H3750A, FL12-Nsp11-K3779A, FL12-Nsp11-D3786A, and FL12-Nsp11-D3810A. 
Only FL12-Nsp11-WT, FL12-Nsp11-S3754A, and FL12-Nsp11-S3802A showed the RT-PCR 
positive for both genomic RNA and sgmRNA (Fig. 2.11C), indicating that no progeny virus was 
produced when the NendoU activity was destroyed. 
Discussion 
Viruses have developed various mechanisms during evolution to modulate IFN induction 
so as to evade the host innate immunity. For PRRSV, both North American and European types 
have been shown to produce type I IFN at only low levels (Genini et al., 2008), and different 
isolates may produce varying degrees of IFN production (Lee, Schommer, and Kleiboeker, 2004). 
The VR-2332 and FL12 strains in particular have shown a potent ability of IFN regulation. 
Viruses may code for more than one protein to antagonize type I IFN production (Frieman et al., 
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2009; Siu et al., 2009; Wathelet et al., 2007), and for PRRSV, Nsp1α, Nsp1β, Nsp2, and N 
proteins have been shown to modulate the NF-κB or IFN signaling pathways (Beura et al., 2010; 
Fang et al., 2012; Kim et al., 2010; Song, Krell, and Yoo, 2010; Sun et al., 2012). In the present 
study, we have examined the Nsp11-regulated IFN suppression and found that both the IRF3 and 
NF-κB activations were suppressed by Nsp11. Nsp11 inhibited the phosphorylation of IRF3 and 
IκB and thus blocked their nuclear translocation. When stimulated with an active form of RIG-I 
and IPS-1, Nsp11 caused the reduction of IFN suggesting that Nsp11 functions downstream of 
RIG-I. It is intriguing that IPS-1 mRNA was degraded by Nsp11, and accordingly, IPS-1 protein 
was not expressed. This explains the molecular basis for how Nsp11 suppressed the IRF3 and 
NF-κB activities. When IPS-1 mRNA is degraded, downstream kinases including TBK-1 and 
TAK-1 fail to associate with IPS-1 to form a complex, and thus results in the suppression of 
IRF3 and IκB activation. Although the exact mechanism for IPS-1 mRNA degradation by Nsp11 
remains to be further investigated, it may be explained with the NendoU function. Since NendoU 
contains the endoribonuclease activity, this nuclease activity may degrade IPS-1 mRNA. The 
mutational studies support this hypothesis that the NendoU activity is essential for suppression of 
the NF-κB and IRF3-mediated IFN production. H3735A, H3750A, and K3779A mutants, whose 
RNase catalytic sites were mutated, showed the loss of IFN suppressive function. In the case of 
EAV Nsp11, a double mutation of H3735A and H3750A caused the loss of RNase activity 
(Nedialkova et al., 2009), and it is possible that a single mutation on one of the two residues may 
result in a partial RNase activity. This may explain why H3735A and H3750A showed a partial 
suppression on the IFN-β activation. Residues at D3786 and D3810 may play a role in stabilizing 
the secondary structure of Nsp11 as seen for nsp15 of SARS-CoV (Joseph et al., 2007). Thus, 
D3786A and D3810A that lost their inhibitory function may be due to a structural change of the 
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mutant proteins. S3754A and S3802A, which retained the inhibitory function for IFN-β 
production, degraded IPS-1 mRNA as with Nsp11-WT. Taken together, our data show that the 
Nsp11 mutants that lost their IFN suppressive activity produced the IPS-1 proteins normally, 
suggesting that the IPS-1 mRNA degradation is associated with the RNase activity of Nsp11. 
PRRSV Nsp11 is a cytosolic protein (Fig. 2.4B, bottom panel, lane 6). During the course 
of our study for the IPS-1 mRNA degradation however, it was noted that the subcellular 
distribution of Nsp11 differed in gene-transfected cells and virus-infected cell. In virus-infected 
cell, Nsp11 localized in the perinuclear region, whereas it was widely distributed throughout the 
cytoplasm in gene-transfected cell. Nevertheless, Nsp11 in both virus-infected cells and 
gene-transfected cells retained the ability for IPS-1 mRNA degradation regardless of its 
subcellular distribution.  
Cell cytotoxicity was of an initial concern during our study, since it would be possible 
that the observation of IFN suppression could be the result of “dying cells” due to the 
cytotoxicity by ectopically over-expressing Nsp11. Cell counting experiments however showed 
that Nsp11 mutants mostly exhibited similar to or higher rates of dead cells than that of 
Nsp11-WT. D3810A in particular caused a higher rate of cell death, but this mutant had no IFN 
suppressive activity and no IPS-1 mRNA degradation (Fig. 2.2B, 3A, 3B, 7C), indicating that the 
IFN suppressive activity by Nsp11 was not due to the cell cytotoxicity. In addition, in 
virus-infected MARC-145 cells, Nsp11 was localized to the perinuclear region, which may help 
minimize the Nsp11 toxicity to cells and viruses by preventing from degradation of viral RNA 
and essential cellular RNAs. Therefore, the reduction of IPS-1 mRNA and thus IPS-1 protein in 
virus-infected cells is likely a specific function of Nsp11. 
Examples are available that viral proteins target cellular mRNAs to modulate the 
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expression of host proteins and eventually counteract the antiviral responses of host cells. The 
SARS-CoV nsp1 protein binds to 40S ribosomes and inactivates their translation functions and 
induces template-dependent endonucleolytic cleavages of mRNA (Huang et al., 2011). The 
herpes simplex virus VHS protein specifically targets actively translating mRNA through 
interaction with host EIF4F components and degrades them by endonucleolytic RNA cleavages 
(Feng, Everly, and Read, 2001; Saffran, Read, and Smiley, 2010). Some other viral proteins 
cleave viral RNAs, prevent them binding to pattern recognition receptors (PRRs), and therefore 
evade from the host immune responses. The influenza virus NS1 protein targets intracellular 
viral RNA and prevents RNA binding to RIG-I and PKR, resulting in IRF3 inhibition 
(Garcia-Sastre, 2004; Li et al., 2006; Min and Krug, 2006; Pichlmair et al., 2006). The Erns 
protein of bovine viral diarrhea virus (BVDV) is an exoribonuclease targeting extracellular 
RNAs (Magkouras et al., 2008), and the cleavage of those RNAs by Erns prevents the activation 
of TLR-3 and blocks the RNA-mediated signaling pathways (Magkouras et al., 2008). In the case 
of PRRSV Nsp11, prevention of the binding of viral RNAs to their receptors seems unlikely. 
Binding of RNA to their sensors is the first step in the IFN pathways, and Nsp11 was able to 
block the IFN-β production when stimulated with an active form of RIG-I (Fig. 2.6A). This 
indicates that the signaling components upstream of RIG-I are rather unaffected by Nsp11. Since 
Nsp11 is an endoribonuclease, it may nonspecifically cleave any species of intracellular RNAs. 
Nsp11 however did not reduce the luciferase activity of the control plasmid (Fig. 2.6C), and 
furthermore, the total amounts of IRF3 and p65 were not decreased in Nsp11-expressing cells, 
while phosphorylated IRF3 and phosphorylated IκB were reduced, ruling out the possibility of 
non-specific RNA degradation. Indeed, RIG-I and IPS-1 mRNAs were degraded by Nsp11 (Fig. 
2.9), suggesting that the degradation was rather specific and selective.  
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Based on the consensus sequence of the regulatory TRS motif present in the viral genome, 
a possible role of NendoU has been proposed for regulation of transcription attenuation during 
the minus-strand sgRNA synthesis. For PRRSV, the leader TRS (UUAACC) is highly conserved 
among virus isolates whereas the body TRS is variable in different genes and different isolates. 
The IPS-1, RIG-I, IRF3, and p65 genes do not contain sequences same as the leader TRS. 
Although the consensus body TRS sequences of PRRSV were found at several places in all four 
genes (Table 2.4), the frequency of the sequences in each gene does not support the preferential 
degradation of IPS-1 and RIG-I mRNA as seen in Fig. 2.9. Alternatively, the degradation of 
IPS-1 and RIG-I mRNAs may be due to cellular factors associated with Nsp11, which 
determines the affinity of Nsp11 to different species of mRNA. For SARS-CoV, Nsp15 
recognizes GUU or GU in RNA sequences, cleaving next to the most 3’-uridylate in vitro 
(Ivanov et al., 2004), and the purified form of Nsp15 is able to cleave any input RNA in vitro. 
The non-specific cleavage of RNA by Nsp15 in vitro may also be true for PRRSV Nsp11. In 
cells however, it is possible that the RNA cleavages may require cellular factors, thus binding of 
Nsp11 to these factors may determine different affinities to different mRNA species. The IPS-1 
mRNA may be recognized by these factors to recruit Nsp11 for more efficient degradation than 
p65 and IRF3 mRNAs as seen in Fig. 2.9.  
In our study, the Nsp11 mutant genomic clones were constructed so that type I IFN 
modulation mediated by Nsp11 could be studied using infectious mutant viruses. 
FL12-Nsp11-H3735A, FL12-Nsp11-H3750A, and FL12-Nsp11-K3779A were NendoU-catalytic 
site mutants and these genomic clones appeared non-viable. Although cells transfected with these 
mutant clones were positive for N protein staining in transfected cells, no CPE was observed 
when the P1 culture supernatants were inoculated to fresh MARC-145 cells. Two Asp mutant 
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clones FL12-Nsp11-D3786A and FL12-Nsp11-D3810A were totally negative for N and Nsp2/3 
proteins in genomic RNA-transfected cells as well as P1-inoculated cells, indicating that these 
mutations were also lethal for infectivity and non-viable. The data obtained using the mutant 
genomic clones were mostly consistent with EAV Nsp11 mutant viruses and SARS-CoV Nsp15 
mutant viruses, except for mutant viruses of 3 catalytic-site mutations, FL12-Nsp11-H33735A, 
FL12-Nsp11-H3750A, and FL12-Nsp11-K3779A. (Ivanov et al., 2004; Kang et al., 2007; 
Posthuma et al., 2006). Nevertheless, our data suggests that the NendoU domain of PRRSV 
Nsp11 plays an important role for virus replication and is also involved in the processing of viral 
RNA synthesis. In summary, we showed that PRRSV Nsp11 has an ability to degrade IPS-1 
mRNA and provide evidence for a correlation between the type I IFN inhibition and NendoU 
activity of Nsp11 which is crucial for viral replication. 
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CHAPTER 3: VARIATION OF NON-STRUCTURAL PROTEIN 11 OF PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS FOR IFN SUPPRESSION 
Abstract 
Type I interferons (IFN-α and IFN-β) play an important role in innate host defense 
against viral infection and PRRSV is known to modulate the type I IFN responses. Previous 
studies in our lab demonstrate that the Nsp11 NendoU activity was associated with the IFN 
suppression and was also essential for PRRSV replication. To study whether other IFN 
suppression activity is present in Nsp11 independent from the NendoU activity, 16 North 
American PRRSV isolates were examined with regard to their IFN-β suppression. PRRSV 
isolates differentially suppressed IFN-β promoter activity in MARC-145 cells. These activities 
were correlated with the amount of MxA mRNA. Nsp11 gene was cloned and sequenced for 
individual isolate, and examined for their ability for IFN-β regulation. Among different Nsp11s, 
Nsp11 from isolate 17401 (17401-Nsp11) showed lesser IFN suppressive activity when 
compared to that of other viruses. Based on the sequence comparisons, nine mutants were 
generated using 17401-Nsp11 as backbone, and alanine at position 160 in 17401-Nsp11 was 
identified as the amino acid responsible for IFN suppression. All mutants retained the IPS-1 
degradation activity, suggesting that the mechanism for IFN suppression may differ from the 
NendoU RNase activity.  
Introduction 
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Porcine reproductive and respiratory syndrome virus (PRRSV) is the causative agent of 
porcine reproductive and respiratory syndrome (PRRS) in swine and contains a single-stranded 
positive RNA genome. The virus belongs to the family Arteriviridae in the order Nidovirales. 
PRRSV causes reproductive failure in pregnant sows and respiratory disease in nursery and 
finish pigs and is the major economic problem in the swine industry. The primary target of 
PRRSV is porcine alveolar macrophage (PAM) (Vilcek et al., 1968; Wensvoort et al., 1991).  
Type I interferons (IFN-α and IFN-β) are synthesized and secreted by many eukaryotic 
cells in response to viral infection (Haller and Weber, 2007; Randall and Goodbourn, 2008; 
Samuel, 1991). Initiation of IFN synthesis typically involves binding of IFN-β gene promoters’ 
positive regulatory domain (PRD) by specific transcription factors that collectively comprise the 
transcriptional enhanceosome. These transcription factors include ATF-2/c-jun (AP-1), nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB), and members of IFN regulatory 
factor (IRF) family. Among these NF-κB and IRFs play a major role and AP-1 contributes less 
(Bowie and Unterholzner, 2008; De Clercq, 2006; Sadler and Williams, 2008). Viral infection 
leads to activation of these transcription factors and subsequently to the synthesis and secretion 
of IFN-β. This process triggers a cascade that leads to the secretion of a subset of IFN-α gene 
products to express IFN-stimulated genes (ISGs) which have diverse functions to protect host 
from virus infection (Honda et al., 2006; Schindler and Darnell, 1995). 
Previous studies have shown that only low levels, if any, of IFN-α are recovered from the 
lung of PRRSV-infected pigs or virus-infected alveolar macrophages in vitro (Buddaert et al., 
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1998; van Aken et al., 2006); (Albina et al., 1998). Furthermore, PRRSV replication was 
inhibited by IFN-α (Albina et al., 1998), suggesting that PRRSV may have the ability to suppress 
type I IFN production.  
Recent studies on the molecular basis of IFN suppression by PRRSV have identified 
Nsp1, Nsp2, Nsp11, and N proteins as IFN antagonists (Fang et al., 2012; Kim et al., 2010; Li et 
al., 2010; Song et al., 2010; Sun et al., 2010). Nsp11 down-regulates the type I IFN production 
pathway by blocking the activation of both IRF3 and NF-κB in MARC-145 cells and 
interferon-beta promoter stimulator 1 (IPS-1) has been found to be reduced due to its mRNA 
degradation by the Nsp11 NendoU activity. The NendoU activity was essential for PRRS 
infectivity and NendoU knockout mutant genomic clones failed to produce progeny mutant 
viruses. In current study, we explored to identify an additional site in Nsp11 that may modulate 
IFN suppression. Nsp11 gene was cloned from different PRRSV isolate and examined for the 
IFN suppression. The Nsp11 gene from isolate 17401 (17401-Nsp11) was observed to contain a 
weak but additional activity suppressive activity for IFN-β and IRF3 reporters but not NF-κB 
reporter, suggesting that 17401-Nsp11 may be a natural mutant involved in the IFN suppression 
besides the NendoU activity. By site-directed mutagenesis, alanine at position 160 (Ala160) was 
identified to contribute to the suppression of IFN induction likely independent from the NendoU 
activity.   
Materials and Methods 
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Cells and viruses: MARC-145 (a subline of Africa green monkey kidney cells; (Kim et al., 1993) 
was maintained in Dulbecco’s modified Eagle’s medium (DMEM; Mediatech Inc, Manassas, VA) 
containing 10% heat-inactivated fetal bovine serum (FBS; Hyclone, Logan, UT) in a humidified 
incubator with 5% CO2 at 37°C. PRRSV strain FL12 was generated from its infectious clone 
pFL12 (Truong et al., 2004) and propagated in MARC-145 cells. PRRSV isolates 18402, 
16244B, 10100, 16138, 12773, 15959, 11176, 39049, 14680, 20169, 17401, 11604, 17405, 
RespPRRSV, and PrimePac were obtained from Dr. Fernando Osorio (University of Nebraska, 
Lincoln, NE). PRRSV PA8 is described elsewhere (Wootton et al., 2000). All virus isolates were 
propagated in Zmac cells (Calzada-Nova et al., 2011) and aliquoted and stored at -80°C until use. 
Virus titers were determined in MARC-145 cells by microtitration infectivity assay and recorded 
as 50% tissue cultural infectious does per ml (TCID50/ml).  
DNA cloning: To construct FL12-Nsp11, the Nsp11 coding sequence was amplified by PCR 
from FL12 (Truong et al., 2004) using primers listed in Table 3.1. The PCR fragment was cloned 
into the mammalian expression vector pCMV-Tag1 (Strategene, La Jolla, CA) using BamHI and 
XhoI sites. The Nsp11 gene fused with the N-terminal Flag tag was digested with BamHI and 
XhoI and ligased into the mammalian expression vector pXJ41 (Xiao et al., 1991). To clone 
Nsp11 sequence from other viruses, viral RNAs was extracted using QIAamp according to the 
instruction (QIAGEN, Valencia, CA). The reverse primer was used for reverse transcription to 
produce cDNA followed by PCR to amplify Nsp11 gene using the Nsp11 specific primers (Table 
3.1). The amplified fragment was then cloned into pXJ41 using BamHI and XhoI. The plasmids 
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IRF3-luc and IFN-β-luc were provided by Stephen Ludwig (Institute of Molecular Medicine, 
Heinrich-Heine-Universitat, Germany). The IRF3-luc plasmid contains the luciferase gene in 
front of four copies of positive regulatory domain I/III (PRD I/III) of the IFN-β promoter region. 
The IFN-β-luc plasmid contains the luciferase reporter gene which was placed under the IFN-β 
promoter. PRDII-luc contains two copies of the NF-κB binding region PRDII of the IFN-β 
promoter in front of the luciferase gene and was provided by Stanley Perlman (University of 
Iowa, Iowa city, IA; Zhou and Perlman, 2007).  
Dual luciferase assay: MARC-145 cells were used to examine luciferase reporter activities. 
Double-stranded RNA (dsRNA) stimulation was conducted using poly(I:C) by transfection. Cells 
were seeded in 12-well plates and in each well, 0.05 µg of pRL-TK, 0.5 µg of IFN-β-luc, or 
IRF3-luc, and 0.5 µg of Nsp11 plasmids were co-transfected using Lipofectamine 2000 
according to the manufacturer’s instruction (Invitrogen). Alternatively, cells were first infected 
with viruses at an MOI of 5 followed by transfection of 0.5 µg of IFN-β-luc and 0.05 µg of 
pRL-TK 3h post-infection. Twenty-four hours after DNA transfection, 0.5 µg of poly(I:C) was 
transfected into cells for 16 h. Cells were lysed using Passive Lysis buffer (Promega) and 
supernatants were measured for luciferase activity using the Dual Luciferase reporter assay 
system (Promega) in the luminometer (Wallac 1420 VICTOR mutilabel counter, Perkin Elmer, 
Waltham, MA).  
Reverse transcription and quantitative PCR: MARC-145 cells were either infected with 
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PRRSV or transfected with the Nsp11 gene. Twenty-four hours post-infection or 
post-transfection, intracellular RNA was extracted from cells using Trizol according to the 
manufacture’s instruction (Invitrogen). Random primer was used for reverse transcription to 
produce cDNA followed by quantitative PCR. Quantitative PCR was performed using ABI Prisn 
7000 Sequence Detector System (Applied Biosystems) in the final volume of 25 μl containing 
2.5 μl of cDNA from the reversed transcription reaction, primer mix (2.5 pM each of sense and 
antisense primers), 12.5 μl of SYBR Green master mix (Applied Biosystems) and 5 μl of water. 
The oligonucleotide primers were designed using Vector NTI (Invitrogen) or obtained from 
literatures (Table 3.1). The amplification parameters were 40 cycles of two steps each comprised 
of heating to 95°C and 60°C. The final mRNA levels of the genes were normalized using 
GAPDH as the internal standard.  
Site-directed mutagenesis: Mutations in the PRRSV Nsp11 NendoU domain were introduced 
into the 17401-Nsp11 by PCR based on mutagenesis. PCR was performed using 5 μl of 10x 
buffer (500 mM KCl, 100 mM Tris HCl PH 9.0, 1% Triton-X, 2 mM Mg2+), 200 ng of 
17401-Nsp11 plasmids, 125 ng each of forward and reverse primers, 1 unit of Pfu, and 1 μl of 
dNTP (25 mM each NTP) in a 50 μl reaction. The amplification was carried out under the 
following conditions: 95°C for 2 min followed by 18 cycles of 95°C for 1 min, 58°C for 50 sec 
and 68°C for 22 min ending with 68°C for 7 min. PCR products were digested with 1 unit of 
DpnI for 1 h and transformed into E.coli DH5α. Desired nucleotide changes and respective 
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primers are listed in Table 3.1.  
Results 
Suppression of IFN-β promoter activity by various PRRSV isolates: The field isolates of 
PRRSV were propagated in PAMs and their titers were obtained to be between approximately 
5-6 log10 TCID50/ml (Table 3.2). To examine the IFN suppressive ability of PRRSV field isolates, 
cells were infected and transfected with IFN-β-luc, followed by stimulation with poly(I:C) and 
determination of the luciferase activity. In the absence of virus infection, poly(I:C) induced the 
IFN-β promoter activity up to 8 fold (Fig. 3.1A). In PRRSV-infected cells, however, PA8, 
RespPRRSV, and 16138 showed the most suppressive activity and the IFN-β promoter activity 
was suppressed by 75%, and 39039, 16244B, 18402, 17401, and PrimePac showed the 
suppressive activity by approximately 50%. The remaining isolates of 20169, 12773, 15959, 
11604, 17405, 11176, 14680, and 10100 reduced the IFN-β promoter activity the least (Fig. 
3.1A). Based on the suppressive activities, the viruses were derived into 3 groups; strong, 
medium and weak groups. To confirm the results from the luciferase assays, one or two viruses 
were selected from each group and the MxA gene expression was determined. MARC-145 cells 
were infected with chosen viruses for 24 h followed by stimulation with poly(I:C), and 16 h 
post-transfection, total RNA was extracted. The amounts of MxA mRNA were determined by 
quantitative PCR. The MxA gene is one of IFN stimulated genes (ISGs) and thus the change in 
its amounts correlates with the IFN production in PRRSV-infected cells (Sang et al., 2010). MxA 
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mRNA increased up to 80 fold in mock-infected cells after poly(I:C) treatment, but decreased 
significantly in cells infected with PA8 or RespPRRSV from strong group viruses (Fig. 3.1B). 
This is consistent with previous findings (Fig. 3.1A). For 18402 from the medium group 
exhibited the medium level of IFN suppression, the amount of MxA mRNA was in the middle 
among those of all selected viruses (Fig. 3.1B). Isolates 12773 and 11176 were chosen from the 
weak group of the least suppressive isolates and these two isolates exhibited the most amount of 
MxA mRNA. Taken together, 16 PRRSV field isolates showed a different ability to suppress the 
IFN-β production, suggesting that their containing Nsp11s may contain different IFN suppressive 
abilities.   
Suppression of IFN-β, IRF3, and NF-κB activities by Nsp11 of various PRRSV isolates: 
Since FL12-Nsp11 has the ability to suppress the activation of both IRF3 and NF-κB (Sun et al., 
2010), it was of interest whether the various ability for IFN suppression of different isolates was 
due to their Nsp11 genes. Nsp11 genes were cloned from 16 isolates and sequenced. When 
compared, Nsp11 sequences from RespPRRSV, 16138, 20169, 11176, 14680, and 10100 were 
identical and thus 16138 was chosen to represent the others. Nsp11 sequences from isolates 
17405 and 18402 were identical and thus 18402 was chosen (Fig. 3.2). Nsp11 genes from 10 
isolates as well as FL12 were individually transfected to cells and examined for their luciferase 
activities. FL12-Nsp11 was used as a positive control, and GST was used as a negative control. 
For IFN-β-luc reporter, Nsp11 of most isolates showed significant reduction as with FL12-Nsp11 
when compared to GST and mock transfection under poly(I:C) stimulaiton. However, Nsp11 
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from the particular isolate 17401 (17401-Nsp11) exhibited less reduction (Fig. 3.3A, 3.3B), 
suggesting that 17401-Nsp11 behaved differently with respect to the IFN suppression. The 
expression of Nsp11 was monitored for all isolates by western blot and no visible changes were 
observed. Since FL12-Nsp11 was fused with the Flag tag, the migration was slightly slower than 
the others (Fig. 3.3A, bottom). For IRF3-luc reporter, 17401-Nsp11 showed a higher luciferase 
reporter activity compared to others, although the reporter activity was reduced compared to the 
induction control (Fig. 3.3C). For PRDII-luc reporter, 17401-Nsp11 did not show obvious 
differences from other Nsp11s and all of the Nsp11 proteins exhibited significant suppression in 
the IRF3 reporter activity (Fig. 3.3D). The experiments were repeated three times in duplication 
each time and the similar results were obtained. 17401-Nsp11 and FL12-Nsp11 were compared 
each other for their reporter activity. The activation of both IFN-β and IRF3 showed less 
inhibition in the presence of 17401-Nsp11, while the NF-κB activation remained the same for 
17401-Nsp11 and FL12-Nsp11 (Fig. 3.3E). Taken together, different virus isolates containing 
different IFN suppressive ability (Fig. 3.1A) shared the identical Nsp11 gene sequence. The 
variation of IFN suppression among different viruses may not be due to the IFN inhibitory 
function of Nsp11 alone. Among all the Nsp11 proteins, 17401-Nsp11 was indicated to have a 
lesser IFN suppressive ability than others and this difference was more towards IRF3 pathways 
than NF-κB pathway. Since 17401-Nsp11 and FL12-Nsp11 shared the identical sequence for 
catalytic sites of NendoU, the different IFN suppressive activities are not likely be due to the 
different RNase activity between the two Nsp11 proteins, but an additional active site may be 
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present in Nsp11.  
Construction of 17401-Nsp11 mutants: Since 17401-Nsp11 showed a weaker activity for IFN 
suppression than FL12-Nsp11, their amino acid and nucleotide sequences were compared to 
examine for any possible sequence changes. Nine amino acid residues were identified for 
17401-Nsp11 to be different (Fig. 3.4B). Four of them resided within the NendoU domain, but 
the catalytic sites for ribonuclease activity and two aspartic acid residues responsible for protein 
structural conformation in the NendoU domain were conserved. Using 17401-Nsp11 as 
backbone, the nine residues were mutated to the corresponding amino acids in FL12-Nsp11 (Fig. 
3.4B): I58V, K92R, L97M, V123I, A125E, R149K, V154F, A160V, and L175V (Fig. 3.4A, 
3.4B). 
Suppression of IFN-β, IRF3, and NF-κB by 17401-Nsp11 mutants: To identify the amino acid 
responsible for the weaker suppression in 17401-Nsp11, the mutant constructs were transfected 
into cells and examined their luciferase activities for IFN-β-luc, IRF3-luc, and PRDII-luc 
reporters. For IFN-β-luc, FL12-Nsp11 suppressed the reporter activity significantly as expected, 
while 17401-Nsp11 showed lesser inhibition. R149K and V154F showed similar or higher 
luciferase activity to 17401-Nsp11. The luciferase activity of I58V, K92R, L97M, V123I, A125E, 
and L175V were between those of FL12-Nsp11 and 17401-Nsp11, and A160V showed a lesser 
luciferase activity than FL12-Nsp11, suggesting that the residue Ala160 in 17401-Nsp11 may be 
responsible for its less IFN inhibition (Fig. 3.5A). For IRF3-luc reporter, similar results were 
obtained. A160F inhibited the activation of IRF3 the most, which was similar to FL12-Nsp11, 
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and other mutants showed the inhibition values between FL12-Nsp11 and 17401-Nsp11 (Fig. 
3.5B). For PRDII-luc reporter, the noticeable difference was not observed between FL12-Nsp11 
and 17401-Nsp11, and thus 17401-Nsp11 mutants did not display any difference as anticipated 
(Fig. 3.5C). These data demonstrated that once Ala160 of 17401-Nsp11 was mutated to Val as 
with the amino acid in FL12-Nsp11, the IFN phenotype changed from 17401-Nsp11 to 
FL12-Nsp11. Ala160 residue is likely the additional active site involved in IFN suppression 
within Nsp11 besides NendoU catalytic sites.  
Degradation of IPS-1 mRNA by 17401-Nsp11, FL12-Nsp11, 16138-Nsp11, and 
PrimePac-Nsp11: Previously, IPS-1 mRNA was shown to be degraded in the presence of 
FL12-Nsp11 and the degradation was associated with the endoribonuclease activity of Nsp11. 
Since 17401-Nsp11 was less suppressive than FL12-Nsp11 in the current study, the IPS-1 mRNA 
degradation was examined for FL12-Nsp11, 17401-Nsp11, 16138-Nsp11, and PrimPac-Nsp11. 
Quantitative PCR showed that IPS-1 mRNA was significantly reduced by at least 5 fold in the 
presence of Nsp11s and no difference in the IPS-1 mRNA was found between FL12-Nsp11 and 
17401-Nsp11 (Fig. 3.6), suggesting that the Nsp11 NendoU activity of 17401-Nsp11 and 
FL12-Nsp11 remained the similar. 
Discussions 
The type I IFN response plays an important role in host defense against viral infection. In 
the present study, 16 North American PRRSV isolates were examined for their suppressive 
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activity for IFN induction in MARC-145 cells. The suppressive activity differed among PRRSV 
isolates. Three of 16 isolates suppressed the IFN production significantly in the cells infected 
with viruses and stimulated with poly(I:C). Five isolates showed lesser suppression of IFN 
production, whereas eight isolates showed only a little or no suppression to IFN-β production. 
The data from q-PCR were consistent with those from luciferase assays. Similar observations 
were reported previously (Lee et al., 2004). The differences in IFN suppression from 16 North 
American PRRSVs may be due to their biological, antigenic, pathogenic, and genetic variances. 
Previous studies using bovine viral diarrhea virus (BVDV) has shown evidence for a relationship 
between IFN phenotypes and viral virulence (Charleston et al., 2001). In that study, the 
capability of a non-cytopathic virus to establish persistent infection in early fetus was related to 
its ability to suppress type I IFN synthesis. Further studies are needed to determine whether the 
various abilities for IFN suppression by PRRSV are correlated with the virulence or persistence 
for PRRSV. 
Since different isolates of PRRSV have different ability to regulate type I IFN, it is of 
importance to identify viral proteins that contribute to the different IFN response among isolates. 
Recently, studies have been conducted to investigate the basis of IFN suppression by PRRSV. 
Nsp11 has been shown to be one of the viral proteins that blocked activation of both IRF3 and 
NF-κB by degrading IPS-1 mRNA, likely through its NendoU activity. Among the isolates, 
RespPRRSV and isolates 16138, 20169, 11176, 14680, and 10100 shared the identical Nsp11 
sequences. RespPRRSV and 16138 showed a strong IFN inhibition, whereas 20169, 11176, and 
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10100 showed a relatively weak suppression (Fig. 3.1A). In addition, 11 different Nsp11s, except 
for 17401-Nsp11, exhibited similar IFN-β promoter activities (Fig. 3.3A, 3.3C) despite of the 
variation of IFN phenotypes from their corresponding viruses, suggesting that Nsp11 alone was 
not likely the reason causing the different IFN phenotypes of PRRSV isolates. Other viral 
proteins, including Nsp1, Nsp2 or N protein may also participate in the down-regulation of type I 
IFN during virus infection (Fang et al., 2012; Kim et al., 2010; Li et al., 2010; Song et al., 2010; 
Sun et al., 2010).  
17401-Nsp11 behaved differently and showed lesser suppression compared to 
FL12-Nsp11 and other Nsp11s. Similarly, 17401 isolate also showed less IFN suppression 
compared to FL12 and PA8 viruses. When the amino acids in 17401-Nsp11 were mutated to 
those of FL12-Nsp11, stronger IFN suppression was expected as with FL12-Nsp11. From our 
study, Ala160 was identified to be responsible for the IFN phenotype of 17401-Nsp11, since only 
Ala160V mutation showed IFN promoter activity as little as FL12-Nsp11. Two mechanisms are 
possible as to how Ala160 was associated with IFN suppression of Nsp11. One possibility is that 
Ala160 may indirectly affect the NendoU activity of Nsp11 and thus influence the IFN regulation 
of Nsp11. Although Ala160 resides in the subdomain B of NendoU (Fig. 3.4), it is not the 
catalytic site of NendoU nor within the region affecting the protein folding according to the 
crystal structure of nsp15 of SARS-CoV, which is the homolog of Nsp11 of PRRSV. According 
to the crystal structure of nsp15, the RNA binding domain locates at the inter-trimer interface 
which is in the N-terminal region of the protein (Bhardwaj et al., 2006), whereas the NendoU 
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domain is located at C-terminal region of the protein, which is distinct from the inter-trimer 
interface and functions in intra-trimer interaction (Ricagno et al., 2006). Two aspartic acid 
residues in subdomain B are shown to be responsible for the formation of intra-trimer interaction 
in nsp15 of SARS-CoV and Nsp11 of EAV and PRRSV (Nedialkova et al., 2009; Posthuma et al., 
2006; Ricagno et al., 2006). Therefore, Ala160 is less likely to affect the RNA-binding or RNase 
activity of Nsp11. Indeed, the q-PCR indicates a similar level of IPS-1 mRNA degradation 
between 17401-Nsp11 and FL12-Nsp11, suggesting that the endoribonuclease activity does not 
involve in this difference of suppressive activity (Fig. 3.6). 
Alternatively, Ala160 may determine the affinity to some cellular factors involved in the 
IFN induction, irrelevant from the NendoU activity and IPS-1 mRNA degradation. This 
possibility is supported by the fact that 17401-Nsp11 shows less suppression for IFN-β-luc and 
IRF3-luc reporters, but no influence on the PRDII-luc reporters, and further Ala160V mutant 
does not differ from the other mutants for PRDII-luc reporter activities, implying that Ala160 
disturbed the IFN-β production through the IRF3 pathway rather than the NF-κB pathway.  
In summary, different PRRSV isolates showed various IFN responses, and this may be 
due to multiple viral proteins. Ala160 in 17401-Nsp11 may be an additional active site associated 
with IFN inhibition of Nsp11. The molecular action of Ala160 is independent from the NendoU 
activity, which need further investigation. Since the residue Ala160 was identified from a natural 
field isolate, the Ala160 mutant virus is highly likely to be alive and possesses less IFN 
suppressive ability. Therefore, this newly newly identified active site could be a good candidate 
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for the development of a new vaccine of PRRSV in the future. 
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CHAPTER 4: DIFFERENTIAL HOST CELL GENE EXPRESSION AND REGULATION 
OF CELL CYCLE PROGRESSION BY NON-STRUCTURAL PROTEIN 11 OF 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
Abstract 
Non-structural protein 11 (Nsp11) of porcine reproductive and respiratory syndrome virus 
(PRRSV) is a vial endoribonuclease that is essential for infectivity with an unknown mechanism. 
To examine the cellular gene expression profiles regulated by Nsp11, MARC-Nsp11 cells were 
constructed by retrovirus-mediated gene transfer to express Nsp11, and an RNA microarray was 
conducted in these cells. In MARC-Nsp11 cells, the IFN-β, IRF3 (interferon regulatory factor 3), 
and nuclear factor (NF)-κB luciferase reporter activities were suppressed compared to those of 
MARC-145 parental cells, indicating that Nsp11 is an IFN antagonist of PRRSV and retains its 
regulatory role in MARC-Nsp11 cells. Differential cellular transcription profiles regulated by 
Nsp11 were then examined using Affymatrix exon chips representing 28,536 human gene 
transcripts. After statistical analyses, 66 cellular genes were shown to be up-regulated and 104 
genes were down-regulated. These genes were further examined and grouped into 5 major 
cellular pathways according to their functional relations; histone-related, cell cycle and DNA 
replication, mitogen activated protein kinase (MAPK) signaling, complement, and 
ubiquitin-proteasome pathways. Of these, the modulation of cell cycle by Nsp11 was further 
examined. Flow cytometry analysis showed that Nsp11 caused the delay of cell cycle 
progression, and the BrdU staining for cellular DNA in replicating cells indicated slower cell 
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cycle through the S-phase. Our study shows that the PRRSV Nsp11 protein plays a role to 
modulate the host cell cycle progression and provides insights into specific cellular responses to 
Nsp11 during infection. 
Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is one of the most significant 
infectious diseases for the pig industry and causes severe economic losses worldwide. The 
etiological agent is PRRS virus (PRRSV) which belongs to the family Arteriviridae in the order 
Nidovirales (King, 2012) and possesses a single-stranded positive-sense RNA genome of 15.4 kb 
in size (Conzelmann et al., 1993; Gorbalenya et al., 2006; Meulenberg et al., 1993; Snijder, 
1998). PRRSVs are grouped into two genotypes; European (type I) and North American (type II) 
genotypes (Allende et al., 1999; Nelsen, Murtaugh, and Faaberg, 1999). The PRRSV genome 
contains 10 open reading frames (ORFs) including the newly identified ORF5a (Firth et al., 2011; 
Johnson et al., 2011). ORF1a and ORF1b code for two slightly overlapping polyproteins that are 
post-translationally processed into 14 cleavage products. These products are non-structural 
proteins (Nsp’s) that are believed to participate in viral genome replication and sub-genomic 
mRNA transcription (den Boon et al., 1991; Fang and Snijder, 2010; Wootton, Yoo, and Rogan, 
2000). Of these, Nsp11 is a 223 amino acids protein containing a nidovirus-wide conserved 
domain in the C-terminal region, termed NendoU. NendoU is known to contain an 
endoribonuclease activity and consists of two subdomains, A and B (Gorbalenya et al., 2006; 
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Ivanov et al., 2004; Nedialkova et al., 2009; Posthuma et al., 2006). Mutational studies using 
equine arteritis virus (EAV) Nsp11, a homolog of PRRSV Nsp11, show that three enzymatically 
catalytic sites reside in subdomain A, while two aspartic acids in subdomain B are responsible 
for the overall protein structure (Posthuma et al., 2006). In EAV, Nsp11 plays a key role in viral 
RNA synthesis and thus it may also be essential for PRRSV. PRRSV is able to modulate type I 
IFN response (Yoo et al., 2010) and Nsp11 has been suggested to participate in the IFN 
regulation during infection (Beura et al., 2010). 
With the application of microarray technology, genome-wide transcriptional responses of 
cell to PRRSV infection have previously been studied (Xiao et al., 2010; Zhou et al., 2011). Such 
studies in virus-infected cells however do not identify viral proteins responsible for specific 
transcriptional changes regulating host cell responses. Thus in the present study, a cell line was 
established to stably express the Nsp11 protein and an RNA microarray was conducted in these 
cells. Based on the microarray data, five major cellular pathways were identified to be regulated 
by Nsp11, and of the five pathways, the cell cycle pathway was further examined. Here we 
provide the evidence that the PRRSV Nsp11 protein participates in modulating the cell cycle 
progression at the S-phase during infection.  
Materials and Methods 
Cells: MARC-145 (a subline of Africa green monkey kidney cells; (Kim et al., 1993)), 
MARC-Nsp11 was maintained in Dulbecco’s modified Eagle’s medium (DMEM; Mediatech Inc, 
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Manassas, VA) containing 10% heat-inactivated fetal bovine serum (FBS; Hyclone, Logan, UT) 
in a humidified incubator with 5% CO2 at 37 °C. 
Plasmids, antibodies, and chemicals: The Nsp11 coding sequence was PCR-cloned from the 
FL12 strain of PRRSV and inserted into the retroviral expressing vector pLNCX2 (Clontech) and 
mammalian expression vector pXJ41 with a Flag tag at its N-terminus using the following 
primers: forward: 5’-AAACTCGAGGCCACCATGGGGTCGAGCTCCCCGCTCCC-3’ and 
reverse:5’-GCGGCCGCTTACTTATCGTCGTCATCCTTGTAATCTTCAAGTTGAAAATAGG
C-3’. The FL12-Nsp11 gene was inserted into the E. coli expression vector pET-28a+ with the 
His-tag at both N- and C-termini. Polyinosinic:polycytidylic (poly[I:C]), anti-Flag MAb M2, and 
anti-BrdU antibody were purchased from Sigma (St. Louis, MO). The donkey anti-rabbit 
antibody conjugated with Texas-red and goat anti-mouse antibody conjugated with FITC were 
purchased from Invitrogen (Carlsbad, CA). The Nsp11-specific rabbit antibody was generated in 
our laboratory as follow. Since wild-type PRRSV Nsp11 was toxic to E. coli (Nedialkova et al., 
2009), one of its NendoU mutants, Nsp11-K3779A, was subcloned into pET-28a(+) to contain 
the His tag at both N- and C-termini, and this plasmid was transformed into E. coli BL21.The 
transformants were grown overnight and transferred to fresh LB broth for 2 h, followed by 1 mM 
IPTG induction for 3 h. Cells were centrifuged and pellets were treated with DNase I (20 μg/ml) 
and lysosome (200 μg/ml) for 1h at 4°C, followed by sonication on ice three times for 5 min 
each (Soniprep 150, Sanyo Gallenkamp PLC, Leicester, UK). After centrifugation at 12000 rpm 
for 30 min (J2-21 centrifuge, Beckman Coulter, Brea, CA), supernatants and pellets were 
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collected separately and subjected to SDS-PAGE to determine the presence of Nsp11-K3779A 
protein in each fraction. Proteins in the supernatants were purified and concentrated to 1 mg/ml 
using the HisTrap column according to the manufacturer’s instruction (GE Healthcare Life 
Sciences, Piscataway, NJ). A total of 2 mg of Nsp11 protein was used to immunize a rabbit 5 
times at 2 weeks interval and the rabbit anti-PRRSV-Nsp11 serum was generated 
(Immunological Research Center, University of Illinois, Urbana, IL). The specificity of the 
antiserum was determined by immune-blot and immunofluorescence using PRRSV-infected 
cells.  
Establishment of Nsp11 expressing cells (MARC-Nsp11): MARC-145 cells were transduced 
with the Nsp11 gene using the retroviral gene transfer system (Clontech). Briefly, 0.5 μg of the 
pLNCX2-Flag-Nsp11 plasmid was co-transfected with pVSV-G into the pantropic packaging cell 
line GP2-293 to produce an infectious lentivirus containing the PRRSV-Nsp11 gene. After 48 h 
of incubation, supernatants from GP2-293 cells were collected and infected MARC-145 cells. 
Nsp11 gene-integrated cells were then selected using 1 mg/ml of G418 (Invitrogen) for about 2 
weeks. G418 was replaced at least every 4 days. When the majority of cells died, G418 resistant 
cell colonies were picked using cloning cylinders and amplified as putative Nsp11-expressing 
MARC-145 cells. Seven cell clones were initially selected and one clone was chosen for further 
studies. These cells were designated MARC-Nsp11. 
PCR, RT-PCR, and quantitative (q)-PCR: For PCR, cellular DNA was extracted from 
MARC-145 and MARC-Nsp11 cells using QIAamp DNA kit (Qiagen), and PCR was performed 
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to determine the Nsp11 gene integration using primers indicated in Table 4.1S. For RT-PCR, total 
cellular RNA was extracted using Trizol (Invitrogen), and treated with RQ1 RNase-free DNase I 
(Promega), followed by reverse transcription (RT) using the Nsp11-specific reverse primer and 
PCR using the primer set mentioned above. Real-time quantitative (q)-PCR was performed using 
ABI Prism 7000 Sequence Detection System and software (Applied Biosystems) in a final 
volume of 25 μl containing 2.5 μl of cDNA made from the reversed transcription reaction, 2.5 
pmol of each sense and antisense primers, 12.5 μl of SYBR Green Master Mix (Applied 
Biosystems), and 5 μl of water. The oligonucleotide primer sequences were designed using 
Primer 5.0 software (Invitrogen) or obtained from previous reports (Table 4.1S). The 
amplification parameters were 40 cycles of two steps, each step comprised of heating at 95°C 
and extension at 60°C. The final mRNA levels of target genes were normalized using GAPDH as 
a house keeping gene.  
Immunoprecipitation: Total cell lysates were incubated with the anti-Nsp11 rabbit serum 
overnight at 4°C. The reactions were then incubated with Protein A Sepharose beads (GE 
Healthcare) at 4°C for 4 h. Following centrifugation for 5 min, supernatants were aspirated off 
and washed with the lysis buffer twice. The beads were mixed with the loading buffer, boiled, 
and subjected to 12% SDS-PAGE followed by transfer to Immobilon-P membrane (Millipore). 
After blocking membranes with 5% skim milk powder dissolved in TBS-T (10 mM Tris-HCl 
[pH 8.0], 150 mM NaCl, 1% Tween 20) for 1 h at room temperature, membranes were incubated 
with anti-Flag monoclonal antibody (sigma) in TBS-T containing 5% skim milk powder at 4°C 
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overnight. After 5 washes with TBS-T, membranes were incubated with horse radish 
peroxidase-conjugated anti-mouse antibody for 1 h at room temperature. Membranes were 
washed again 5 times and proteins were visualized using the ECL detection system (Thermo, 
Minneapolis, MN) 
Dual luciferase reporter assays: Double-strand (ds) RNA stimulation was conducted using 
poly(I:C). For Nsp11 transfection, cells were seeded in 12-well plates and in each well, 0.05 µg 
of pRL-TK, 0.5 µg of pIFN-β-luc, pIRF3-luc, or pPRDII-luc, and 0.5 µg of pXJ41-Flag-Nsp11 
were co-transfected using Lipofectamine 2000 according to the manufacturer’s instruction 
(Invitrogen). For MARC-Nsp11 cells, only pRL-TK and three reporter plasmids were 
co-transfected with the same amount as indicated in Nsp11 transfection. Twenty-four hours 
post-transfection, 0.5 µg of poly(I:C) was transfected into cells for 16 h. Cells were lysed using 
the passive lysis buffer (Promega), and supernatants were measured for luciferase activities using 
the Dual Luciferase reporter assay system (Promega) in the luminometer (Wallac 1420 VICTOR 
mutilabel counter, Perkin Elmer, Waltham, MA). 
RNA microarray design and data analyses: MARC-145 and MARC-Nsp11 cells were seeded 
one day prior to experiments and total cellular RNAs were extracted using Trizol (Invitrogen) 
and purified by RNeasy mini kit (Qiagen). The quantity and quality of RNA were determined 
using an Align 2100 bioanalyzer (Agilent Technologies, Palo, Alto, CA, USA), and the RNA 
integrity was determined above 7. The RNA samples were then subjected to microarray using 
Human Gene 1.0 ST arrays (Affymetrix UK Ltd, High Wycombe, UK) at the Keck 
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Biotechnology Center, University of Illinois, Urbana, IL). The microarray was repeated twice in 
triplicates each. For data analyses, quality control assessments, data processing, and statistical 
analyses were conducted using the package from the Bioconductor project (Gentleman et al., 
2004) as indicated below. The Affymetrix's Human Gene 1.0 ST array contains probes to 
interrogate 253,002 exons representing 28,536 annotated genes. Comparisons were made either 
on the exon-level to investigate alternative splicing or on the whole gene-level to summarize all 
transcripts of the gene. The individual probe values were background-corrected, normalized, and 
summarized into one value at the both exon- and gene-levels using the robust multi-array 
average (RMA) algorithm available from the oligo packages (Irizarry et al., 2003). Testing for 
differential gene expressions between MARC-145 cells and MARC-Nsp11 cells was conducted 
separately at the exon- and gene-levels by fitting a linear model including a term to account for 
the separate processing batches using the Linear Models for Microarray Data (Limma) package 
(Smyth, 2004; Smyth, 2005). The criteria for significance varied for the exon- and gene-levels. 
At the exon-level, the criteria were at least a 2 fold-change and a raw p-value < 0.02, resulting in 
8,693 significant exons. At the gene-level, the Limma model was fit and raw p-values were 
calculated using all genes on the array, but the correction for multiple hypothesis testing using 
the FDR (false discovery rate) method (Benjamini and Hochberg, 1995) was done for only the 
9,241 genes that varied in expression across all the samples of at least 1.5 fold-change. The 
criteria used to select significant genes within the filtered database for up-regulation and 
down-regulation were FDR P-value <0.1 and fold change >2, or <-2, respectively. 
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Flow cytometry and cell cycle analysis: Identical numbers of MARC-145 cells and 
MARC-Nsp11 cells were seeded and grown for 24 h in DMEM containing 10% FBS. For flow 
cytometry, cells were collected by trypsinization, washed with PBS, and resuspended in cold 
PBS to 1x106 cells per ml. The cell suspension was added dropwise to an equal volume of cold 
ethanol with continuous agitation to fix. After overnight incubation at 4°C, cellular DNA was 
stained with 10 μg/ml propidium iodide (PI) prepared in PBS containing 0.1% Triton X-100 
(Sigma-Aldrich) and 10 μg/ml RNase A (Roche) for 30 min at room temperature in the dark. 
Samples were then analyzed by flow cytometry (BD AccuriC6, BD Accuri Cytometers, Ann 
Arbor, MI), and the data were analyzed using FACS Express software supplied at the Keck 
Biotechnology Center (University of Illinois, Urbana, IL). 
BrdU incorporation and immunofluorescence assay: DNA synthesis in proliferating cells was 
determined by measuring the bromodeoxyuridine (BrdU) incorporation using 
immunofluorescence since BrdU incorporation into DNA occurs during the S phase. Cells were 
seeded on cover slips at a density of 1x105 cells/cover slip and allowed to rest for 24 h. The 
medium was removed and cells were incubated for a 10 min, 20 min, or 24 h pulse in the BrdU 
labeling medium. For 10 min and 20 min pulses, 10 μM of BrdU was applied and for 24 h pulse, 
100 nM of BrdU was applied. After BrdU incubation, cells were fixed in 2% paraformaldehyde 
in PBS for 15 min and washed with PBS three times. Cells were then permeabilized with 0.5% 
Triton X-100 for 7 min on ice followed by blocking with 1% normal goat serum (NGS) in PBS 
three times, 10 min each time. To observe the nuclei of cells, anti-Lamin (1:200) rabbit antibody 
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was used as the primary antibody for 1 h in PBS containing 1% NGS, and then cells were 
incubated with donkey anti-rabbit antibody conjugated with Texas red (1:1000) for 30 min. 
Followed by washing four times, 5 min each, 2% paraformaldehyde was used again to fix the 
bound antibodies. Cells were then incubated with 4 N HCl for 25 min at room temperature to 
denature DNA and to allow the BrdU antibody recognize the incorporated BrdU in the nuclei. 
After three times of 10 min wash with PBS and two times of 10 min wash with 1% NGS in PBS, 
anti-BrdU monoclonal antibody (1:500) was applied to cells for 90 min. Cells were then 
incubated with goat-anti-mouse antibody conjugated with FITC (1:600) for 30 min. Washing 
with PBS was applied four times after every incubation with antibodies. The cover slips were 
mounted on microscope slides in the mounting buffer and visualized using a Zeiss Axioimager 
z1 fluorescence microscope (Carl Zeiss Inc.) equipped with Chroma filters (Chroma Technology).  
Images were collected using Axiovision software (Zeiss) and Hamamatsu ORCA cooled CCD 
camera. The BrdU-incorporated cells and total number of cells (Lamin positive) were counted 
for both MARC-145 and MARC-Nsp11 cells, and the percentage of BrdU incorporation was 
calculated as follow: % BrdU incorporation = (number of BrdU positive cells)/ (number of 
Lamin positive cells). The cell counting areas were selected randomly on slides and 200 cells 
were counted. 
Results 
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Establishment of MARC-Nsp11 cells stably expressing the PRRSV Nsp11 protein: To study 
the regulatory role of PRRSV Nsp11 in cellular processes, a cell line was established to express 
the Nsp11 protein. MARC-145 was chosen as the parental cell line since it is one of the few 
established cell lines permissive for PRRSV infection. MARC-145 cells were transduced with 
the lentivirus containing the Nsp11 gene, and neomycin-resistant cells were selected. A total of 
seven cell clones were obtained and propagated for analyses. Cellular DNA was extracted and 
PCR was conducted to identify the gene integration. All cell clones appeared to be positive for 
Nsp11 (Fig. 4.1A), and thus cell clone ‘a’ was chosen for further studies. This clone was 
confirmed positive for Nsp11 mRNA by RT-PCR with the specific amplification of the 660 bp 
fragment in size. This was the predicted size that was absent in the parental cells (Fig. 4.1B), 
indicating the Nsp11 gene integration. This cell clone was designated MARC-Nsp11. The 
expression level of Nsp11 appeared to be low and thus the detection was conducted by 
immunoprecipitation using rabbit anti-Nsp11 antibody followed by immunoblot using mouse 
anti-Flag antibody. A 26 KD protein was specifically identified in MARC-Nsp11 cells (Fig. 4.1C, 
lane 3), and a much stronger band with the same size was present in Nsp11 gene-transfected cells 
(Fig. 4.1C, lane 2), demonstrating the expression of Nsp11 and thus these cells were subjected to 
further studies. 
Suppression of IFN pathway by MARC-Nsp11 cells: Nsp11 contains the NendoU domain 
associated with the endoribonuclease activity (Bhardwaj, Guarino, and Kao, 2004; Ivanov et al., 
2004; Nedialkova et al., 2009) and has been suggested as a potential type I interferon (IFN) 
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regulator (Beura et al., 2010; Yoo et al., 2010). Previously in chapter 3, Nsp11-transfected cells 
exhibited a strong suppression of the pIFN-β-luc (Fig. 2.1A), pIRF3-luc (Fig. 2.3A), and 
pPRDII-luc (Fig. 2.3B) three reporter activities, and the suppression was dose-dependent. 
pIRF3-luc contains 4 copies of IRF3-binding sequence while pPRDII-luc contains 2 copies of 
NF-κB binding sequence in front of the luciferase reporter gene. These results show the 
suppressive activities of Nsp11 on IRF3 and NF-κB activation. And this suppression is likely due 
to the IPS-1 RNA degradation by Nsp11, since the IPS-1 mRNA amount was shown to be 
reduced in Nsp11 transfected MARC-145 cells (Fig. 2.7). 
To examine whether Nsp11 expressed in MARC-Nsp11 cells was biologically active, the 
reporter activities for IFN-β, IRF3, and NF-κB and IPS-1 mRNA amount were examined by 
transfection with relevant constructs and stimulation with poly(I:C), and quantitative PCR, 
respectively. For luciferase assay, MARC-Nsp11 cells (black bars) showed the decreased 
luciferase activities compared to empty vector-transfected (gray bars) or un-transfected (white 
bars) MARC-145 cells for all three reporters (Fig. 4.2A). The suppressive activities in 
MARC-Nsp11 cells were less significant than in Nsp11-gene transfected cells. For Q-PCR, 
parental and MARC-145 cells were harvest by Trizol and total RNAs were extracted. IPS-1 
mRNA amount was examined after RT (Fig. 4.2B). It is shown that the IPS-1 RNA amount in 
MARC-Nsp11 cells was reduced compared to parental MARC145 cells. However, this reduction 
was also less significant than that in Nsp11 transfected MARC-145 cells and this was probably 
due to the lower level expression of Nsp11 in MARC-Nsp11 cells. Both reporter assays and 
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Q-PCR showed that the Nsp11 protein expressed in MARC-Nsp11 retained the ability to 
modulate the type I IFN pathways and was biologically active in spite of the low level 
expression.   
Transcriptome analysis in Nsp11-MARC cells: To study the transcription regulation of host 
cells by Nsp11, an RNA microarray was conducted using human gene exon chips. The chips 
contain 253,002 exons from 28,536 annotated genes. After microarray analyses, 9,241 genes 
were initially identified to have been altered after filtering by fold changes greater than 1.5, 
among which 66 and 104 cellular genes were considered significantly up-regulated and 
down-regulated, respectively, under the criteria of a fold change of 2 or greater and a false 
discovery rate (FDR) of 10% (Supplementary Tables 4.2S and 4.3S). Based on the Database for 
Annotation, Visualization, and Integrated Discovery (DAVID), 79 of the significantly expressed 
genes were classified into 17 categories, some of which shared the common function 
(Supplementary Table 4.4S). According to their functional correlations, the functional groups 
were summarized into five major cellular pathways that were regulated by Nsp11; histone related 
proteins, cell cycle and DNA replication pathways, MAPK signaling pathways, 
ubiquitin-proteasome pathways, and complementary pathways (Table 4.1).  
To validate the changes in the gene expression profiles, five genes (TNFSF10, DEPTOR, 
SH2, NOL6, and EGR1) were chosen based on their fold changes, and quantitative (q)-RT-PCR 
was conducted using specific primers (Table 4.1S). NOL6 and EGR1 were selected to represent 
up-regulated genes, and TNFSF10 and DEPTOR were selected to represent down-regulated 
 94  
genes, while SH2 was chosen as an un-regulated gene. The q-RT-PCR results for these genes 
were in good agreement with the RNA microarray data and confirmed the differential gene 
expression profiles (Fig. 4.3).  
Regulation of histone-related functions, complement, MAPK signaling, and proteasome 
pathways: Seventeen histone-related genes (HIST2H3D, HIST1H2AI, HIST1H2BH, 
HIST1H2AK, HIST1H2BK, HIST1H2AI, HIST1H4I, HIST1H2BM, HIST2H2AA3, 
HIST2H3A, HIST1H2AH, HIST2H2BE, HIST1H3A, HIST1H3F, HIST1H2BB, HIST1H2BI, 
HIST1H3G) were identified to be up-regulated, while three components (C1S, C1R, C3) in the 
complement system were down-regulated (Table 4.1). C1S and C1R are responsible for initiation 
of the classic pathway activation of the complement system. Auto-activation of C1R is the first 
enzymatic step taking place, which then cleaves C1S and activates it. Activated C1S cleaves C4 
and C2, resulting in the activation of C3 convertase complex (Gal et al., 2009). C3 is a central 
molecule in the complement system whose activation is essential for all the important functions 
performed by this system (Sahu and Lambris, 2001). The down-regulation of C1S, C1R, and C3 
suggested the suppression of complement system activation by Nsp11.  
Six genes (DUSP1, FOS, MYC, JUN, DUSP6, and SRF) related to the MAPK signaling 
pathways were found to be up-regulated, and five genes (SUMO1, SNCA, PSMD3, PSMB10, 
and PSMA7) in the proteasome pathways were regulated, among which, SUMO1 and SNCA 
were down-regulated and PSMD3, PSMB10, and PSMA7 were up-regulated (Table 4.1). Dual 
specificity phosphatase 1 (DUSP1) and DUSP6 belong to the DUSP family. The activity and 
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localization of MAPK are regulated by DUSPs, many of which dephosphorylate threonine and 
tyrosine residues on MAPKs and thus function in the negative feedback loop of ERK regulation 
(Jeffrey et al., 2007). In particular, DUSP1 is a nuclear protein and thus dephosphorylates ERK 
in the nucleus and allows its trafficking back to the cytoplasm (Caunt et al., 2008). DUSP6 is a 
cytoplasmic protein and contains a nuclear export signal to cause the cytoplasmic retention of 
ERK2 (Caunt et al., 2008). C-Jun/AP-1 and c-Fos genes were also found to be up-regulated 
significantly in the microarray analyses, which can be activated by JNK and p38 MAPK (Silvers, 
Bachelor, and Bowden, 2003). For the proteasome pathways, three (PSMD3, PSMB10, and 
PSMA7) out of five were proteasome subunits, and their up-regulation suggested an enhanced 
effect on proteasomal pathways by Nsp11. SUMO1 (small ubiquitin-like modifier 1) gene has 
multiple functions through attaching itself to substrates, referred to as sumoylation. After 
sumoylation, protein may undergo degradation through the proteasome (Shuai and Liu, 2005; 
Wilkinson and Henley, 2010). 
Cell cycle delay at the S-phase by Nsp11: The microarray data suggested that the cell cycle and 
DNA replication pathways were regulated by Nsp11. A total of 10 genes were found to be 
regulated for these pathways (Table 4.1). Among these genes, cell division cycle 45 (cdc45)-like 
and cdc25 homolog A are important proteins controlling the cell cycle progression (Lim et al., 
2009; Liu et al., 2006; Moss, Sharma, and Brindle, 2009), whereas mini-chromosome maintenance 
complex 2 (MCM2), MCM4, and MCM5 are the components of helicase during DNA replication 
(Labib, Kearsey, and Diffley, 2001). 
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The MCM2-7 complex is assembled on the eukaryotic chromosomes during the G1 phase 
of a cell cycle, which is then activated during the S phase by MCM10, CDC45, and the GINS 
complex (Takahashi, Wigley, and Walter, 2005). The regulation of MCMs and CDC genes by 
Nsp11 suggests that Nsp11 may perturb the normal host cell cycle. Thus to examine this 
possibility, identical numbers of MARC-Nsp11 and MARC-145 cells were seeded, and 24 h later 
cells were collected for DNA staining and flow cytometry. In two independent experiments, the 
MARC-Nsp11 cells at the S phase constituted 28.5% (Fig. 4.4B) as compared to 12.6% for 
MARC-145 cells (Fig. 4.4A), which was more than 2-fold increase of cells indicating that 
MARC-Nsp11 cells were accumulating at the S phase by 24 h. 
In order to examine the nature of DNA accumulation at the S phase by Nsp11, cells were 
pulsed-labeled for 10 min, 20 min, or 24 h with BrdU and stained for BrdU and Lamin. BrdU is a 
nucleotide analog and thus can be incorporated into replicating DNA, whereas Lamin proteins 
are the major architectural proteins of the nucleus lining inside of the nuclear membrane in 
animal cells. Thus, all cellular nuclei can be stained with anti-Lamin antibody, while only cells 
synthesizing new DNA in the S phase will be stained with anti-BrdU antibody. A short time pulse 
such as 10 min or 20 min would detect the BrdU incorporation within a single cell cycle, 
whereas longer time incubation such as 24 h would detect multiple cell cycles and thus the 
majority of normal cells would be positive for BrdU staining (Fig. 4.5A). For each slide, a total 
of 200 Lamin-positive cells (in red) were randomly chosen, from which BrdU positive cells (in 
green) were counted. Then, BrdU incorporation percentages were calculated using the formula 
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described in Materials and Methods. MARC-Nsp11 cells exhibited less numbers of 
BrdU-positive cells at the 10 min and 20 min pulses compared to those of MARC-145 cells (Fig 
4.5A), and the percentage for BrdU incorporation (Fig. 4.5B) dropped from 47.07% (white bar) 
to 38.07% (black bar), and from 57.8% (white bar) to 44% (black bar), respectively. After 24 h of 
labeling, a greater reduction of BrdU staining was observed in MARC-Nsp11 cells, where the 
percentage for BrdU incorporation decreased from 92% (while bar) to 49.73% (black bar) (Fig 
4.5B). It was also noticed that the intensity of BrdU staining of MARC-Nsp11 cells was 
significantly reduced compared to that of the control cells at 24 h pulse (Fig. 4.5A), 
demonstrating the substantial suppression of DNA synthesis by Nsp11. Both the flow cytometry 
analysis and BrdU staining results indicate that PRRSV Nsp11 retards the cell cycle progression 
through the S phase. 
Discussion 
Enzymatically active Nsp11 is toxic in cells (Nedialkova et al., 2009), suggesting that 
Nsp11 may target broad spectrum substrates including viral RNAs and cellular RNAs. This may 
be the reason why the Nsp11 expression was low in MARC-Nsp11 cells where the toxic enzyme 
was constitutively produced. Nevertheless, the luciferase assays showed that Nsp11 expressed in 
MARC-Nsp11 cells suppressed the IFN activity, indicating that Nsp11 in these cells was 
biologically active. To understand the cellular transcriptional responses to Nsp11, Nsp11 
expressing cells were established using the retrovirus gene-transduction system. The microarray 
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studies in these cells identified 170 differentially regulated cellular genes with the threshold of 2. 
The number of down-regulated genes was 104, which was greater than that of up-regulated genes 
of 66. These differentially regulated genes were grouped into 5 different pathways according to 
their functional relevance; histone-related proteins, cell cycle and DNA replication pathways, 
MAPK signaling pathway, ubiquitin-proteasome pathway, and complement pathway. Compared 
to the number of genes identified previously, the genes identified in the current study are much 
less and less diverse, and this is probably because the regulated genes in the current study are 
mostly Nsp11-specific whereas the genes in the previous studies were responders to entire viral 
proteins. Thus, the identified genes in the current study should mostly be included in the 
previously identified genes. Indeed, the genes grouped into 5 major pathways are mostly found 
in the previous reports. Zhou et al (Zhou et al., 2011)showed that the genes regulating cell cycle 
processes and DNA damage are regulated in PAMs by highly pathogenic PRRSV (HP-PRRSV). 
Besides, chromosome organizing proteins were also shown to be regulated including various 
histone related proteins. In the previous study, the complement system for tissue remolding and 
inflammation was regulated, which is also identified in our study as a single pathway. The 
regulation of proteasome pathway was also previously reported by Xiao et al (Xiao et al., 2010). 
In that study, the proteasome genes were up-regulated by PRRSV, which is also found in our 
study. Both c-JUN and c-Fos are two effectors of the MAPK signaling pathway, and they were 
specifically up-regulated during PRRSV infection (Xiao et al., 2010). PRRSV-mediated 
activation of the MAPK signaling pathway and the increase of JNK and p38 phosphorylation 
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have recently been demonstrated (Lee and Lee, 2012), which also supports our data. Thus, Nsp11 
is likely the viral protein, at least partially if not totally, responsible for the regulation of cell 
cycle, MAPK signaling, complement, and proteasome pathways in cells during PRRSV 
infection. 
Of the pathways identified from our microarray studies, the regulation of cell cycle 
pathways was of particular interest and we explored this further. The flow cytometry and BrdU 
staining results indicated clearly that the cell cycle progression was delayed at the S phase in 
MARC-Nsp11 cells compared to MARC-145 cells. A recent observation supports our finding 
that Nsp15, a coronavirus homolog of PRRSV Nsp11, regulates the cell cycle (Bhardwaj et al., 
2012). In that study, SARS-CoV Nsp15 was shown to down-regulate the retinoblastoma (pRb) 
activity which is responsible for cell proliferation. As a consequence, a higher percentage of cells 
were observed to be at the S phase in cells expressing SARS-CoV Nsp15. In our study, a slow 
progression at the S phase was observed in Nsp11-expressing cells, leading to the increase of 
MARC-Nsp11 cells to the S phase. The S phase tardiness may be associated with the altered 
DNA replication, since several MCM proteins which are components of DNA helicase were 
shown to be up-regulated (Table 4.1). It is possible that the abnormal amount of helicase protein 
caused malfunction or malformation of the replication fork, which caused the inhibition of DNA 
synthesis in MARC-Nsp11 cells and therefore resulted in the S phase change by the Nsp11 viral 
protein.  
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In fact, a cell cycle regulation by viruses is common and beneficial to viruses. It is 
especially true for DNA viruses replicating in the nucleus including SV40, herpes simplex virus, 
and adeno-associated virus, in which by arresting the infected cells at a certain stage of cell 
division, a cellular DNA replicative machinery may be captured and utilized for viral replication 
(Friedrich et al., 2005; Nash, Chen, and Muzyczka, 2008; Stedman et al., 2004). For RNA 
viruses, influenza virus replication has been shown to be regulated by DNA replicase helicase 
and MCM complex consisting of MCM2-7 (Kawaguchi and Nagata, 2007). The interaction 
between the influenza virus polymerase PA protein and MCM complex increases the stability of 
replicating RNA polymerase, which produces only abortive short RNA chains in the absence of 
MCM. In our study, MCM2, MCM4, and MCM5 were identified to be up-regulated in the 
presence of PRRSV Nsp11 (Table 4.1). Although the PRRSV replication occurs entirely in the 
cytoplasm, unlike most DNA viruses, the regulation of cell cycle progression is considered 
beneficial for the virus, since the available pool of cellular machineries can be maximally 
utilized towards the production of progeny virus at an early stage of infection. For PRRSV, the 
nucleocapsid (N) protein has been suggested to regulate the cell cycle progression by modulating 
the ribosomal RNA synthesis in the nucleolus (Yoo et al., 2003). Thus, it seems that both N and 
Nsp11 proteins are involved in the regulation of cell cycle to facilitate virus growth in different 
ways by targeting different cellular components regulating host cell cycle. The N protein is an 
RNA-binding protein which contains the nuclear localization signal (NLS) and thus locates in 
the nucleus and nucleolus. Through the yeast-2 hybrid screening, the inhibitor of MyoD family 
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‘a’ (I-mfa) domain-containing protein was identified to interact with the N protein (Song et al., 
2009). Since the I-mfa domain-containing protein interacts with cyclin T1 (Young et al., 2003) 
which is known to participate in the control of cell cycle, this interaction suggests the 
participation of N in the regulation of cell cycle (Yoo et al., 2010). Different from the N protein, 
Nsp11 is an RNA-cleavage enzyme containing the NendoU activity of uridylate-preference RNA 
cleavage and resides in the cytoplasm. Nsp11 may alter the function or expression of cytoplasmic 
cellular components such as mRNA modification which may then results in the regulation of cell 
cycle. Indeed, cellular mRNA modification by Nsp11 has been suggested (Sun, 2011). Taken 
together, our data show that the PRRSV Nsp11 protein is responsible for delay of the S phase 
and thus, together with the N protein, may regulate the host cell cycle progression. While N 
functions in the nucleus, Nsp11 functions in the cytoplasm.  
Only a few immune-related cytokine genes were found to be regulated in our study, 
specifically for IFN-related genes. This is probably due to the cell type and the treatments used in 
our study. MARC-145 cells are epithelial cells of African green monkey kidney origin and these 
cells will produce only a minimal amount of cytokines and thus the ability to secret IFN is 
limited without stimulation. It will be of interest to examine differentially regulated genes in 
Nsp11-expressing cells under IFN stimulation and compare the profiles to those of the present 
study obtained without stimulation. In summary, the microarray analysis has allowed us to 
identify differential effects of the PRRSV Nsp11 protein on cellular gene expression. Further 
studies are required so as to the significance of the differential gene regulation identified in the 
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present study. Additional techniques and experiments including the analysis of relative protein 
modifications and activations especially certain checkpoint proteins will help understand the 
molecular basis of the S phase change, whether slow the S phase or arrest in the S phase, caused 
by Nsp11. Clearly, our data provide new insights into the understanding of cell-virus interactions 
and the pathogenic mechanisms of PRRSV and host responses to the infection. 
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GENERAL CONCLUSION 
Innate immune response especially the type I IFN responses is the first line of defense of 
host cell to fight against virus infection. During infection, intricate cellular signaling processes 
are turned on and multiple pathways are activated or inhibited by viruses. For PRRSV, the 
nucleocapsid protein appears to activate the NF-κB pathway, and its nuclear localization and 
dimerization may be associated. Nsp1 and Nsp2 are identified to be responsible for viral 
immune-modulation in IRF3-mediated and NF-κB-mediated IFN production pathway and 
JAK-STAT pathway by blocking different steps in different cell types. In the present study, such 
modifications induced by PRRSV Nsp11 have been investigated. Nsp11 has been studied for its 
role in suppression of type I IFN. As a common effector molecule in the IFN production pathway, 
IPS-1 was found to be affected by PRRSV Nsp11. The endoribonuclease activity of Nsp11 was 
associated with the IPS-1 mRNA degradation. When Nsp11 was expressed in the cell, the IPS-1 
protein was reduced and the downstream signaling was suppressed. Both IRF3 and IκB 
phosphorylation was inhibited and the IFN-β promoter was not activated. In addition to the 
stimulation of type I IFN, IPS-1 can participate in the mitochondria-mediated apoptosis to 
function as a bridge between the type I IFN induction and apoptosis. Nsp11 is able to degrade 
IPS-1 mRNA and results in the suppression of type I IFN induction. Whether the degradation of 
IPS-1 will inhibit the cellular apoptosis remain to be studied. For SARS-CoV, nsp15 suppresses 
the IPS-1 induced apoptosis independent from IRF3 activation (Lei et al., 2009), implying that 
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the IPS-1 degradation by PRRSV Nsp11 may lead to the inhibition of apoptosis as a means of 
immune evasion for PRRSV.  
Nsp11 contains a nidovirus-specific NendoU domain. Mutational studies using EAV have 
demonstrated that NendoU is important for virus replication (Posthuma et al., 2006). In PRRSV, 
NendoU knockout mutants completely lost their infectivity, indicating that NendoU activity is 
essential for PRRSV replication.  
Despite the progress made on the PRRSV-mediated modulation of innate immune responses, 
identification of viral proteins playing a role for IFN suppression during infection was unknown. 
To understand this better, 16 North American PRRSV isolates were obtained and the Nsp11 gene 
was cloned and sequenced. Different PRRSV isolates appeared to differ in their sensitivity to 
IFN-α to some extent and they may have different ability to down-regulate the IFN response. 
Several isolates shared the identical Nsp11 gene sequences, but exhibited different phenotypes 
for IFN suppression. This result demonstrates that other viral protein also participate in the IFN 
suppression during infection. Nsp1, Nsp2, and N have been shown to be involved and function 
together. Although most Nsp11 proteins showed similar levels of inhibition for IFN-β promoter, 
Nsp11 from the 17401 isolate (17401-Nsp11) displayed a slightly less potency compared to 
FL12-Nsp11 and others. Since all Nsp11 genes were cloned from field isolates and contain 
conserved NendoU catalytic sites, this phenotypic difference would be derived from other active 
site(s) rather than the NendoU activity. Based on the sequence alignments between FL12-Nsp11 
and 17401-Nsp11, 9 amino acids have found to be different, and Ala160 in 17401-Nsp11 was 
 105  
identified to be responsible for the additional suppressive function for IFN.  
To expand our understanding other modulations of host cells gene expression by Nsp11, a 
cell line stably expressing Nsp11 proteins (MARC-Nsp11) was established, and an RNA 
microarray was conducted using these cells. A total of 170 cellular genes were identified as 
differentially regulated. The number of down-regulated genes was 104 and 66 genes were 
up-regulated. These differentially regulated genes were grouped into 5 different pathways 
according to their functional relevance; histone-related proteins, cell cycle and DNA replication 
pathways, MAPK signaling pathway, ubiquitin-proteasome pathway, and complement pathway. 
Of them, cell cycle was of our interest for further study. The flow cytometry and BrdU staining 
indicated clearly that the cell cycle progression was delayed at the S phase in MARC-Nsp11 cells 
compared to MARC-145 cells. The S phase tardiness may be associated with the altered DNA 
replication, since several MCM proteins that are components of DNA helicase were shown to be 
up-regulated in the RNA microarray assay. It is possible that the abnormal amount of helicase 
protein caused malfunction or malformation of the replication fork, which caused the inhibition 
of DNA synthesis in MARC-Nsp11 cells and therefore resulted in the S phase change by the 
Nsp11 viral protein. Although the PRRSV replication occurs entirely in the cytoplasm, the 
regulation of cell cycle progression is considered beneficial for the virus, since the available pool 
of cellular machineries can be maximally utilized towards the production of progeny virus at an 
early stage of infection. 
    The lack of knowledge on the mechanistic basis for how PRRSV evades host immune 
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response leads to an inadequate control of the disease. One of the key questions is whether the 
virulence of PRRSV is linked to the immunosuppression. My study contributes to the 
understanding of the modulation of host cells during PRRSV infection. Studies on Nsp11 provide 
better insights into how PRRSV interferes with the host innate immune response and modulates 
host cell cycle. This information may provide a basis to generate mutant PRRSV using infectious 
cDNA clones to eliminate the immune suppressive functions from the virus, which may be 
feasible ways to generate new generation of attenuated vaccines for PRRS. 
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FIGURES AND TABLES 
 
 
 
 
Fig. 1.1. Schematic representation of the PRRSV virion. The virion is spherical in shape and is composed of the 
envelop and icosahedral nucleocapsid, consisting of nucleocapsid (N) protein and the single-stranded RNA (ssRNA) 
genome. At least six membrane proteins, GP2, E, GP3, GP4, and GP5 and matrix (M) protein are embedded on the 
membrane surface. M and GP5 form a heterodimer, while GP2, GP3, and GP4 form a hetrotrimer. Some of GP3 is 
soluble. 
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Fig. 1.2. Schematic representation of the PRRSV genome. Genome organization based on the sequence of North 
American PRRSV PA-8 (Wootton et al., 2000). The replicase genes consisting of the ORF1a and ORF1b are located 
at the 5’ two thirds of the genomic RNA. The structural genes are located at the 3’ one third of genome. ORF2-ORF5 
encodes GP2 through GP5. ORF6 and ORF7 encodes for M and N protein, respectively. An internal ORF within 
ORF2 encodes E protein. ORF5a is newly identified within ORF5. The scale bar on top indicates the length of the 
genome in kb. The ribosomal frameshift site is indicated by filled circle and the leader sequence is indicated by the 
grey box. Numbers indicate position of nucleotides. 
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Fig. 1.3. Overview of the putative proteolytic processing of PRRSV Nsp’s and general features of Nsp11. (A), 
PRRSV genome. (B), the processing of pp1a yields 10 end-products, Nsp1α, Nsp1β, Nsp2 through Nsp6, Nsp7α, 
Nsp7β, and Nsp8. ORF1b codes for Nsp9 through Nsp13. The papain-like cysteine protease (PCP) within Nsp1 
cleaves out Nsp1α and Nsp1β. The chymotrypsin cysteine protease (CP) in Nsp2 cleaves out Nsp2. Serine protease 
(SP) in Nsp4 cleaves the rest Nsps. Cleavage sites are indicated in arrowheads. Nsp2, Nsp3, and Nsp5 contain the 
hydrophobic domain (HD). RdRp is located in Nsp9. Nsp9 also contains the helicase and a zinc (Z) binding domain. 
Nsp11 contains the NendoU (N) activity. (C), Nsp11 contains the NendoU domain (indicated in grey) at its 
C-terminal region. There are two subdomains in NendoU domain, subdomain A and subdomain B. Based on the 
alignment of EAV Nsp11 and PRRSV Nsp11 and previous studies on NendoU and XendoU, subdomain A contains 
the ribonuclease activity associated with three catalytic sites located in this domain, 2 histidines and 1 lysine. 
Subdomain B contributes to the conformational structure of the protein. Two Asp located in this domain are 
responsible for maintaining the protein protein interaction.     
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Fig. 1.4. Transcription of PRRSV. The replicase proteins are expressed from the genomic RNA and the structural 
proteins are expressed from a nested set of subgenomic mRNAs. The 5’ terminal sequence of all subgenomic 
mRNAs is identical to the 5’ terminal leader sequence (blue box) of the genomic RNA. All subgenomic mRNAs are 
structurally polycistrnic except for mRNA7, but functionally monocistronic with the exception of mRNA2 which is 
bicistronic, and only the 5’ most ORF (slash filled box) is translated. The leader and body sequence of mRNA are 
fused by the body TRS (black box) which is homologous to the leader TRS (grey box) located at the 3’ end of the 
leader RNA.  
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Fig. 1.5. Overview of the replication cycle of PRRSV. PRRSV enters cells by receptor-mediated endocytosis. 
Upon entry, the viral nucleocapsid is released to the cytoplasm. The positive RNA genome is then translated into 
polyprotein precursors which are cleaved to form a replicase complex. The replicase complex then was targeted to 
the double membrane vesicles to direct the genomic and subgenomic RNA synthesis. The structural proteins are 
expressed from subgenomic RNA in the cytoplasm. Except the N protein, structural proteins are transported to the 
ER membrane. In the cytoplasm, the newly synthesized genomic RNA (+) is encapsidated by N protein to form 
nucleocapsid which is then budded into the luman of ER and/or Golgi where other structure proteins are present and 
finally assembled as virions. The intracellular budded virions are released by exocytosis or cell lysis. The entire life 
cycle occurs in the cytoplasm. 
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Fig. 1.6. Signal pathways for type I IFN production and IFN stimulated gene expressions. 
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Fig. 1.6. Signal pathways for type I IFN production and IFN stimulated gene expressions. Double-stranded 
RNA, single-stranded RNA, and CpG DNA are recognized by TLR3, TLR7/8, and TLR9, respectively, in the 
endosomes, which leads to the dimerization of receptors and recruitment of TRIF or MyD88. The stimulation results 
in the assembly of signaling complexes and initiation of signaling cascades leading to the phosphorylation and 
activation of IRF3/IRF7, NF-κB, and AP-1. Once activated, these transcription factors translocate to the nucleus, and 
together with CBP, induce the transcription of IFN-α and IFN-β. Activation of RIG-I/MDA5 by viral RNA may be 
inhibited by LGP2. Both RIG-I and MDA5 activates IPS-1 through the CARD domain. IPS-1 then induces signaling 
pathways resulting in the activation of IRF3, IRF7, and NF-κB through different adaptors and kinases. IPS-1 signaling 
also likely involves the MAP kinase cascade for activation of AP-1. The nuclear signal of IRF3/IRF7, NF-κB, and 
AP-1 is similar to that of TLR. Once IFN-α and IFN-β are secreted extracellularly outside the cell after production, 
they bind to IFN receptors on itself (autocrine) or neighbor cells (paracrine), the receptor associated JAK1 kinase is 
phosphorylated and activated to recruit STAT1 and STAT2 through their SH2 domain for phosphorylation. The 
phosphorylated STAT1 and STAT2 are detached from the IFN receptors and associated each other to form ISGF3 
complexes along with IRF9. ISGF3 then undergoes nuclear translocation and binds to ISRE to induce the transcription 
of hundreds of ISGs. Five major kinds of ISGs are listed here; MxA, OAS-1/RNaseL, RIG-I/MDA5, ISG15, and PKR. 
For their modes of action, see the text. Grey circle indicates the lysine-48-linked ubiquitin chain which leads to the 
degradation of proteins. Yellow circle indicates phosphorylation (adapted from Yan et al., 2012).  
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Fig. 1.7. The modulation of type I IFN production by PRRSV. PRRSV has been shown to reduce the expression 
of TLR3 and IRF7 in pDCs. While Nsp1 has the ability to degrade CBP in the nucleus, Nsp1α subunit inhibits the 
IκB phosphorylation in the cytoplasm. Nsp2 inhibits IFN production by blocking the ubiquitinylation of 
phosphorylated IκB and phosphorylation of IRF3 through the OTU domain. PRRSV Nsp1β blocks the 
phosphorylation of STATs and inhibits the nuclear translocation of ISGF3 complex. Nsp1 interacts with PIAS. 
Since PIAS is a multi-functional protein, Nsp1 interaction may also modulate pathways other than the JAK-STAT 
pathway. PKR is redistributed during PRRSV infection. Nsp2 has the potential to deconjugate ISGylation.  The 
GP5 and N proteins induce apoptosis (adapted from Yan et al., 2012) 
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Fig. 2.1. Suppression of type I Interferon induction by PRRSV Nsp11. (A), Determination of IFN-β promoter 
activity by luciferase reporter assays. HeLa or MARC-145 cells were co-transfected with indicated amounts 
pXJ41-Flag-Nsp11 along with 0.5 µg of pIFN-β-luc and 0.05 µg of pRL-TK. At 24 h post-transfection, cells were 
transfected with 0.5 µg/ml of poly(I:C) for 16 h, and luciferase activities were determined using the Dual Luciferase 
assay system (Promega).The experiments were conducted in duplication and repeated three times and the overall 
trend was described in panel A. Each Nsp11 transfected sample was compared with poly(I:C) induction and the data 
was analyzed using 2-tail t-test (*, P<0.01; **, P<0.005). (B) Suppression of IFN-β production by Nsp11 determined 
by VSV-GFP bioassay. Culture supernatants collected from gene-transfected HeLa cells were serially diluted in 2 
fold and inoculated to MARC-145 cells freshly grown in 96-well plates. At 24 h, cells were infected with VSV-GFP 
at an MOI of 0.1. At 16 h post-infection, cells were fixed and GFP expression was observed by fluorescence 
microscopy. PIC, poly(I:C). 
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Fig. 2.2A. Sequence alignments of the NendoU domain of arteriviruses and introduction of mutations. 
Numbers refer to amino acid positions with respect to PP1ab of PRRSV strain FL12. The cleavage sites flanking 
Nsp11 are indicated. PRRSV Nsp11 spans between G3607 and E3829 and the NendoU domain lies from L3733 to 
F3811 forming the conserved 79 residue core. Subdomain A is conserved across the XendoU/NendoU family and 
includes 3 putative catalytic residues of H3735, H3750 and K3779. Subdomain B is specific for nidoviruses and 
includes two conserved Asp residues at 3786 and 3810. S3754 in subdomain A and S3802 in subdomain B are 
predicted not to affect the NendoU function. Stars in black indicate the amino acids targeted for mutation in the 
present study. A closed circle indicates the site for out-of-frame mutation (Int-mutant) in which a ‘C’ was inserted 
after the proline codon (CCC) to serve as a negative control. Thirty one arterivirus isolates were aligned including a 
strain of EAV (NC_002532), a strain of LDV (NC_003092), a strain of SHFV (DQ489311), and 28 isolates of 
PRRSV as follow: FL12 (NC_002534), VR2332 (EF536003), 16244B (AF046869), CH-1a (AY032626), HB-1 
(AY150312), HB-2 (AY262352), HN1 (AY457635), HuN (EF517962), JX0612 (EF488048), JXA1 (EF112445), 
JXwn06 (EF641008), LMY (DQ473474), MLV (EF484033), MN184 (EF484031), MN184B (DQ176020), SD01 
(AY545985), NVSL-97-798 (AY545985), p129 (AF494042), PA8 (AF176348), pL97-1 (AY585241), PrimePac 
(DQ779791), SHH (EU106888), SY0608 (EU144079), Wuh1 (EU187484), Lelystad(M96262), 01CB1 (DQ864705), 
EuroPRRSV (AY366525), and HKEU16 (EU076704). Parentheses indicate GenBank accession numbers. 
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Fig. 2.2. Loss of suppressive activities for IFN induction by various Nsp11 mutants. (B), HeLa or MARC-145 
cells were co-transfected with pIFN-β-luc (0.5 μg), pRL-TK (0.05 µg), and pXJ41-Flag-Nsp11 or individual Nsp11 
NendoU mutant plasmids (0.5 μg/plasmid). At 24 h post-transfection, cells were treated with 0.5 μg/ml of poly(I:C) 
for 16 h. Cells were lysed and determined for reporter activities Experiments were duplicated each time and repeated 
for three times (**, P<0.005). (C) VSV-GFP bioassay for Nsp11 mutants. HeLa cells were transfected with 
individual Nsp11 mutant plasmids and treated with poly(I:C) for 6 h. Culture supernatants were collected and 
serially diluted 2 fold up to 1/1024. Fresh MARC-145 cells were incubated with each dilution for 24 h and then 
infected with VSV-GFP at an MOI of 0.1. At 16 h post-infection, GFP expressions were observed by fluorescent 
microscopy. The dilutions where VSV-GFP started to grow were recorded as end-point dilution 
titers−log2 ( average point dilution titer ). The experiments were repeated three times in triplicate each (*, P<0.05).  
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Fig. 2.3. Suppression of IRF3 and NF-κB activities by Nsp11 and its NendoU mutants. Cells were co-transfected 
with pIRF3-luc (A) or pPRDII-luc (B), pXJ41-Flag-Nsp11 or individual Nsp11 mutant plasmids along with pRL-TK 
at ratios of 1:1:0.1, respectively. At 24 h post transfection, cells were treated with 0.5 μg/ml of poly(I:C) for 16 h 
followed by luciferase determination. The reporter activities are presented as the fold changes relative to the activity 
of the poly(I:C)-treated cells divided by the activity of the control Experiments were constructed three times and in 
duplicates each (**, P<0.005). 
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Fig. 2.4. Inhibition of IRF3 activation by Nsp11. (A) subcellular localization of IRF3. HeLa cells were transfected 
with pXJ41-Flag-Nsp11 for 24 h and treated with poly(I:C) for 6 h. Cells were then costained with rabbit α-IRF3 
polyclonal antibody for endogenous IRF3 (red, middle column) and mouse α-Flag MAb to detect Nsp11 (green, left 
column), followed by Alexa Fluor 488-labled anti-mouse Ab and Alexa Fluor 594-labeled anti-rabbit Ab, respectively. 
The nuclei were stained by DAPI (blue). White Arrows indicate Nsp11-expressing cells (green).  
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Fig. 2.4. (conti.) (B) Cell-fractionation and western blot for IRF3. HeLa cells were transfected with 
pXJ41-Flag-Nsp11 and at 24 h post-transfection, treated with poly (I:C) for 6 h. Cells were harvested and fractionated 
for nuclear and cytosolic fractions using Nuclear/Cytosol Fractionation kit (BioVision). Both fractions were resolved 
by SDS-PAGE and immunoblotted as indicated. PARP and HSP90 served as a marker for nuclear and cytoplasmic 
proteins, respectively. β-action served as a house keeping protein. (C) The K3779A mutant was chosen as a 
comparison to wild-type Nsp11 to examine the phosphorylation of IRF3 during Nsp11 expression. HeLa cells were 
transfected with pXJ41-Flag-Nsp11, K3779A, or pXJ41, and at 24 h post-transfection, cells were stimulated with 
poly(I:C) for 6 h. Cell lysates were prepared and subjected to SDS-PAGE and Western blot using the phosphorylated 
IRF3-specific Ab to determine the phosphorylation status of IRF3. 
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Fig. 2.5. Inhibition of NF-κB activation by Nsp11. (A) subcellular localization of NF-κB in HeLa cells. Cells were 
transfected with pXJ41-Flag-Nsp11 or 24 h and stimulated with poly(I:C) for 6 h. Cells were co-stained with rabbit 
α-p65 PAb for endogenous NF-κB (red, middle column) and mouse α-Flag MAb for Nsp11 (green, left column), 
followed by Alexa Fluor 488-labled α-mouse Ab and Alexa Fluor 594-labeled α-rabbit Ab, respectively. The nuclei 
were stained by DAPI (blue). White arrows indicate Nsp11-expressing cells, and yellow arrow indicates p65 in 
Nsp11-non-expressing cell.  
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Fig. 2.5. (conti.). (B) HeLa cells were co-transfected with pXJ41-Flag-Nsp11 or pXJ41 and at 24 h post-transfection 
stimulated with 20 ng/ml of TNF-α for 5, 10, or 20 min. Cells were lysed at indicated times and subjected to 
SDS-PAGE and Western blot using α-phosphorylated-IκBα PAb, α-Nsp11 PAb, and α-β-actin MAb. (C) HeLa cells 
were transfected with pXJ41, or pXJ41-Flag-Nsp11, or K3779A. At 24 h post-transfection, cells were stimulated 
with TNF-α, and at indicated times harvested to detect phosphorylated IκB using α-IκB MAb. Stars indicate the 
phosphorylated form of IκB and crosses indicate the unphosphorylated form of IκB.  
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Fig. 2.6. Induction of IFN-β by RIG-I and IPS-1 and suppression by Nsp11. HeLa or MARC-145 cells were 
co-transfected with pIFN-β-luc, indicated amounts of pXJ41-Flag-Nsp11 or pFlag-K3779A, and pRL-TK at ratios of 
1:1:0.1, along with the constitutively active form of RIG-I (A) or IPS-1 (B). Cells were lysed at 40 h 
post-transfection and assayed for luciferase activities. Experiments were duplicated each and repeated for three 
times. Each sample was compared to the RIG-I or IPS-1 induction and the data were analyzed using 2-tail t-test (**, 
P<0.005; *, P<0.01). (C) HeLa cells were transfected with pTATA-luc, pRL-TK and pXJ41-Flag-Nsp11, followed 
by poly(I:C) stimulation for 16 h, and determined for luciferase activities.  
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Fig. 2.7. Degradation of IPS-1 mRNA by Nsp11. (A) and (B), RT-PCR for IPS-1 mRNA. HeLa or MARC-145 
cells were co-transfected with either pXJ41-Flag-Nsp11 alone or pXJ41-Flag-Nsp11 and pcDNA3-IPS-1. At 24 h 
post-transfection, total cellular RNAs were extracted using Trizol and treated with DNase I. cDNAs were 
synthesized by reverse transcription using random primers followed by PCR using IPS-1- and GAPDH-specific 
primers (A) and q-RT-PCR using the SYBR Green system (Applied Biosystems) (B). GAPDH gene expressions 
were determined as a control and presented as replication cycle numbers (Ct). Quantitative RT-PCR fold changes 
were calculated using the 2-ΔΔCt equation: -ΔΔCt=-[(Ct IPS-1-Ct GAPDH)(pXJ41-transfected cells)-(Ct IPS-1-Ct 
GAPDH)(Nsp11-transfected cells)]. White bars indicate cells transfected with the empty vector pXJ41 (left) or 
pcDNA3-IPS-1 (right), and the black bars indicate cells transfected with pXJ41-Flag-Nsp11 alone (left) or 
co-transfected with pXJ41-Flag-Nsp11 and pcDNA3-IPS-1 (right). Experiments were triplicated (**, P<0.01; * 
P<0.05). (C), HeLa cells were co-transfected with pcDNA3-IPS-1 and pXJ41-Flag-Nsp11 or individual Nsp11 
mutant plasmids. At 24 h post-transfection, cells were lysed and subjected to Western blot using mouse α-Flag MAb 
(top panel), mouse α-IPS-1 PAb (middle panel), and α-β-actin MAb (bottom panel).       
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Fig. 2.8. Degradation of IPS-1 mRNA in PRRSV-infected cells. (A) and (B), quantitative RT-PCR for IPS-1 
mRNA in PRRSV-infected cells. MARC-145 cells were infected with PRRSV or EAV at an MOI of 5, or with 
VSV-GFP at an MOI of 0.1. EAV-infected cells were harvest at 8 h and 16 h post-infection, while VSV-GFP infected 
cells were harvest at 24 h post-infection. PRRSV-infected cells were harvest at 48 h and 72 h post-infection. 
Samples were lysed by Trizol followed by semi-RT-PCR (B) or quantitative RT-PCR (A) using the SYBR Green.  
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Fig. 2.8. (conti.) GAPDH gene expressions were determined as a control and presented as replication cycle numbers 
(Ct). Quantitative RT-PCR fold changes were calculated using the 2-ΔΔCt equation: -ΔΔCt=-[(Ct IPS-1-Ct 
GAPDH)(pXJ41-transfected cells)-(Ct IPS-1-Ct GAPDH)(Nsp11-transfected cells)]. Each of virus-infected samples was compared 
with its own control and normalized by GAPDH. The GAPDH expression of each sample was presented as the Ct 
number as shown at the bottom of the charts. White bars indicate mock-infection, black bars indicate virus infection 
(**, P<0.01; *, P<0.05). (C) Western blot for IPS-1 in PRRSV-infected cells. MARC-145 cells were infected with 
PRRSV, EAV, or VSV-GFP in the same way as described for (A), and cell lysates were prepared and subjected to 
SDS-PAGE and Western blot using mouse α-IPS-1 PAb, rabbit α-PRRSV Nsp11 PAb, α-PRRSV swine serum, 
α-EAV N MAb and α-β-actin MAb. (D) Decrease of IPS-1 in PRRSV-infected cells and pXJ41-Flag-Nsp11- 
transfected cells. MARC-145 cells were infected with PRRSV at an MOI of 5, and at 24 h post-infection, cells were 
stained with mouse α-IPS-1 PAb, rabbit α-PRRSV Nsp11 PAb, and DAPI. For gene-transfection, MARC-145 cells 
were transfected with 0.5 μg of pXJ41, pXJ41-Flag-Nsp11, or K3779A, and at 24 h post-transfection, stained as 
described for virus-infected cells. White arrows indicate cells expressing Nsp11 or mutant Nsp11 K3779A. Yellow 
arrows indicate cells that are not expressing Nsp11. 
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Fig. 2.9. Specificity of IPS-1 degradation by Nsp11. MARC-145 cells were transfected with pXJ41-Flag-Nsp11 or 
pXJ41, and at 24 h post-transfection, total cellular RNAs were extracted using Trizol. cDNA was synthesized by 
reverse transcription using random primers followed by q-PCR using IPS-1-, RIG-I-, p65-, and IRF3 specific 
primers. The amount of RNA in cells expressing Nsp11 was compared to the amount of RNA in cells that were not 
expressing Nsp11. White bars indicate the amounts of RNA in cells transfected with pXJ41 and black bars indicate 
the amounts of RNA in cells transfected with pFlag-Nsp11. Experiments were repeated for three times (*, P<0.01). 
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Fig. 2.10. Expression of Nsp2/3 and N proteins in cells transfected with various NendoU mutant genomic RNA. 
MARC-145 cells were transfected with mutant viral genomic RNAs transcribed from infectious cDNA clones using 
the T7 polymerase. Cells were fixed at 16 h post-transfection and co-stained with α-Nsp2/3 PAb and α-N MAb 
SDOW17 to examine the genome replication and subgenomic (sg) mRNA7 synthesis, respectively. All images were 
recorded under the same exposure time and contrast/brightness settings.  
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Fig. 2.11. Identification of genomic RNA and sgmRNA7 in cells transfected with Nsp11 mutant RNA. (A), 
schematic representation of the RT-PCR analysis used to detect the genomic RNA replication and sgmRNA7 
synthesis. (B), detection of the passage 1 (P1) viral RNAs in cells transfected with different mutant genomic RNAs. 
Total cellular RNA was extracted at 16 h post-transfection and RT-PCR was performed to amplify the region as 
illustrated in (A). β-actin served as an internal control. (C), detection of the P2 viral RNAs in cells infected with P1. 
Total cellular RNA was extracted at 6 days post-infection followed by RT-PCR. 
 
  
genomic RNA   
669bp    
Nsp11    
5’ UTR   3’ UTR   
520bp      
sg mRNA7   
Subdomain B Subdomain A 
- genomic RNA     
- sg mRNA7        
- β-actin                  400 bp -  
650 bp -    
650 bp -    
850 bp -    
650 bp -   
400 bp -    
- genomic RNA     
- sg mRNA7        
- β-actin                  
A           
B           
C          
M
arker 
M
ock 
N
egative 
FL12-H
3735A 
FL12-H
3750A 
FL12-S3754A 
FL12-K
3779A 
FL12-D
3786A 
FL12-S3802A 
FL12-D
3810A 
FL12-W
T 
 130  
Oligonucleotides Primer sequence 
  Nsp11-F  5'-AAAGGATCCATATGGGGTCGAGCTCCCCGCTCCC-3'  
  Nsp11-R  5'-CCCCTCGAGTTCAAGTTGAAAATAGGC-3'  
  Nsp11-H3735A-U  5’-GAGTCCCTCCCCGCTGCTTTCATTGGC-3’  
  Nsp11-H3735A-L  5’-GCCAATGAAAGCAGCGGGGAGGGACTC-3’  
  Nsp11-H3750A-U  5’-CGTTGGAGGATGTGCCCATGTCACCTC-3’  
  Nsp11-H3750A-L  5’-GAGGTGACATGGGCACATCCTCCAACG-3’  
  Nsp11-S3754A-U  5’-CCATGTCACCGCCAAATACCTTCCG-3’  
  Nsp11-S3754A-L  5’-CGGAAGGTATTTGGCGGTGACATGG-3’  
  Nsp11-K3779A-U  5’-GGAAAGCCGCAGCAGCAGTTTGCAC-3’  
  Nsp11-K3779A-L  5’-GTGCAAACTGCTGCTGCGGCTTTCC-3’  
  Nsp11-D3786A-U  5’-GTTTGCACATTAACAGCTGTGTATCTCCCAG-3’  
  Nsp11-D3786A-L  5’-CTGGGAGATACACAGCTGTTAATGTGCAAAC-3’  
  Nsp11-S3802A-U  5’-CCAGAGACCCAGGCCAAGTGCTGG-3’  
  Nsp11-S3802A-L  5’-CCAGCACTTGGCCTGGGTCTCTGG-3’  
  Nsp11-D3810A-U  5’-GAAAATGATGTTGGCCTTCAAGGAAGTTCG-3’  
  Nsp11-D3810A-L  5’-CGAACTTCCTTGAAGGCCAACATCATTTTC-3’  
  Nsp11-Sab-D-U  5’-GGACTCAGCAATTTCTCGCTCCC-3’  
  Nsp11-Sab-D-L  5’-GAAGTTCGACTGATGGTCTGGAAG-3’  
  Nsp11-Sa-D-L  5’-CTAACAGATGTGTATCTCCCAGATCTCG-3’  
  Nsp11-Sb-D-U 5’-GGTGCAAACTGCTTTTGCGG-3’ 
  hIPS-1-F 5’-CGGGCATCAGGAGCAGGACA-3' 
hIPS-1-R 5'-TCACAGGCATCAAGGTGGTAGGC-3' 
hRIG-I-F 5'-AAACCAGAGGCAGAGAAGAGCAA-3' 
hRIG-I-R 5'-TCGTCCCATGTCTGAAGGCGTAAA-3' 
hp65-F 5'-CTGCAGTTTGATGATGAAGA-3' 
hp65-R 5'-TAGGCGAGTTATAGCCTCAG-3' 
hIRF3-F 5'-ACCAGCCGTGGACCAAGAG-3' 
hIRF3-R 5'-TACCAAGGCCCTGAGGCAC-3' 
 
Table 2.1. Oligonucleotides and their sequences  
 
Underlines indicate restriction enzyme recognition sequences used for cloning.   
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Plasmid %  cell cytotoxicitya 
Total amount of 
RNA (μg)b 
- 2.0 9 
Lipofectamine 
2000 
3.6 8.2 
pXJ41 2.1 10 
Nsp11 WT 2.3 7.3 
H3735A 2.5 7.6 
H3750A 2.6 9.2 
S3754A 2.4 7.3 
K3779A 3.3 8.5 
D3786A 2.6 7.2 
S3802A 3.2 8.3 
D3810A 13.4 7.0 
Table 2.2. Cell cytotoxicity of Nsp11 and its NendoU mutants in MARC-145 cells  
a % cell cytotoxicity was calculated using the following formula:  (# of dead cells) /(total # of cells) x 100. 
b The total amount of RNA was determined from 2.5 x 105 cells/well  
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Mutant 
virus 
Nsp11 mutation 
(wt → mutated 
sequence) 
Passage 1 (P1)
a
 
Passage 2 
(P2)
a
 
Viability
e
 
Nsp2/3 
IFA
b
 
N 
IFA
b
 
Log titre
c
 
(16hr) 
Log titre
c
 
(24hr) 
N 
IFA
d
 
RT- 
PCR
d
 
FL-12 WT none  +++ +++ 2 2.75 +++ + wild type 
Defective 
One nt insertion 
(CAT)→(CCAT) 
- - - - - - nonviable 
Subdomain A 
H3735A 
His3735 
(CAT)→Ala (GCT) 
++ + <10 <10 - - Low titer 
H3750A 
His3750 (CAC)→Ala 
(GCC) 
++ + <10 <10 - - Low titer 
S3754A 
Ser3754 (TCC)→Ala 
(GCC) 
+++ +++ 1 1.75 +++ + viable 
K3779A 
Lys3779 (AAA) →Ala 
(GCA) 
++ + <10 <10 - - Low titer 
Subdomain B 
D3786A 
Asp3786 (GAT)→Ala 
(GCT) 
- - - - - - nonviable 
S3802A 
Ser3802 (TCC)→Ala 
(GCC) 
+++ +++ 1.75 2.5 +++ + viable 
D3810A 
Asp3810 (GAC)→Ala 
(GCC) 
- - - - - - nonviable 
Table 2.3. Overview of genotype and viability of PRRSV NendoU mutant viruses  
aMARC-145 cells were transfected with genomic RNA transcripts. Cell culture supernatants and intracellular RNA 
were collected at indicated time points, and the progeny virus in the supernatants was designated as ‘passage 1’ (P1). 
Fresh MARC-145 cells were inoculated with P1 and the culture supernatant was designated as ‘passage 2’ (P2).  
bImmunofluorescence assay (IFA) was conducted at 16 h post-transfection for P1. Percentage of IFA positive cells 
was indicated as +/-. ++++, greater than 12%; +++, 10%; ++, approximately 5%; + weakly positive in less than 2%.  
cVirus titers were determined by end-point dilution on MARC-145 cells at 6 days post-infection of P1 virus and 
expressed as log 50% tissue culture infective dose per ml (TCID50 /ml).  
dImmunofluorescence assay and RT-PCR for P2 were performed at 6 days post-infection.  
eNonviable indicates no detectable signal in P2 cells by IFA and RT-PCR.  
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Table 2.4. Frequencies of leader TRS (transcriptional regulatory sequence) and body TRS present in the 
IPS-1, RIG-I, IRF3, and p65 gene sequences  
a UUAACC is the leader TRS of PRRSV. 
b Lower case letters indicate non-consensus nucleotides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
cellular 
gene 
GenBank No. 
Size 
(nt) 
Frequency 
UUAACCa UUgACab UUggCCb UcAACub UUxxCx  
ccuuu 
(non-ca
nonical) 
IPS-1 NM_020746.3 1623 0 1 1 1 11 1 
RIG-I AF092922.1 768 0 0 0 0 8 0 
IRF3 
NM_0011357
97 
1269 0 0 1 0 10 0 
p65 
NM_0011451
38 
1647 0 1 1 1 18 5 
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Fig. 3.1. Suppression of IFN-β promoter activity by 16 different PRRSV isolates.  
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Fig. 3.1. Suppression of IFN-β promoter activity by 16 different PRRSV isolates. (A), Suppression ability of 
IFN-β promoter activity by 16 different PRRSV isolates by luciferase assay. MARC-145 cells were infected with 16 
different PRRSVs followed by transfection of IFN-β-luc promoter and pRL-TK as an internal control. Twenty-fours 
hour post-transfection, cells were treated with poly(I:C) for 16 h and determined for dual luciferase reporter 
activities. Mock represented mock infection without poly(I:C) stimulation. PIC indicated mock infection with 
poly(I:C) stimulation. RespPRRSV and PrimPac are two vaccine strains from Noble Laboratories Inc. and 
Schering-Plough Animal Health, respectively. Other numbers indicated different field isolates. (B), 
Quantitative-PCR of MxA mRNA in cells infected with chosen PRRSV isolates. According to the suppressive 
ability of IFN-β promoter activities, PA8 and RespPRRSV were chosen from strong group, 18402 was chosen from 
medium group, and 12773 and 11176 were chosen from weak group. MARC-145 cells were infected with those 5 
viruses and total RNAs were extracted after poly (I:C) induction. Random primers were used to synthesize cDNA. 
The quantities of MxA mRNA were measured from mock infection and 5 PRRSVs infection using MxA specific 
primer. GAPDH was used as internal control. 
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Fig. 3.2. Sequence alignments of Nsp11 sequences from 16 PRRSV isolates. Nsp11s from 17 North American 
PRRSV isolates were cloned, sequenced, and aligned including FL12 (NC_002534), PA8 (AF176348), PrimePac 
(DQ779791), RespPRRSV (AJ223082), 16244B (AF046869), 11604 (JX443641), 11176 (JX462645), 14680 
(JX462646), 17405 (JX462647), 20169 (JX462648), 39049 (JX462649), 17401 (JX462650), 16138 (JX462651), 
12773 (JX462652), 15959 (JX462653), 18402 (JX462655), 10100 (JX462654). 17405 and 18402 isolates had the 
identical Nsp11 sequence and were represented by 18402-Nsp11. RespPRRSV, 16138, 20169, 11176, 14680, and 
10100 had the identical Nsp11 sequence and were represented by 16138-Nsp11. “[ “ indicated the virus isolates 
containing identical Nsp11 sequence and two representatives were indicated in bold.  
      
FL12-Nsp11 GSSSPLPKVAHNLGFYFSPDLTQFAKLPVELAPHWPVVTTQNNEKWPDRLVASLRPVHKYSRACIGAGYMVGP
39049-Nsp11 ..................H........................D............I................
PA8-Nsp11 ........................................................I................
18402-Nsp11 .........................................D..............I..H.............
17405-Nsp11 .........................................D..............I..H.............
17401-Nsp11 ........................................................I................
11604-Nsp11 .......Q.................................................................
16244B-Nsp11 ........................................................I................
PrimePac-Nsp11 ............................A...........................I.E..............
16138-Nsp11 ........................................................I................
RespPRRSV-Nsp11 ........................................................I................
20169-Nsp11 ........................................................I................
11176-Nsp11 ........................................................I................
14680-Nsp11 ........................................................I................
10100-Nsp11 ........................................................I................
12773-Nsp11 ........................................................I................
15959-Nsp11 ..................X......................................................
FL12-Nsp11 SVFLGTPGVVSYYLTKFVRGEAQMLPETVFSTGRIEVDCREYLDDREREIAESLPHAFIGDVKGTTVGGCHHVTSKYLPR
39049-Nsp11 ..................K....L.........................V.A.......................R....
PA8-Nsp11 ..................K....L.........................V.A.......................R....
18402-Nsp11 ..................K....V.........................V.A....................I.......
17405-Nsp11 ..................K....V.........................V.A....................I.......
17401-Nsp11 ..................K....L.........................V.A.......................R....
11604-Nsp11 ................................................................................
16244B-Nsp11 ..................K....L.........................V.A.......................R....
PrimePac-Nsp11 ..................K....V.........................V.A.......................R....
16138-Nsp11 ..................K....L.........................V.A.......................R....
RespPPRSV-Nsp11 ..................K....L.........................V.A.......................R....
20169-Nsp11 ..................K....L.........................V.A.......................R....
11176-Nsp11 ..................K....L.........................V.A.......................R....
14680-Nsp11 ..................K....L.........................V.A.......................R....
10100-Nsp11 ..................K....L.........................V.A.......................R....
12773-Nsp11 ..................K....L.........................VSA.......................R....            
15959-Nsp11 ................................................................................
FL12-Nsp11 FLPKESVAVVGVSSPGKAAKAVCTLTDVYLPDLEAYLHPETQSKCWKMMLDFKEVRLMVWKDKTAYFQLE
39049-Nsp11 V....................L................................................
PA8-Nsp11 V....................L................................................
18402-Nsp11 .......................................K.L............................
17405-Nsp11 .......................................K.L............................
17401-Nsp11 V....................L................................................
11604-Nsp11 ......................................................................
16244B-Nsp11 V....................L................................................
PrimePac-Nsp11 .....................L................................................
16138-Nsp11 V....................L................................................
RespPPRSV-Nsp11 V....................L................................................
20169-Nsp11 V....................L................................................
11176-Nsp11 V....................L................................................
14680-Nsp11 V....................L................................................
10100-Nsp11 V....................L................................................
12773-Nsp11 V....................L................................................
15959-Nsp11 ...............................................................S......
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Fig. 3.3. Suppression of IFN-β, IRF3, and NF-κB activities of Nsp11 from different PRRSV isolates. 
MARC-145 cells were co-transfected with individual Nsp11 genes from different PRRSV isolates, pRL-TK, and 
IFN-β-luc for A, B or IRF3-luc for C or PRDII-luc for D at ratios of 1:0.1:1. At 24 h post transfection, cells were 
stimulated with poly(I:C) for 16 h. Cells were lysed and assayed for luciferase activity. (E), similar method was 
applied mentioned above. Instead of transfection of all 11 Nsp11s, only FL12-Nsp11 and 17401-Nsp11 were used. 
(A) indicated the luciferase values of individual Nsp11 before and after the stimulation with 0.5 ug poly(I:C). The 
western blot showed the expression of individual Nsp11s.  
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Fig. 3.3 (cont.) (E), the luciferase assays between FL12-Nsp11 and 17401-Nsp11 were repeated for seven times 
with duplicates each time and bars indicate average fold-changes for induction of luciferase activity±SEM compared 
to the vector control (*, P<0.05).  
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Fig. 3.4. Construction of 17401-Nsp11 mutants. The regions containing 9 substitutions in Nsp11 genes were 
presented in nucleotide sequences (A) and amino acid sequences (B). The boundaries of PRRSV Nsp11 are Gly3607 
and Glu3830 with the NendoU domain expanding Leu3733 to Phe3811 to form the 79-amino acid core. The 
NendoU domain of Nsp11 is composed of subdomain A and subdomain B, which were indicated using black lines.   
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Fig. 3.5. Inhibitory ability of activation of IFN-β, IRF3, and NF-κB of 9 17401-Nsp11 mutants.  
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Fig. 3.5. Inhibitory ability of activation of IFN-β, IRF3, and NF-κB of 9 17401-Nsp11 mutants. MARC-145 
cells were co-transfected with IFN-β-luc (A), IRF3-luc (B), or PRDII-luc (C), with FL12-Nsp11, or individual 
17401-Nsp11 mutants and pRL-TK (0.05 μg) at ratios of 1:1:0.1. At 24 h post-transfection, cells were stimulated 
with poly(I:C) (0.5 μg/ml) for 16 h followed by luciferase examination. Bars indicate average fold-changes for 
induction of luciferase activity±SEM compared to the vector control. Western blot in (A) indicated the expression of 
Nsp11.   
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Fig. 3.6. Degradation of IPS-1 mRNA by 17401-Nsp11, FL12-Nsp11, 16138-Nsp11, and PrimePac-Nsp11. 
MARC-145 cells were transfected with designated Nsp11 genes. At 24 h post-transfection, total cellular RNAs were 
extracted using Trizol for cDNAs synthesis using random primers (Promega). Q-PCR was constructed using IPS-1- 
and GAPDH-specific primers via Syber Green System (Applied Biosystem). 
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primer name primer sequence   
  Nsp11-F  5'-AAAGGATCCATATGGGGTCGAGCTCCCCGCTCCC-3'  
  Nsp11-R  5'-CCCCTCGAGTTCAAGTTGAAAATAGGC-3'  
  I58V-F 5’- CTGGTTGCCAGCCTTCGCCCTGTCCATAAATACA-3’  
  I58V-R 5’- TGTATTTATGGACAGGGCGAAGGCTGGCAACCAG -3’  
  K92R-F 5’- TGTCATACTATCTCACAAAATTTGTTAGGGGCGAGGCTCAAT -3’  
  K92R-R 5’- ATTGAGCCTCGCCCCTAACAAATTTTGTGAGATAGTATGACA -3’  
  L97M-F 5’- TTAAGGGCGAGGCTCAAATGCTTCCGGAGAC -3’  
  L97M-R 5’- GTCTCCGGAAGCATTTGAGCCTCGCCCTTAA -3’  
  V123I-F 5’- TTGATGATCGGGAGCGAGAAATTGCTGCGTCC -3’  
  V123I-R 5’- GGACGCAGCAATTTCTCGCTCCCGATCATCAA -3’  
  A125E-F 5’- GCGAGAAGTTGCTGAGTCCCTCCCACACG -3’  
  A125E-R 5’- CGTGTGGGAGGGACTCAGCAACTTCTCGC -3’  
  R149K-F 5’- TCATGTCACCTCCAAATACCTCCCGCGCG -3’  
  R149K-R 5’- CGCGCGGGAGGTATTTGGAGGTGACATGA -3’  
  V154F-F 5’- GATACCTCCCGCGCTTCCTTCCCAAGGAA -3’  
  V154F-R 5’- TTCCTTGGGAAGGAAGCGCGGGAGGTATC -3’  
  A160V-F 5’- GGAAAAGCCGCGAAAGCAGTTTGCACACTGAC -3’  
  A160V-R 5’- GTCAGTGTGCAAACTGCTTTCGCGGCTTTTCC -3’  
  L175V-F 5’- TCCCAAGGAATCAGTCGCGGTAGTCGGGG -3’  
  L175V-R 5’- CCCCGACTACCGCGACTGATTCCTTGGGA -3’ 
  IPS-1-F 5’-CGGGCATCAGGAGCAGGACA-3' 
  IPS-1-R 5'-TCACAGGCATCAAGGTGGTAGGC-3' 
  GAPDH-F 5'- CGGAGTCAACGGATTTGGTCGTA-3' 
  GAPDH-R 5'- AGCCTTCTCCATGGTGGTGAAGAC-3' 
  MxA-F 5'- TGTGGTGCGGAACCTCGTGT-3' 
  MxA-R 5'- AAATGTGGGTGGTCCTCAAAGA-3' 
Table 3.1. Oligonucleotides and their sequences  
Underlines indicate restriction enzyme recognition sequences used for cloning.  
 144  
 
PRRSV isolates Virus titer (TCID50/ml) 
PA8 106.3 
18402 105.7 
16244B 105 
10100 105.5 
16138 106 
12773 106 
RespPRRSV 106.3 
PrimePac 105.7 
15959 105.8 
11176 105.8 
39049 5105 
14680 105.7 
20169 105.5 
17401 105 
11604 106.7 
17405 105.7 
 
Table 3.2. Virus titers of 16 PRRSV isolates 
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Fig. 4.1. Establishment of MARC-Nsp11 cells stably expressing PRRSV Nsp11. (A), incorporation of Nsp11 
gene in cellular DNA and identification of cell clones. A total of 7 clones, designated Nsp11-a through Nsp11-g, 
were obtained and screened for Nsp11 sequence by PCR. Cellular DNA was extracted and PCR was performed 
using the primers described in Materials and Methods. The Nsp11-a clone was chosen to conduct RT-PCR (B) and 
immune-blot (C) and designated as MARC-Nsp11 cells. (B), total cellular RNA was extracted from MARC-145 and 
MARC-Nsp11 cells and subjected to DNase I treatment followed by RT-PCR or PCR. (C), cell lysates were 
prepared from MARC-145 (lane 1), Nsp11-gene transfected MARC-145 (lane 2), and MARC-Nsp11 (lane 3) cells, 
and incubated with protein A Sepharose beads and anti-rabbit Nsp11-specific polyclonal Ab, followed by 
immunoblot using anti-Flag monoclonal Ab. 
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Fig. 4.2. Suppression of IFN induction in Nsp11-gene transfected MARC-145 cells and stably expressing 
MARC-Nsp11 cells by luciferase reporter assays and IPS-1 mRNA degradation. (A), MARC-145 or 
MARC-Nsp11 cells were co-transfected with pIFN-β-luc, pIRF3-luc, or pPRDII-luc, and pRL-TK. MARC-145 cells 
were transfected with the pLNCX2 empty vector as a negative control. All samples were treated (transfected) with 
0.5 µg/ml of poly (I:C) for 16 h at 24 h post transfection, and harvested for reporter expression. The results were 
presented as the arithmetic means ± s.e. (n=3). White bars represent MARC-145 cells, grey bars represent the 
pLNCX2 retrovirus expression vector-transfected MARC-145 cells, and black bars represent MARC-Nsp11 cells. 
Luciferase assay repeated for three times (*, P<0.05). (B), the total RNAs were extracted for MARC-145 or 
MARC-Nsp11 cells. Reverse transcription were constructed using random primer, followed by Q-PCR using 
specific IPS-1 and GAPDH primers by Syber Green systerm. GAPDH was used as internal control. IPS-1 RNA 
amount was noemalized by GAPDH RNA amount (*, P=0.05). 
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Fig. 4.3. Quantitative RT-PCR for differentially expressing genes in MARC-Nsp11 cells. Quantitative RT-PCR 
was conducted using the same RNA that was used for microarray. The genes were chosen from 10 most 
up-regulated and 10 most down-regulated genes identified from the microarray (Table 2S and Table 3S). The chosen 
genes included TNFSF10 and DEPTOR as down-regulated genes, NOL6 and EGR1 as up-regulated genes, and SH2 
as a non-regulated gene. The bars illustrate differential expressions via quantitative RT-PCR. White bars represent 
MARC-145 cells and black bars indicate MARC-Nsp11 cells. Table shows the comparisons between quantitative 
RT-PCR and microarrays in numbers.  
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Fig. 4.4. Cell cycle analyses for MARC-Nsp11 cells by flow cytometry. A total of 1x106 MARC-145 and 
MARC-Nsp11 cells were seeded in 60 mm dishes and cultivated for 24 h. Cells were then harvested by 
trypsinization, fixed with 100% cold ethanol. Cells were then stained with 10 µg/ml of propidium iodide (PI) and 
subjected to flow cytometry. The flow cytometry data were analyzed using FCS Express software as described in 
Materials and Methods. Shown are the PI trace (red areas), principally showing the proportion of cells with the 2N 
and 4N DNA contents. The areas were calculated and presented in relative % numbers. G1, first gap period; G2, 
second gap period; S, DNA synthesis and chromosome replication. 
 
  
N
um
be
r o
f e
ve
nt
s
G1
S
G2
N
um
be
r o
f e
ve
nt
s
G1
S
G2
MARC-145 cells MARC-Nsp11 cells 
%G1 74.0 
%S 12.6 
%G2/M 13.4 
%G1 55.6 
%S 28.5 
%G2/M 15.9 
A B 
2N 4N 2N 4N 
 149  
     
 
Fig. 4.5A. BrdU staining to determine newly synthesized cellular DNA at the S phase. 
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Fig. 4.5 (conti.) BrdU incorporation and DNA synthesis in MARC-Nsp11 cells. (A), BrdU staining to determine 
newly synthesized cellular DNA at the S phase. Cells were pulse-labeled with 10 µM of BrdU for 10 min and 20 
min, or 100 nM for 24 h. Cells were then fixed with 2% paraformaldehyde for 15 min and permeabilized with 0.5% 
Triton X-100 for 7 min on ice followed by blocking with 1% goat serum, followed staining with anti-Lamin 
antibody (shown in red color). Cells were then incubated with 4N HCl for 25 min to denature DNA, and anti-BrdU 
antibody was applied for 90 min to stain DNA-incorporated BrdU (shown in green color). The scale bar shown in 
white indicates 10 micron. (B), BrdU incorporation rates in MARC-Nsp11 cells. A total of 200 Lamin positive cells 
were chosen, from which BrdU positive cells were counted, and BrdU incorporation rates were calculated using the 
following formula: number of BrdU positive cells/ number of Lamin positive cells x 100. The results were presented 
as the arithmetic means ± s.e. (n=3) (**, P<0.001; *, P<0.005). White bars indicate MARC-145 cells and black bars 
indicate MARC-Nsp11 cells.  
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Table 4.1. 
Pathway Gene Gene assignment Transcript 
cluster ID 
Gene Bank No. Fold 
change 
H
is
to
ne
-r
el
at
ed
 fu
nc
tio
ns
 
 
HIST2H3D histone cluster 2, H3d 7919589 NM_001123375 2.48 
HIST1H2AI histone cluster 1, H2ai 8117580 NM_003509 2.69 
HIST1H2BH histone cluster 1, H2bh 8117426 NM_003524 2.31 
HIST1H2AK histone cluster 1, H2ak 8124524 NM_003510 3.66 
HIST1H2BK histone cluster 1, H2bk 8068898 NM_080593 1.98 
HIST1H2AI histone cluster 1, H2ai 8117583 NM_003509 2.31 
HIST1H4I histone cluster 1, H4i 8117537 NM_003495 1.84 
HIST1H2BM histone cluster 1, H2bm 8117594 NM_003521 2.13 
HIST2H2AA3 histone cluster 2, H2aa3 7905079 NM_003516 1.94 
HIST2H3A histone cluster 2, H3a 7905085 NM_001005464 2.60 
HIST1H2AH histone cluster 1, H2ah 8117543 NM_080596 2.83 
HIST2H2BE histone cluster 2, H2be 7919637 NM_003528 2.06 
HIST1H3A histone cluster 1, H3a 8117330 NM_003529 2.00 
HIST1H3F histone cluster 1, H3f 8124437 NM_021018 3.81 
HIST1H2BB histone cluster 1, H2bb 8124394 NM_021062 2.14 
HIST1H2BI histone cluster 1, H2bi 8117429 NM_003525 1.95 
HIST1H3G histone cluster 1, H3g 8124440 NM_003534 2.95 
C
om
pl
em
en
t p
at
hw
ay
 
 
C1S 
 
complement component 1, s 
subcomponent 
7953603 
 
NM_201442 
 
-2.93 
 
C1R 
 
complement component 1, r 
subcomponent 
7960744 
 
NM_001733 
 
-1.93 
 
C3 complement component 3 8033257 NM_000064 -2.19 
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Table 4.1. (conti.) 
Pathways Gene Gene assignment Transcript 
cluster id 
Gene Bank No. Fold 
change 
M
A
PK
 si
gn
al
in
g 
pa
th
w
ay
 
 
DUSP1 dual specificity phosphatase 1 8115831 NM_004417 2.96 
FOS FBJ murine osteosarcoma viral oncogene 
homolog 
7975779 NM_005252 6.42 
MYC v-mycmyelocytomatosis viral oncogene 
homolog 
8148317 NM_002467 1.96 
JUN jun proto-oncogene 7916609 NM_002228 2.02 
DUSP6 dual specificity phosphatase 6 7965335 NM_001946 2.81 
SRF serum response factor (c-fos serum 
response element-binding transcription 
factor) 
8119712 NM_003131 1.83 
Pr
ot
ea
so
m
al
 p
at
hw
ay
 
 
SUMO1 SMT3 suppressor of mif two 3 homolog 1 8058335 NM_003352 -1.62 
SNCA synuclein, alpha (non A4 component of 
amyloid precursor) 
8101762 NM_000345 -2.14 
PSMD3 proteasome (prosome, macropain) 26S 
subunit, non-ATPase, 3 
8006984 NM_002809 1.74 
PSMB10 proteasome (prosome, macropain) subunit, 
beta type, 10 
8002133 NM_002801 1.82 
PSMA7 proteasome (prosome, macropain) subunit, 
alpha type, 7 
8067382 NM_002792 1.81 
D
N
A
 re
pl
ic
at
io
n 
&
 C
el
l c
yc
le
 
 
MCM5 minichromosome maintenance complex 
component 5 
8072687 NM_006739 2.05 
MCM4 minichromosome maintenance complex 
component 4 
8146357 NM_005914 2.11 
MCM2 minichromosome maintenance complex 
component 2 
8082350 NM_004526 1.94 
CDC25A Homo sapiens cell division cycle 25 
homolog A 
8086880 NM_001789 2.12 
CDC45 cell division cycle 45 homolog 8071212 NM_001178010 2.00 
MYC Homo sapiens v-myc myelocytomatosis 
viral oncogene homolog 
8148317 NM_002467 1.96 
ORC1 origin recognition complex, subunit 1 7916167 NM_004153 1.73 
Table 4.1. Pathway profiles regulated by PRSSV Nsp11 
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 Primer   Primer sequence   
TNFSF10-F 5'-AAGTGGCATTGCTTGTTTCT -3'  
TNFSF10-R 5'-TTGATGATTCCCAGGAGTTTA-3'  
DEPTOR-F 5’-TTTTGTGGTGCGAGGAAGTAAGC -3’  
DEPTOR-R 5’-GCAGGACATTGAGCCCGTTG -3’  
NOL6-F 5’-AACCGAGGACAGGAAAGGATTG -3’  
NOL6-R 5’-TGTAGACCAGACTGAAAGGAGGC -3’  
SH2-F 5’-TCTGTGAGTTTGAAGCCCTGAG -3’  
SH2-R 5’-GCAATGTTTATCATCCCACCC -3’  
EGR1-F 5’-AGCGATGAACGCAAGAGGCA -3’  
EGR1-R 5’-GGATGGGTATGAGGTGGTGGC -3’  
GAPDH-F 5'- CGGAGTCAACGGATTTGGTCGTA-3' 
GAPDH-R 5'- AGCCTTCTCCATGGTGGTGAAGAC-3' 
Table 4.2. Oligonucleotides and their sequences 
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Table 4.3. 
Transcript 
cluster IDa 
Symbolb Gene assignmentc Fold 
change 
Fdr 
P-vald 
Gene 
Expressione 
★8108370 EGR1 early growth response 1 11.58 0.08 12.07 
8029693 FOSB FBJ murine osteosarcoma viral 
oncogene homolog B 
7.49 0.08 9.23 
7975779 FOS FBJ murine osteosarcoma viral 
oncogene homolog 
6.42 0.08 9.23 
7935228 NA NA 4.82 0.08 4.90 
8016213 NA NA 3.84 0.08 6.23 
8078918 SNORA62 small nucleolar RNA, H/ACA 
box 62 
3.83 0.08 8.63 
8124437 HIST1H3F histone cluster 1, H3f 3.80 0.08 10.25 
8124524 HIST1H2AK histone cluster 1, H2ak 3.66 0.08 9.09 
7899502 RNU11 RNA, U11 small nuclear 3.56 0.08 7.75 
8058388 NA NA 3.48 0.09 4.68 
8141358 NA NA 3.21 0.05 6.51 
7981322 RTL1 retrotransposon-like 1 3.10 0.10 7.19 
7948904 SNORD28 small nucleolar RNA, C/D box 
28 
2.98 0.08 4.47 
8115831 DUSP1 dual specificity phosphatase 1 2.96 0.09 11.70 
8124440 HIST1H3G histone cluster 1, H3g 2.95 0.10 6.61 
★8160682 NOL6 nucleolar protein family 6 
(RNA-associated) 
2.90 0.08 8.48 
8117543 HIST1H2AH histone cluster 1, H2ah 2.83 0.09 5.25 
7965335 DUSP6 dual specificity phosphatase 6 2.81 0.08 9.06 
7948900 SNORD30 small nucleolar RNA, C/D box 
30 
2.77 0.09 8.90 
8117580 HIST1H2AI histone cluster 1, H2ai 2.69 0.08 6.38 
8085052 NA NA 2.62 0.09 4.18 
8106403 F2RL1 coagulation factor II (thrombin) 
receptor-like 1 
2.62 0.09 9.80 
7919614 HIST2H3A histone cluster 2, H3a 2.60 0.08 11.81 
7905085 HIST2H3A histone cluster 2, H3a 2.60 0.08 11.81 
7919612 HIST2H3D histone cluster 2, H3d 2.57 0.08 13.04 
8089701 ZBTB20 zinc finger and BTB domain 
containing 20 
2.56 0.10 8.06 
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Table 4.3. (conti.) 
8175177 MBNL3 muscleblind-like 3 (Drosophila) 2.51 0.08 6.77 
7922418 SNORD74 small nucleolar RNA, C/D box 
74 
2.51 0.09 10.83 
7919589 HIST2H3D histone cluster 2, H3d 2.48 0.08 12.83 
8027746 NA NA 2.42 0.09 5.09 
7984620 NA NA 2.41 0.08 8.34 
8016898 SRSF1 serine/arginine-rich splicing 
factor 1 
2.39 0.09 11.55 
8081838 ARHGAP31 Rho GTPase activating protein 
31 
2.38 0.08 9.05 
7992789 TNFRSF12A tumor necrosis factor receptor 
superfamily, member 12A 
2.34 0.08 11.46 
7948908 SNORD26 small nucleolar RNA, C/D box 
26 
2.33 0.09 8.92 
8117426 HIST1H2BH histone cluster 1, H2bh 2.32 0.08 12.56 
8063345 SNORD12C small nucleolar RNA, C/D box 
12C 
2.31 0.09 9.35 
7960702 CDCA3 cell division cycle associated 3 2.31 0.09 8.94 
8117583 HIST1H2AI histone cluster 1, H2ai 2.30 0.09 7.52 
7905481 NA NA 2.30 0.08 4.62 
8043187 MAT2A methionine adenosyltransferase 
II, alpha 
2.28 0.09 11.89 
8159963 NA NA 2.28 0.09 4.55 
8018803 SRSF2 serine/arginine-rich splicing 
factor 2 
2.27 0.08 9.89 
7948906 SNORD27 small nucleolar RNA, C/D box 
27 
2.18 0.09 3.65 
8024900 UHRF1 ubiquitin-like with PHD and 
ring finger domains 1 
2.17 0.08 9.21 
7949364 CDCA5 cell division cycle associated 5 2.16 0.08 7.59 
7958375 NA NA 2.15 0.09 7.62 
8124446 NA NA 2.15 0.08 7.73 
8045816 GPD2 glycerol-3-phosphate 
dehydrogenase 2 
(mitochondrial) 
2.15 0.09 6.83 
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Table 4.3. (conti.) 
8124394 HIST1H2BB histone cluster 1, H2bb 2.14 0.08 7.01 
8117594 HIST1H2BM histone cluster 1, H2bm 2.13 0.09 8.25 
8086880 CDC25A cell division cycle 25 homolog 
A (S. pombe) 
2.11 0.08 8.18 
7898549 MRTO4 mRNA turnover 4 homolog (S. 
cerevisiae) 
2.11 0.08 9.53 
8146357 MCM4 minichromosome maintenance 
complex component 4 
2.10 0.10 8.84 
8033025 DUS3L dihydrouridine synthase 3-like 
(S. cerevisiae) 
2.10 0.09 7.92 
7909610 ATF3 activating transcription factor 3 2.09 0.08 5.99 
8143486 PRSS58 trypsin X3 2.08 0.10 6.37 
7919637 HIST2H2BE histone cluster 2, H2be 2.06 0.09 7.02 
8164696 NA NA 2.06 0.08 7.99 
8072687 MCM5 minichromosome maintenance 
complex component 5 
2.05 0.08 9.72 
8050240 ODC1 ornithine decarboxylase 1 2.03 0.10 11.61 
7912374 SRM spermidine synthase 2.02 0.10 9.68 
8119241  NA 2.01 0.09 3.08 
8077731 FANCD2 Fanconi anemia, 
complementation group D2 
2.01 0.10 7.50 
7916609 JUN jun proto-oncogene 2.01 0.10 9.40 
8018791 NA NA 2.01 0.10 5.95 
8001111 UBE2MP1 ubiquitin-conjugating enzyme 
E2M pseudogene 1 
2.01 0.08 8.84 
Table 4.3. A complete gene list up-regulated by PRRSV Nsp11 
a Transcript cluster ID: Affymetrix’s internal ID for the gene 
b Symbol: short term of each gene 
c Gene assignment: full name of each gene 
d Fdr P-val: the false discovery rate adjusted p-value 
e Gene expression: The largest gene expression across all samples   
Stars (*) indicate the genes examined in the quantitative PCR 
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Table 4.4. 
Transcript 
cluster IDa 
Symbolb Gene assignmentc Fold 
change 
Fdr 
P-vald 
Gene 
Expressione 
8148059 DEPTOR DEP domain containing 6 -5.99 0.08 10.34 
8045539 KYNU kynureninase (L-kynurenine 
hydrolase) 
-5.38 0.09 8.17 
8091385 CP ceruloplasmin (ferroxidase) -5.26 0.08 6.14 
8044225 SULT1C4 sulfotransferase family, 
cytosolic, 1C, member 4 
-4.76 0.08 6.82 
8092169 TNFSF10 tumor necrosis factor (ligand) 
superfamily, member 10 
-4.56 0.09 8.95 
7992861 NA NA -4.07 0.10 4.48 
8101086 NAAA N-acylethanolamine acid 
amidase 
-3.98 0.08 7.40 
8098060 RXFP1 relaxin/insulin-like family 
peptide receptor 1 
-3.78 0.08 7.36 
7957023 LYZ lysozyme -3.64 0.05 7.67 
7915910 PDZK1IP1 PDZK1 interacting protein 1 -3.53 0.08 9.22 
8039280 NLRP7 NLR family, pyrin domain 
containing 7 
-3.35 0.09 7.18 
8094609 FAM114A1 family with sequence similarity 
114, member A1 
-3.19 0.05 8.52 
8148070 COL14A1 collagen, type XIV, alpha 1 -2.99 0.09 7.38 
7953603 C1S complement component 1 -2.93 0.08 6.17 
8138363 SOSTDC1 sclerostin domain containing 1 -2.92 0.08 6.89 
8044450 ZC3H6 zinc finger CCCH-type 
containing 6 
-2.90 0.08 6.93 
8114415 GFRA3 GDNF family receptor alpha 3 -2.85 0.10 7.74 
8081890 PLA1A phospholipase A1 member A -2.82 0.08 8.86 
7951662 CRYAB crystallin, alpha B -2.75 0.08 10.52 
7983928 LIPC lipase, hepatic -2.72 0.08 7.23 
7965156 LIN7A lin-7 homolog A (C. elegans) -2.70 0.08 7.03 
8115041 PDE6A phosphodiesterase 6A, 
cGMP-specific, rod, alpha 
-2.64 0.08 6.54 
7947512 PAMR1 peptidase domain containing 
associated with muscle 
regeneration 1 
-2.60 0.08 6.71 
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Table 4.4. (conti.) 
7982100 NA NA -2.59 0.09 4.08 
8082133 PDIA5 protein disulfide isomerase 
family A, member 5 
-2.54 0.08 8.63 
8151942 HRSP12 heat-responsive protein 12 -2.53 0.08 10.04 
7955317 ACCN2 amiloride-sensitive cation 
channel 2, neuronal 
-2.52 0.09 9.18 
8097991 TDO2 tryptophan 2,3-dioxygenase -2.51 0.09 4.86 
8063458 DOK5 docking protein 5 -2.47 0.08 7.97 
7976307 GOLGA5 golgin A5 -2.46 0.08 7.30 
8106252 HEXB hexosaminidase B (beta 
polypeptide) 
-2.44 0.09 9.36 
7917798 ABCA4 ATP-binding cassette, 
sub-family A (ABC1), member 
4 
-2.43 0.08 7.88 
8099860 RFC1 replication factor C (activator 1) 
1 
-2.41 0.08 9.40 
8152719 ANXA13 annexin A13 -2.41 0.08 5.71 
7974870 SNAPC1 small nuclear RNA activating 
complex, polypeptide 1 
-2.41 0.09 8.13 
8154135 SLC1A1 solute carrier family 1 
(neuronal/epithelial high affinity 
glutamate transporter, system 
Xag), member 1 
-2.40 0.08 7.54 
7982366 SCG5 secretogranin V (7B2 protein) -2.40 0.08 8.12 
7962590 RPAP3 RNA polymerase II associated 
protein 3 
-2.38 0.09 7.48 
8017139 MIR301A microRNA 301a -2.38 0.09 3.59 
7951217 MMP7 matrix metallopeptidase 7 
(matrilysin, uterine) 
-2.36 0.08 9.44 
7906767 FCGR2C Fc fragment of IgG, low affinity 
IIc, receptor for (CD32) 
(gene/pseudogene) 
-2.35 0.08 8.07 
7979085 PYGL phosphorylase, glycogen, liver -2.35 0.08 7.92 
8151532 FABP4 fatty acid binding protein 4 -2.35 0.09 6.93 
7917612 HFM1 HFM1, ATP-dependent DNA 
helicase homolog 
-2.34 0.08 5.39 
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Table 4.4. (conti.) 
8177628 CCDC125 coiled-coil domain containing 
125 
-2.33 0.08 6.08 
7954899 CNTN1 contactin 1 -2.33 0.08 5.60 
8156601 C9orf102 chromosome 9 open reading 
frame 102 
-2.31 0.09 8.49 
7961390 HEBP1 heme binding protein 1 -2.31 0.08 9.32 
8085579 NA NA -2.28 0.08 3.12 
8046536 HOXD10 homeobox D10 -2.28 0.08 7.10 
8007454 RND2 Rho family GTPase 2 -2.27 0.09 8.78 
8031344 KIR3DL1 killer cell immunoglobulin-like 
receptor, three domains, long 
cytoplasmic tail, 1 
-2.27 0.09 6.89 
7952522 PUS3 pseudouridylate synthase 3 -2.26 0.10 7.37 
8150714 PCMTD1 protein-L-isoaspartate 
(D-aspartate) 
O-methyltransferase domain 
containing 1 
-2.25 0.08 7.55 
7965941 GLT8D2 glycosyltransferase 8 domain 
containing 2 
-2.24 0.09 9.23 
8067985 NCAM2 neural cell adhesion molecule 2 -2.24 0.08 6.58 
8070097 DNAJC28 DnaJ (Hsp40) homolog, 
subfamily C, member 28 
-2.23 0.08 5.68 
8038954 ZNF616 zinc finger protein 616 -2.22 0.08 5.46 
8138668 MIR148A microRNA 148a -2.22 0.08 3.99 
8149725 PEBP4 phosphatidylethanolamine-bindi
ng protein 4 
-2.21 0.09 6.54 
7971661 MIR15A microRNA 15a -2.20 0.08 5.76 
8033257 C3 Complement component 3 -2.19 0.08 6.55 
8092541 LIPH lipase, member H -2.19 0.10 6.54 
7952490 FEZ1 fasciculation and elongation 
protein zeta 1 (zygin I) 
-2.18 0.08 7.74 
7941272 MALAT1 metastasis associated lung 
adenocarcinoma transcript 1 
(non-protein coding) 
-2.18 0.08 8.70 
7958262 TCP11L2 t-complex 11 (mouse)-like 2 -2.16 0.10 6.07 
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Table 4.4. (conti.) 
7963986 RAB13 RAB13, member RAS 
oncogene family 
-2.16 0.09 9.83 
7990391 CYP1A1 cytochrome P450, family 1, 
subfamily A, polypeptide 1 
-2.16 0.10 6.46 
8083605 RSRC1 arginine/serine-rich coiled-coil 
1 
-2.16 0.08 8.76 
8101762 SNCA synuclein, alpha (non A4 
component of amyloid 
precursor) 
-2.14 0.09 9.92 
8121861 NCOA7 nuclear receptor coactivator 7 -2.14 0.09 6.15 
7965627 LTA4H leukotriene A4 hydrolase -2.12 0.08 11.03 
7960919 MFAP5 microfibrillar associated protein 
5 
-2.11 0.09 5.95 
8067140 CYP24A1 cytochrome P450, family 24, 
subfamily A, polypeptide 1 
-2.11 0.10 8.95 
8151572 SNX16 sorting nexin 16 -2.09 0.08 7.38 
8178884 HLA-DMA major histocompatibility 
complex, class II, DM alpha 
-2.09 0.08 7.91 
8180086 HLA-DMA major histocompatibility 
complex, class II, DM alpha 
-2.09 0.08 7.91 
8156160 KIF27 kinesin family member 27 -2.08 0.08 6.56 
8007323 CNTNAP1 contactin associated protein 1 -2.08 0.10 6.45 
7943605 ACAT1 acetyl-CoA acetyltransferase 1 -2.07 0.08 8.72 
8152703 FBXO32 F-box protein 32 -2.07 0.08 7.39 
8166784 TSPAN7 tetraspanin 7 -2.07 0.09 8.11 
8080964 GXYLT2 glucoside xylosyltransferase 2 -2.06 0.08 8.74 
8021946 COLEC12 collectin sub-family member 12 -2.06 0.08 7.89 
8125537 HLA-DMA major histocompatibility 
complex, class II, DM alpha 
-2.06 0.08 7.79 
7953943 GABARAPL1 GABA(A) receptor-associated 
protein like 1 
-2.06 0.08 8.47 
8060395 RAD21L1 RAD21-like 1 -2.06 0.10 6.14 
8056829 CIR1 corepressor interacting with 
RBPJ, 1 
-2.05 0.10 5.95 
8090803 RAB6B RAB6B, member RAS 
oncogene family 
-2.05 0.08 8.45 
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7963970 PMEL silver homolog  -2.05  0.08  9.28  
8091954 GOLIM4 golgi integral membrane protein 
4  
-2.05  0.08  9.61  
8157233 HSDL2 hydroxysteroid dehydrogenase 
like 2  
-2.04  0.10  7.87  
8166184 CA5B carbonic anhydrase VB, 
mitochondrial 
-2.04  0.09  6.45  
7904158 OLFML3 olfactomedin-like 3  -2.03  0.08  9.87  
7901565 DIO1 deiodinase, iodothyronine, type 
I  
-2.02  0.09  7.12  
8138776 HIBADH 3-hydroxyisobutyrate 
dehydrogenase  
-2.02  0.08  9.30  
8152522 ENPP2 ectonucleotide 
pyrophosphatase/phosphodiester
ase 2 
-2.01  0.08  4.57  
8102468 PRSS12 protease, serine, 12 
(neurotrypsin, motopsin)  
-2.01  0.08  7.15  
7966851 TAOK3 TAO kinase 3  -2.01  0.09  6.94  
8009277 RGS9 regulator of G-protein signaling 
9  
-2.01  0.09  7.29  
7938687 NUCB2 nucleobindin 2  -2.01  0.09  7.64  
7926661 MSRB2 methionine sulfoxide reductase 
B2  
-2.00  0.08  9.97  
8022473 ESCO1 establishment of cohesion 1 
homolog 1 (S. cerevisiae)  
-2.00  0.10  7.00  
7927179 TMEM72 transmembrane protein 72 -2.00  0.08  7.54  
Table 4.4. A complete gene list down-regulated by PRRSV Nsp11 
a Transcript cluster ID: Affymetrix’s internal ID for the gene 
b Symbol: short term of each gene 
c Gene assignment: full name of each gene 
d Fdr P-val: the false discovery rate adjusted p-value 
e Gene expression: The largest gene expression across all samples   
Stars (*) indicate the genes examined in the quantitative PCR  
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 Term P-Value Transcript cluster IDa 
U
p-
re
gu
la
te
d 
 
Histone core 5.04E-10 8117583, 8117594, 7905085, 8117543, 7919637, 
8124446, 8124437, 8124394, 7919614, 7919612, 
8124524, 8117426, 8117580, 7919589, 8124440 
Histone-fold 1.57E-09 8117583, 8117594, 7905085, 8117543, 7919637, 
8124446, 8124437, 8124394, 7919614, 7919612, 
8124524, 8117426, 8117580, 7919589, 8124440 
Histone H2B 7.40E-06 8124394, 8117594, 8117426, 7919637 
Fos transforming protein 1.26E-04 7975779, 7909610, 8029693 
Basic-leucine zipper (bZIP) 
transcription factor 
2.02E-04 7975779, 7909610, 7916609, 8029693 
Histone H2A 7.59E-04 8124437, 8124446, 8117583, 7919614, 7919612, 
8124524, 7905085, 8117580, 8117543, 7919589, 
8124440 
Rhodanese-like 0.0012 8115831, 8086880, 7965335 
bZIP transcription factor,  
bZIP-1 
0.0020 7975779, 7916609, 8029693 
Dual specificity protein 
phosphatase (MAP kinase 
phosphatase) 
0.015 8115831, 7965335 
DNA-dependent ATPase MCM, 
conserved site 
0.017 8146357, 8072687 
DNA-dependent ATPase MCM 0.019 8146357, 8072687 
MAP kinase phosphatase 0.021 8115831, 7965335 
Basic leucine zipper 0.031 7909610, 8029693 
D
ow
n-
re
gu
la
te
d 
Lipoprotein lipase, LIPH 0.001 8092541, 8081890, 7983928 
Lipase 0.001 8092541, 8081890, 7983928 
Lipase, N-terminal 0.001 8092541, 8081890, 7983928 
Glycosyl transferase, family 8 0.039 8080964, 7965941 
Table 4.5. Functional groups of genes regulated by PRRSV Nsp11 
a Transcript cluster ID: Affymetrix’s internal ID for individual genes 
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